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Abstract
ABSTRACT
The two main groups of biotoxins which affect the Irish shellfish industry are azaspiracids
(AZAs) and the okadaic acid (OA) group (OA, DTX2, DTX1 and their esters) toxins. Since
AZAs were first identified in 1998, well over 30 analogues have been reported. Structural and
toxicological data have been described for AZA1–5 (isolated from shellfish). LC-MS/MS is the
EU reference method for detection of the AZAs (AZA1, -2 and -3) and the OA group toxins in
raw shellfish with the regulatory limit set at 160 µg/kg for each toxin group. Limited supplies of
purified toxins for certified reference materials (CRMs) were available for AZA1−3. Little
knowledge was also available on the relevance of the additional AZA analogues that had been
reported, in terms of human health protection.
The analysis of marine biotoxins by LC-MS/MS can be severely affected by matrix
interferences. Here, a study was performed on two instruments; a quadrapole time of flight
(QToF) and a triple stage quadrupole (TSQ) to assess matrix interferences for AZA1 and OA
using a number of tissue types. Enhancement was observed for OA on the QToF while matrix
suppression was observed for AZA1 on TSQ. The enhancement on the QToF was overcome by
use of an on-line SPE method and matrix matched calibrants, while the suppression on the TSQ
was found to be due to late eluting compounds from previous injections and was overcome by
employing either a column flush method or an alkaline mobile phase.
The isolation of 11 AZA analogues (AZA1−10 and 37-epi-AZA1) from shellfish using an
improved procedure (7 steps) is described. Recoveries increased ~2-fold (~ 52%) from
previously described isolation procedures.
The preparative isolation procedure developed for shellfish was optimised for Azadinium
spinosum bulk culture extracts such that only four steps were necessary to obtain purified AZA1
and -2. A purification efficiency of ~70% was achieved, and isolation from 1,200 L of culture
yielded 9.3 mg of AZA1 and 2.2 mg of AZA2 (purities >95%). This work demonstrated the
1
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feasibility of sustainably producing AZA1 and -2 from A. spinosum cultures. In addition to
AZA1 and -2, the novel analogues AZA33, -34 were isolated (also from A. spinosum).
Sufficient quantities were purified to enable full structural elucidation, the preparation of
reference standards and CRMs, and toxicity studies. Nine of these analogues were fully
characterised for the first time (Table 7.1). Structural determination was achieved by NMR and
chemical analysis, while toxicity was assessed using the Jurkat T lymphocyte cell assay, mouse
intraperitoneal (AZA1−3 and -6) and mouse oral (AZA1−3) administration.
The preparation of reference standards for the analogues AZA4−10, 37-epi-AZA1, AZA33 and 34 enabled their relevance in terms of human health protection to be determined. The in vitro and
in vivo toxicity studies performed confirmed AZA toxicity. Using the Jurkat T lymphocyte assay
the order of potency is: AZA2 > AZA6 > AZA34  37-epi-AZA1 > AZA8  AZA3 > AZA1 >
AZA4  AZA9 > AZA5  AZA10 > AZA33.
The results from the oral and intraperitoneal mice studies correlated very well, contradicting
previous reports and showing that AZA1 is more toxic than AZA2 and -3 and that AZA6 is
slightly less toxic than AZA1 i.e., AZA1 > AZA6 > AZA2 > AZA3.
Analysis of shellfish (Mytilus edulis) submitted to the Irish biotoxin monitoring programme
using the reference standards confirmed previous reports showing that levels of AZA3, -4, -6 and
-9 increase following cooking due to heat induced decarboxylation of AZA17, -21, -19 and -23.
Very high levels of AZA3 (up to 3-fold that of AZA1) and -6 (up to 3- fold that of AZA2) were
detected in some samples (with levels varying most likely due to different rates of metabolism
and time of harvesting). As the concentrations of AZA3 and -6 are negligible in raw mussels, yet
can increase significantly during the cooking of mussels, the overall concentrations are
underestimated by methods used according to current legislation.
In cooked shellfish the AZA analogues -4, -5, -7–10, as well as AZA33 and -34, comprise on
average ~5% of the total AZA content, however in some samples levels of AZA4 were higher
2

Abstract
than AZA6. Levels of the 37-epimers in the cooked shellfish extracts were ~ 15% that of the
parent analogues.
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1.1.

The Irish shellfish industry

Since the 1970s the Irish shellfish industry has expanded rapidly. The value was estimated to be
worth over €60 million in 20121 and there is significant potential for further growth. The main
products are mussels, oysters, scallops and clams. Currently there are ~ 90 shellfish harvesting
sites around the coasts of Ireland. 76% of all aquaculture production is conducted along the
Western seaboard and is an important contributor to job creation and the economy for these
coastal communities.
Mussels account for the biggest production – 6,000 tonnes of bottom and 9,000 tonnes of rope
mussels were produced in 2012. Total employment in the mussel industry was 444 in the same
year with exports valued at over €20 million. Over 50% of the mussels produced in Ireland are
certified organic.
Oysters are the second largest shellfish product produced in Ireland with ~ 7,600 tonnes
produced in 2012 and employing 933 people. Oyster exports in 2012 were valued at over €35
million. France was the biggest export market accounting for 86% of oyster exports.
Other varieties produced are scallops, clams, razor fish, cockles and limpets.
One of the limiting factors for the industry is the occurrence of biotoxin producing algae on
which the shellfish feed. These algae can accumulate in shellfish to toxic levels (for human
health) over a very short time period.
The adverse impacts of harmful algal blooms (HABs) on farmed shellfish in Europe was
estimated to cost €53.78 million per annum from 2001 to 2009. In Ireland, the figure was
estimated at €1.64 million over the same period.2
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1.2.

EU regulated marine biotoxins

1.2.1. Hydrophilic toxins
1.2.1.1.

Domoic acid

Figure 1.1. Structure of domoic acid.

The first reported case of an amnesic shellfish poisoning (ASP) event was in 1987 in Canada
following the consumption of mussels. The symptoms included nausea, vomiting, abdominal
cramps and diarrhoea which appeared within the first 24 h following consumption. Neurological
systems then kicked in within 48–72 h and included confusion, disorientation, loss of short term
memory, seizures and coma. A number of people were hospitalised and four people died as a
result of this poisoning event. Domoic acid (a tricarboxylic acid) was soon discovered as the
toxin responsible3 and has since been found worldwide, although no other poisoning incident
associated with this toxin group has since been reported.
The toxin is produced by the genus Pseudo-nitzchia,4 a marine diatom and is typically associated
with mussels and scallops in Ireland.5 Domoic acid induces toxicity by activating the kainite
class of glutamate neurotransmitter receptors.6 The EU regulatory limit is set at 20 µg/g for
domoic acid and epi-domoic acid.
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1.2.1.2.

Paralytic shellfish poisoning toxins

Figure 1.2. Structure of saxitoxin.

The paralytic shellfish poisoning (PSP) toxins are the most serious shellfish toxins in terms of
effects on human health with very low levels capable of inducing human fatalities. These toxins
are produced by the dinoflagellates Alexandrium spp7 and Gymnodinium spp8 and are distributed
globally. More than 20 analogues have been reported to occur naturally, with saxitoxin (STX)
being the parent analogue.
The basic structure consists of a tetrahydropurine skeleton with two guanidinium groups (Figure
1.2). They exert their toxic effects by blocking the sodium ion channel and symptoms include
tingling sensations, numbness of the extremities, headache, dizziness, nausea, vomiting,
diarrhoea and in severe cases, death by asphyxiation.9 The EU regulatory limit for PSP toxins is
800 µg/kg STX equivalents.
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1.2.2. Lipophilic toxins
1.2.2.1.

Azaspiracids

Toxin

R1

R2

R3

AZA1

H

H

CH3

AZA2

H

CH3

CH3

AZA3

H

H

H

Figure 1.3. Structure of azaspiracid1−3.

AZAs were first discovered in 1998 following a poisoning outbreak in 1995 in the Netherlands
associated with Irish shellfish.10 Symptoms included nausea, vomiting, abdominal cramps and
diarrhoea which appeared within the first 24 h following consumption.11 AZA1 was initially
isolated and characterised10 followed by the analogues AZA2 and -312 in 1999 and AZA4 and -5
in 2001.13 The AZAs were found to have highly oxygenated polyether structures with a spiro
ring, a cyclic amine and a carboxylic acid moiety. More than 20 additional analogues were
subsequently observed in shellfish by LC-MS/MS.14 It was not until 2009 that the producer of
these toxins was identified – a small (5 µm in width) thecate dinoflagellate, subsequently named
Azadinium spinosum.15 A. spinosum was found to produce only AZA1 and -2 in culture16 and it
is believed that many of the other analogues are produced in the shellfish via metabolism.14,17
AZAs have been detected globally and there have been a number of poisoning events associated
with this toxin group since the first report in 1995, all of which were sourced back to Irish
shellfish.18 The EU regulatory limit is set at 160 µg/kg for AZA1, -2 and -3.
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1.2.2.2.

Okadaic acid group

Toxin

R1

R2

R3

OA

CH3

H

H

DTX1

CH3

CH3

H

DTX2

H

H

CH3

Figure 1.4. Structure of OA group.

OA group toxins result in a syndrome known as diarrhetic shellfish poisoning (DSP), the
symptoms of which mimic those of AZAs; nausea, vomiting, abdominal cramps and diarrhoea
which appear within the first 24 h following consumption. The first poisoning incident
associated with this toxin group occurred in Japan in 1976 following the consumption of
mussels.19 The OA group consists of OA, dinophysis toxin 1 (DTX1), dinophysis toxin 2
(DTX2) and their esters. Structurally they consist of long chain compounds containing transfused or spiro-linked cyclic polyether rings (Figure 1.4). The induced toxicity is due to inhibition
of protein phosphatases PP1 and PP2A. This toxin group has been detected globally5,20–22 and is
produced

by the marine dinoflagellate species of the

genus

Dinophysis20,23

and

Prorocentrum.24.25 The EU regulatory limit is set at 160 µg/kg for OA, DTX1, DTX2 and their
esters.
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1.2.2.3.

Pectenotoxins

Toxin

R1

PTX1

CH2OH

PTX2

CH3

Figure 1.5. Structure of PTX1 and PTX2 group.

Pectenotoxins (PTXs) are produced by some of the algae (Dinophysis26–30) that also produce the
OA group toxins and these toxins regularly co-occur in shellfish. PTX1 and PTX2 were
originally isolated from shellfish in 198431 and are included with the OA group toxins for
regulation i.e., the limit is 160 µg/kg for the OA group and PTX1 and PTX2. They have also
been found in Protoperidinium.32 They are cyclic polyether lactone compounds. PTX2 is the
most common analogue which is metabolised in shellfish to produce other derivatives, such as
PTX1, PTX3 PTX623 and PTX2 seco acid.32
These toxins have not been shown to be toxic when administered orally.30,32 In addition no
human poisoning events have been associated with this toxin group hence these compounds are
not considered of major concern to human health.

9

Chapter 1 - Introduction
1.2.2.4.

Yessotoxins

Figure 1.6. Structure of yessotoxin.

Yessotoxins (YTXs) were first discovered in 1986 in scallops from Japan.33 They are produced
by Proroceratium reticulatum,34 Lingulodinium polyedrum35 and Gonyaulax spinifera.36 A wide
range of compounds belonging to the YTX group have been identified. The basic structure
consists of a disulphated polyether with an unsaturated side chain. YTX was initially classified
as a DSP toxin33 however it has since been found not to induce toxic effects in oral mouse
studies37,38 and is therefore not deemed to be of significance to human health. Furthermore,
studies investigating the combined effects of AZAs and YTXs found that YTX does not have
any synergistic effects when administered orally with AZA1.39 Recently EU legislation was
amended increasing the limit to 3.75 mg/kg.40

1.3.

Toxic episodes in Ireland

AZAs have been detected in shellfish since the monitoring programme was established in 2001.
Since that time there was only one year (2004) in which there were no closures due to AZAs
being over the regulatory limit (160 µg/kg), Figure 1.7. Typically onset of toxicity occurs mid to
late summer. Those sites that are affected can remain closed for long periods due to the slow
10
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depuration rates of AZAs from shellfish. The highest recorded levels in shellfish were in 2005
where concentrations reached 9 µg/g (60 times over the regulatory limit) at a site in Donegal.
Mussels are the worst affected shellfish. 2012 was the most extensive and protracted toxicity
period with sites all along the West coast being closed, some of which were closed for almost
one year. This trend was repeated in 2013 and is causing severe economic hardship for shellfish
farmers. Interestingly, the AZAs appear to be only problematic in Ireland and all of the
poisoning incidents associated with these toxins can be sourced back to shellfish harvested in
Ireland. Norway and the UK are the only other countries to date that have reported AZAs being
just over the regulatory limit in shellfish.
The second most important toxin group which affects the shellfish industry in Ireland is the OA
group toxins. Since 2002 these toxins have been detected in shellfish every year resulting from
blooms of Dinophysis acuta or Dinophysis acuminata (which produce OA and DTX2). The
Southwest of the country is particularly prone to accumulation of both OA group and AZA
toxins in shellfish, Figure 1.7. Typically OA group toxicity occurs early to mid-summer and
regularly there is co-occurrence with the AZAs. Again mussels are the worst affected shellfish,
however the OA group toxins are quicker to depurate than the AZAs.
Closure of sites has also resulted due to levels of domoic acid being over the regulatory limit
(20 µg/g). Typically only scallops are tested for this toxin group however at certain times of the
year (usually spring time) large blooms of the producing species Pseudo-nitzchias result in high
levels of domoic acid in mussels. Such onsets occur quickly but also the concentration levels in
the shellfish reduce very quickly.
Fortunately the PSP toxins are not problematic for the Irish shellfish industry, to date, with
closures only ever occurring in Cork Harbour due to these toxins being over the regulatory limit
(>800 µg/kg STX equivalents). The PSPs have been detected in shellfish from other parts of the
country, however, levels have been extremely low.
11
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PTXs were detected for the first time in Irish shellfish in 2014, while YTXs have not been
detected to date.5

2002

2006

2010

2004

2003

2007

2011

2005

2008

2009

2012

2013

AZAs in shellfish over the regulatory limit (160 µg/kg)
OA group toxins in shellfish over the regulatory limit (160 µg/kg)

Figure 1.7. Closure of Irish shellfish harvesting sites due to AZAs and OA group toxins from
2002–2013.
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1.4.

Methods of analysis

The marine biotoxin monitoring programme was set up in Ireland in 2001. At that time the EU
regulatory method for the monitoring of the lipophilic toxins and PSPs in shellfish was by the
Mouse BioAssay (MBA).41 Along with the MBA, phytoplankton monitoring and analysis of
shellfish extracts (for the lipophilic toxins) by LC-MS/MS was performed in parallel. Domoic
acid was monitored by a HPLC-UV method.
The LC-MS/MS method was limited by the lack of CRMs for all the regulated toxins with
standard calibrants only available for OA (certified) and AZA1 (non-certified). In 2003 the
Marine Institute received National Development Plan (NDP) funding for a three year project on
AZAs named ASTOX.42 One of the main aims of the project was to purify sufficient amounts of
AZA1–3 to produce CRMs to aid in the monitoring of these toxins. Through collaborations with
other international research teams the project aims were achieved; successful isolations of
AZA1–3 from shellfish, enabling the production of CRMs.43 A number of tissue CRMs were
also prepared for the first time over the course of the project.44,45 In addition to preparing CRMs
for the AZAs the project was also successful in producing a CRM for DTX2.42 CRMs are
essential to ensure accurate results are being produced by monitoring laboratories. The
availability of these CRMs enabled more accurate analysis to be performed by LC-MS/MS and
facilitated the introduction of new legislation replacing the MBA and implementing LC-MS/MS
as the regulatory method.46 In parallel the PSP MBA was replaced by a HPLC-FLD method.
Currently at the Marine Institute, Irish National Accreditation Board (INAB) accredited methods
are employed for the analysis of all the EU regulated toxins. Proficiency testing schemes are also
used to ensure the validity of results being produced – the Marine Institute subscribes to
QUASIMEME (Quality Assurance of Information for Marine Environmental Monitoring in
Europe) twice yearly for all the toxin groups and a Community Reference Laboratory (CRL)
intercomparison, which is run annually.
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In parallel with the chemistry methods, the phytoplankton monitoring programme provides a
complementary service in providing valuable information on the presence of toxin producing
algae in the water.

1.4.1. LC-MS/MS
LC-MS/MS with electrospray ionisation (ESI) is the technique of choice for the analysis of many
of the regulated marine biotoxins offering specificity, selectivity and high sensitivity, particularly
with the newer instruments. The most common instruments used for quantitative, high
throughput analysis are the tandem mass spectrometers (QqQ), also known as a TSQ, consisting
of two quadrupole mass spectrometers in series, with a (non mass-resolving) radio frequency
(RF)-only quadrupole between them to act as a cell for collision-induced dissociation. Precursor
ions selected in the first quadrupole (Q1) are dissociated in the collision cell (Q2) in the presence
of an inert gas such as Ar, He, or N2, with the generated fragment ions from the precursor ion
being scanned in the second quadrupole (Q3).

Figure 1.8. Schematic of a Micromass tandem mass spectrometer. Courtesy of Micromass-Waters

Such instruments can be operated in selected reaction monitoring mode (SRM) whereby the
precursor and fragment ions are selected or selected ion monitoring (SIM) mode where only the
14
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precursor ion is selected (no fragmentation). Due to the targeted nature of SRM, tandem mass
spectrometers have mostly contributed to confirmation of known analytes, and not to the
discovery of novel compounds. Numerous multitoxin MS methods have been developed using
such instruments.47–49 The emergence of fast scanning instruments in parallel with UPLC
systems has enabled rapid sample turnaround time for monitoring laboratories.
High resolution mass spectrometers (HRMS), such as QToF instruments are required for the
detection and characterisation of novel compounds. These instruments have a quadrupole where
the precursor ions are selected, a collision cell followed by a time of flight (TOF) sector. The
TOF has an extended flight path (V or W) through which the ions travel and separate based on
their mass-to-charge ratio, enabling mass spectral data and accurate mass measurements to be
produced. A mass resolution of ~ 10,000 can be obtained with older QToF instruments (Figure
1.9), whereas newer instruments offer resolutions of ≥ 50,000. The discovery of novel AZA
analogues was reported using the QToF shown in Figure 1.9.14
Transfer optics

Quadrapole MS

TOF MS

Extraction
cone

Z spray ion
source

Quadrapole

Collision cell

Reflectron (V
or W mode)

Figure 1.9. Schematic of a Micromass quadrupole time of flight mass spectrometer. Courtesy of
Micromass-Waters
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The increasing complexity of samples and increasing detection of novel compounds has led to
more advanced MS instruments that are robust with high resolving power, mass accuracy,
sensitivity and dynamic range. Non targeted HRMS screening using Orbitrap instruments has
been reported recently for the detection of marine biotoxins.50,51 Such instruments allow for
effective screening of complex samples for

known and unknown compounds, however,

additional analysis by a QToF is required for structural characterisation.

1.4.2. NMR
Many of the marine biotoxins are cyclic polyethers consisting of long carbon chains substituted
with hydrogen atoms. Such structures lend themselves well to 1H and

13

C NMR spectroscopy,

and it is this method, supplemented by mass spectrometry, that has primarily been used for
structure determination.10,12,52,53 Typically the minimum amount of highly purified (>95%)
sample required is 100 µg for purity assessment and structural elucidation. Full stereochemical
elucidation may not always be possible by NMR alone but requires chemical synthesis and/or Xray crystallography. The stereochemistry of OA and AZA were only confirmed following
synthesis of the compounds by Forsyth et al.54 and Nicolaou et al.,55–57 respectively.

1.5.

Toxicology of AZAs

1.5.1. In vivo
Mice exposed to mussel extracts containing AZA via intraperitoneal injection exhibited
“neurotoxin-like” symptoms characterized by sluggishness, respiratory difficulties, spasms,
progressive paralysis, and death within 20–90 min.11,58 The intraperitoneal minimum lethal dose
of partially purified AZA1 was originally determined to be 150 µg/kg,11 while from the first
purified AZA1 a lethal dose was identified to be 200 µg/kg.10 The intraperitoneal minimum
lethal doses of AZA2 and -3 were 110 and 140 µg/kg, respectively,12 suggesting higher potency
16
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relative to AZA1. These results have since been used for toxic equivalent factor (TEF)
determination and application for regulatory purposes.59 The more polar AZA4 and -5
(hydroxylated versions of AZA3) were less potent with lethal dose values of 470 and <1,000
µg/kg, respectively.13
Due to the lack of purified AZAs, limited studies on their acute oral toxicity have been
performed. Previous studies focused only on AZA1. These studies found that the gastrointestinal
tract, liver, spleen and thymus were the main organs affected.37,39,60−63
Studies by Aasen et al.61 and Aune et al.64 using female NMRI mice demonstrated that doses of
100–540 g/kg were insufficient to kill any of the tested animals but doses above 600 g/kg
resulted in some mortality. The experimentally determined LD10 and LD50 levels (with 95%
confidence intervals) were 570 (435–735) and 775 (596–1,055) g/kg, respectively.64
In separate experiments, severe injuries were induced by two repeated doses of 250, 300, 350, or
450 µg/kg, two days apart, and recovery was monitored for up to 90 days. Of the 16 mice
receiving 450 µg/kg, 11 died prior to the second dose, suggesting a revised minimum oral lethal
dose of <450 µg/kg. 65
The most common pathological effect of AZA1 following oral exposure is degradation of the
lining surrounding the upper small intestine.60−64 Despite known uptake and systemic distribution
of AZA1 following oral exposure, only limited and less severe histopathological changes were
observed in other internal organs/tissues. Moderate doses of AZA1 (100–300 g/kg) resulted in
the liver being abnormally pale in coloration,64 which may be the result of fatty acid droplet
accumulation.60 Higher doses (500–700 µg/kg) increased liver weight by 38%. There were timeand dose-dependent effects on the number of necrotic lymphocytes in the thymus, spleen, and
the Peyer’s patches of the small intestine, which was supported by quantitation of the number of
non-granulocytes (lymphocytes, monocytes, macrophages) in the spleen. AZA1 treatments of
600 and 700 µg/kg resulted in a 33% decrease in the number of non-granulocytes, which were
17
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primarily T and B lymphocytes.60 There were no reported histological changes associated with
the kidney, heart, lung, and brain.60,61,64

1.5.2. In vitro
Preliminary experiments performed by Flanagan et al.66–68 using HepG2 hepatoblastoma cells
and human bladder carcinoma cells (ECV-304) exposed to contaminated crude mussel extracts
showed AZAs to have a cytotoxic effect. In the ASTOX project,42 cellular and molecular studies
were designed to investigate the mode of action underlying the toxicity of AZAs. Studies
conducted on seven different mammalian cell lines showed that AZAs strongly affect most cell
types. A functional assay was developed in the project for the specific detection of AZAs using
morphological changes of pseudopodia in lymphocyte T cells (Jurkat). It was subsequently found
to be the most sensitive for AZAs of all the assays tested.42 In T lymphocytes, cells initially
responded to AZA1 by a reduction in membrane integrity, organelle protrusion concurrent with
flattening of cells, and a retraction of their pseudopodia or lamellipodia.69 This was followed by
protracted cell lysis. Using this assay the relative toxicities of the regulated AZAs were:
AZA2>AZA1>AZA3,70 which confirmed the original mouse intraperitoneal relative
toxicities.10,12
In leukaemia cells, AZA2 caused DNA synthesis phase arrest.71 In neuroblastoma cells, AZA1
induced cell rounding and detachment from adjacent cells.72 At the subcellular level, disruption
of the Golgi complex and an accumulation of vesicles have been reported. 73 At the cellular level,
AZA1, -2, and two other semi-synthetic analogues of AZA2 all induced gross morphological
changes.74 AZA1 is a potent cytotoxin towards primary cerebellar granular cells (CGCs),75
neocortical cells,76 and spinal cord neurons.77 In CGCs, AZA-induced cytotoxicity was related to
the activation of the c-Jun-N-terminal kinase (JNK),78,79 whereby AZA1 exposure resulted in
decreased neuronal volume that was protected by pre-incubation of the neurons with a JNK
inhibitor (SP 600125), a chloride channel blocker (4,4-diisothiocyanatostilbene-2,2-disulfonic
18
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acid; DIDS), and a Na+-K+-ATPase blocker (amiloride).78,80 The effects of AZA1 and -2 on
cytotoxicity (and other cellular indices) appear to be irreversible.72,74,77,81 Experiments using
human breast cancer cells and mouse fibroblasts exposed to AZA1 have also demonstrated that
the reductions in cellular proliferation and density are not unlike the actions elicited by YTX,
raising the possibility of similar mechanisms of action for these two phycotoxin classes.82

1.6.

Objectives

One of the limiting issues in the analysis of compounds by LC-MS/MS is matrix effects. Matrix
effects were observed for both the AZA and OA group toxins using instrumentation employed at
the Marine Institute. Such interferences can affect the accuracy of results being produced hence
there was a strong need to try and overcome these issues. The initial study (Chapter 2) was
performed to assess the impact of such interferences on two LC-MS/MS instruments and
implement methods to surmount them where present.

Prior to this study only AZA1–5 were isolated, characterised and assessed for toxicity. However,
more than 30 AZAs had been identified14 with little knowledge of what impact these additional
analogues have on human health. Studies (Chapters 3−6) performed as part of this thesis set out
to try and improve on previously reported methods used to isolate AZAs from shellfish in terms
of efficiency and recoveries. With the discovery of the producing organism A. spinosum in
2009,15 further isolation method development was envisaged from bulk culture extracts. Isolation
of as many of the known and novel AZA analogues as possible was intended to enable full
characterisation, the preparation of reference materials and further toxicological studies. Up to
this point the mode of action of AZAs was unknown, hence the availability of sufficient amounts
of purified toxin was essential to allow such studies to proceed. Furthermore with the change in
19
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legislation from use of the MBA to LC-MS/MS for the detection of these toxins, the sustained
supply of CRMs for the regulated toxins was imperative.
Additional questions remained about the effects of cooking on AZAs in shellfish. This was of
concern due to processed shellfish being rejected by importing countries despite being under the
regulatory limit when tested prior to processing. Heat induced decarboxylation of AZA17, -19,
21 and -23 to AZA3, -6, -4 and 9 respectively had already been reported,17 however, the
significance of these transformations had yet to be fully explored and further work in this area is
detailed in Chapter 6.
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CHAPTER 2 – STRATEGIES FOR THE ELIMINATION OF MATRIX
EFFECTS IN THE LC-MS/MS ANALYSIS OF OKADAIC ACID AND
AZASPIRACID-1 IN MOLLUSCAN SHELLFISH
Kilcoyne, J. and Fux, E., 2010. Strategies for the elimination of matrix effects in the liquid
chromatography tandem mass spectrometry analysis of the lipophilic toxins okadaic acid and
azaspiracid-1 in molluscan shellfish. Journal of Chromatography A, 1217, 7123–7130.

2.1.

Abstract

Considerable efforts are being made worldwide to replace in vivo assays with instrumental
methods of analysis for the monitoring of marine biotoxins in shellfish. Analysis of these
compounds by the preferred technique of liquid chromatography tandem mass spectrometry
(LC-MS/MS) is challenged by matrix effects associated with the shellfish tissues. In methods
validation, assessment of matrix interferences is imperative to ensure the validity and
accuracy of results being produced.
Matrix interferences for the analysis of okadaic acid (OA) and azaspiracid 1 (AZA1) were
assessed using acidic methods on electrospray triple stage quadrupole (TSQ) and hybrid
quadrupole time of flight (QToF) instruments by the use of matrix matched standards for
different tissue types. Using an acidic method no matrix interference and suppression was
observed on the TSQ for OA and AZA1 respectively, whilst the opposite was observed on the
QToF; matrix enhancement for OA and no matrix interference for AZA1. The suppression of
AZAs on the TSQ was found to be due to interfering compounds being carried over from
previous injections. The degree of suppression is very much dependent on the tissue type
ranging from 15–70%. Several strategies were evaluated to eliminate these interferences,
including the partitioning of the extract with hexane, optimisation of the chromatographic
method and the use of on-line SPE.
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Hexane clean up did not have any impact on matrix effects. The use of an alkaline method
and a modified acidic method eliminated matrix suppression for AZA1 on the TSQ
instrument while an on-line SPE method proved to be effective for the elimination of matrix
enhancement of OA on the QToF.

2.2.

Introduction

Diarrhetic shellfish poisoning (DSP) is a human illness caused by the consumption of
shellfish contaminated with the lipophilic marine biotoxins okadaic acid (OA) and
dinophysistoxins (DTX). DSP toxins are produced by marine dinoflagellate species of the
genus Dinophysis and Prorocentrum, and are accumulated in filter-feeding molluscan
shellfish. The DSP syndrome was first reported in Japan in 1978, and the occurrence of DSP
toxins is now a worldwide issue with frequent Dinophysis outbreaks documented in Europe,
Asia, South and North America over the past 20 years.1–4 DSP symptoms include nausea,
vomiting, gastrointestinal disturbances, and stomach pain.5
In 1995, the presence in shellfish of another lipophilic marine toxin, azaspiracid (AZA), was
responsible for diarrhetic illnesses in several individuals who consumed shellfish harvested in
Ireland.6 The AZA group now includes more than 24 analogues that are either produced by
phytoplankton, products of biotransformation in shellfish or by-products of toxin storage.7
However, only AZA1, -2 and -3 are regulated by the European Union.8 AZAs have been
found in shellfish from several European countries, Morocco, Eastern Canada, Japan and
more recently in shellfish from Chile.9–13 The symptoms of azaspiracid shellfish poisoning
(AZP) are similar to that of DSP, and include nausea, vomiting, diarrheoa, and stomach
cramps.
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The EU has set maximum levels of AZP and DSP toxins in shellfish destined for human
consumption. These are 160 µg OA equivalents/kg from the OA group (sum of OA, DTX)
and including pectenotoxin (PTX) and 160 µg AZA equivalents/kg from the AZA group
(sum of AZA1, -2 and -3).14 Until recently the mouse (or rat) bioassay (MBA) was the EU
reference method for the detection of OA group and AZA toxins in shellfish. A study has
shown that the detection limit of the MBA is adequate for the current regulatory limit of
AZAs,15 however, sensitivity is an issue at the lower levels.16,17 Furthermore, additional
concerns relating to accuracy and ethics prompted substantial efforts to replace it with
instrumental methods.
The MBA was replaced by LC-MS/MS as the reference method for the detection of marine
biotoxins in shellfish in 2014.18 LC-MS/MS is considered the technique of choice as it offers
improved sensitivity, selectivity and accuracy as well as being faster and automated.
However, quantitation using LC-MS/MS in biological matrices is often challenging because
of matrix effects which alter the accuracy and the precision of the method. Matrix effects are
believed to be caused by endogenous compounds co-eluting with the analyte and competing
for ionisation in the electrospray (ESI) source.19,20
A number of different approaches have been taken to eliminate or to correct for matrix effects
in LC-MS/MS analyses including sample clean up, standard addition, matrix matched
standards, internal standards or changes in chromatographic conditions such as the pH of the
mobile phase or the nature of stationary phase.
Sample clean-up can be performed using liquid-liquid extraction (LLE) or solid phase
extraction (SPE) which is available with a variety of stationary phases (normal and reverse
phase, ion exchange and immunoaffinity material with antibodies specific to the analyte).
SPE also has the benefit of pre-concentrating samples which can be useful when dealing with
low levels of toxins. Two recent reports have shown this technique to be effective in raising
33

Chapter 2 - Matrix effects in LC-MS/MS
sensitivity as well as eliminating sample impurities,21,22 however, its effectiveness in
overcoming matrix effects was not clearly demonstrated in these studies. Dilution of extracts
has also been reported to reduce matrix interferences,15,23 yet such an approach compromises
the sensitivity of the method.
In addition to sample clean up, various approaches have been used to correct for matrix
effects. Quantitation using matrix matched standards entails the production of a calibration
curve in solutions with the exact same composition as the samples by extracting blank
material or by reconstructing the matrix artificially and spiking the analyte at different
concentrations. Although this approach is perfectly acceptable when the sample matrix is
identical in all samples being analysed its application for the monitoring of marine toxins in
shellfish is limited. Indeed, the production of matrix matched standards in all shellfish
varieties (up to 10 different varieties) that are typically encountered in monitoring
laboratories is impractical. Furthermore, the production of a calibration curve in extracts of a
given variety, does not imply that the matrix composition of another extract of the same
variety but from a different location and/or harvested at a different time of the year will be
identical since environmental factors and food source will influence the composition of the
shellfish tissues e.g., lipid content.
The standard addition method eliminates the need for the availability of a blank matrix and
only requires the analyte to be available as a calibration solution of sufficient concentration.
This method has been used to deal with matrix suppression in the analysis of scallops for
diarrhetic shellfish toxins.24 Although the method is very powerful and widely accepted, its
use in monitoring laboratories remains limited for a number of reasons, primarily due to
increased sample preparation and analysis time.
The use of internal standards is a very efficient approach to ensure that satisfactory accuracy
is obtained through the different steps of the analytical method. Unfortunately, the total or
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partial synthesis of the isotopically labelled compound is required and currently no such
compounds are available for the DSP and AZA toxins to our knowledge.
Elimination or reduction of matrix effects to an acceptable level can also be achieved through
modifications of the chromatographic conditions to change the selectivity towards the
interfering compounds and/or the analyte.
We examined matrix effects associated with shellfish tissues on two LC-MS/MS instruments;
a QToF and a TSQ, using ESI sources and identical LC conditions. Matrix interferences were
assessed using matrix matched standards for six different tissue types; M. edulis, C. gigas, O.
edulis, E. siliqua, P. maximus meat, P. maximus gonad and where interferences are observed
we describe efforts made to overcome them. The performances of the methods employed
were also evaluated in terms of sensitivity, accuracy and precision.

2.3.

Experimental section

CH3CN, MeOH and hexane were purchased as pestican grade solvents from Labscan
(Dublin, Ireland). Formic acid, ammonium formate and ammonium hydroxide were obtained
from Sigma Aldrich (Steinheim, Germany). H2O was obtained from a reverse-osmosis
purification system (Barnstead, Dublin, Ireland). OA and AZA1 certified reference materials
(CRM) were obtained from the NRC (Halifax, Canada).

2.3.1. LC-MS/MS
Two LC-MS/MS systems were used; a Micromass triple stage quadrupole (TSQ) Ultima
coupled to a Waters 2695 HPLC and a Micromass time-of-flight (QToF) Ultima coupled to a
Waters 2795 HPLC. Both systems were equipped with a z spray ESI source. The TSQ was
operated in selected reaction monitoring (SRM) mode and the following transitions were
monitored: OA, m/z 803.5>255.5 and 803.5>803.5 in negative ionisation mode; AZA1 m/z
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842.5>654.4 and 842.5>672.4, AZA2 856.5>654.4 and 856.5>672.4, AZA3 828.5>640.4 and
828.5>658.4 in positive ionisation mode. The cone voltages were set at 70 V and 60 V in
negative and positive modes respectively and the collision voltage was set at 40 V in both
modes. Cone and desolvation gas flows were set at 100 and 800 L/h respectively while the
source and desolvation temperatures were set at 150 °C and 350 °C respectively.
The QToF was operated in fragment ion scan (FIS) mode monitoring for the same precursor
ions as those reported for the TSQ. The cone voltages were set at 80 V and 40 V in negative
and positive modes, respectively. The collision energy was set at 30 V in negative mode and
50 V in positive mode. Cone and desolvation gas flows were set at 100 and 750 L/h
respectively while the source and desolvation temperatures were set at 140 °C and 350 °C
respectively. Quantitation was performed by summing the ions of m/z 824.5, 672.5, 654.5 and
362.5 for AZA1 (and the equivalent fragment ions for AZA2 and -3) and the ions of m/z
803.5 and 255.1 for OA.

2.3.2. Acidic gradient method
A gradient elution method was set with an acidic binary mobile phase, with phase A (100%
aqueous) and phase B (95% aqueous CH3CN), each containing 2 mM ammonium formate
and 50 mM formic acid following the method of Quilliam et al., 2001.25 The gradient elution
started with 30% B, increased to 90% B over 8 min, held for 2.5 min, decreased to 30% B in
0.5 min and held for 4 min to equilibrate the system before the next injection. The
chromatographic separation was achieved using a Hypersil BDS C8 column; 50 x 2.1 mm,
3 µm with a guard column of the same stationary phase 10 x 2.1 mm, 3 µm (Thermo
Scientific, Runcorn, UK). The flow rate was set at 0.25 mL/min and the injection volume at
5 µL. The column and sample temperatures were set at 25 °C and 6 °C, respectively.
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We assessed matrix effects for several shellfish tissues over a number of months. The spike
samples and M. edulis matrix matched standards were run in triplicate against MeOH
standards (seven levels) using in-house validated and accredited methods of analysis for the
monitoring of lipophilic toxins.
A matrix-matched standard curve was prepared with M. edulis in order to compare response
factors over the range of concentrations representative of naturally contaminated shellfish.
The accuracy was calculated as a percentage of difference between the slopes obtained in
MeOH and in the M. edulis extracts. The accuracies reported for all other shellfish varieties
were calculated from spiked samples at a single concentration. Within each batch all samples
were analysed by triplicate injection.

2.3.3. Acidic gradient method with a 100% B flush
A modified gradient method with acidic mobile phase was also evaluated. The gradient
started with 30% B at 0.25 mL/min, increased to 90% B over 8 min, held for 5 min, increased
to 100% B at 0.4 mL/min, held for 5 min and set back to 30% B at 0.25 mL/min which was
held for 4 min to equilibrate the system.

2.3.4. Alkaline method
The alkaline method followed that of Gerssen et al., 2009;26 a binary mobile phase was used,
with phase A (100% aqueous) and phase B (90% aqueous CH3CN), each containing 6.7 mM
ammonium hydroxide. Separation was achieved using a Waters X bridge, C18 column (150 x
3 mm, 5 µm). The flow rate was set at 0.25 mL/min and the injection volume was set at 5 µL.
The column and sample temperatures were set at 25 °C and 6 °C respectively. A gradient
elution was employed, starting with 10% B which was held for 1 min and increased linearly
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to 90% over 9 min. The mobile phase was held at 90% B for 3 min and returned to 10% B in
2 min. The system was then allowed to equilibrate for 4 min.

2.3.5. On-line SPE method
For the on-line SPE method a binary mobile phase was used, with phase A (100% aqueous)
and phase B (95% aqueous CH3CN), each containing 2 mM ammonium formate and 50 mM
formic acid. The loading column was an Oasis HLB, 5 µm, 2.1 x 20 mm column and HPLC
separation was achieved using a Hypersil BDS C8 column; 50 x 2.1, 3 µm; guard column, 10
x 2.1 mm, 3 µm (Thermo Scientific, Runcorn, UK). The flow rate was set at 0.2 mL/min and
the injection volume was 10 µL. The column and sample temperatures were set at 25 °C and
6 °C respectively. The sample was initially injected onto the loading column with 20% B for
2 min after which time the switch valve directed the flow onto the analytical column and the
flow was reduced to 0.02 mL/min. After 3 seconds the flow was increased to 0.075 mL/min
and the % B was increased from 20% to 30% over 27 seconds. The % B was then increased
further to 100% over 10 min, held for 18 min, then decreased to 30% B over 0.5 min and held
for 9 min. The system was then equilibrated for 3 min at 20% B and a flow rate of
0.2 mL/min. The switching valve was set to direct the flow to waste after 23 min.

2.3.6. Partitioning of shellfish extract with hexane
A laboratory reference material (LRM) prepared with M. edulis tissue and contaminated with
both OA group and AZA toxins was extracted using the extraction described below
(preparation of matrix matched standards). A set volume (5 mL) of the filtered extract was
partitioned with 15 mL of hexane. The sample was shaken vigorously for 1 min and the
layers were allowed to settle. The LRM extract (bottom layer) was then collected in a
centrifuge tube and an aliquot transferred into a HPLC vial for analysis.
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A set volume (1 mL) of the hexane layer was then pipetted into HPLC vials and dried down
under nitrogen. Dried residues were re-solubilised with 200 µL of MeOH with vortex mixing
for 30 s. The sample was transferred into an insert vial for analysis. Three MeOH standards
were run directly after three injections of the non-partitioned LRM extract in addition to the
partitioned LRM extract, followed by a four point calibration curve (all performed in
triplicate).

2.3.7. Preparation of matrix matched standards
For each tissue type, uncontaminated raw samples tested as part of the routine monitoring
programme in Ireland were selected from different harvesting dates and sites (around the
coasts of Ireland). The extraction procedure described in this study has been used for several
years in the shellfish toxins monitoring program in Ireland.27 The shellfish were shucked,
homogenised and aliquoted for extraction where 2 g of tissue was extracted by vortexing for
1 min with 9 mL of MeOH, centrifuged at 5,000 rpm for 5 min and the supernatant decanted
into a 20 mL volumetric flask. The remaining pellet was further extracted using an Ultra
turrax for 1 min with an additional 9 mL of MeOH, centrifuged at 5,000 rpm for 5 min and
the supernatant decanted into the same 20 mL volumetric flask which was then brought to
volume with MeOH. The standards were prepared in 25 mL volumetric flasks containing
20 mL of filtered (Whatmann, 0.2 µm, cellulose acetate filter) tissue extract. For the M.
edulis matrix matched standards increasing volumes of standard stock solution were added to
the flasks and the volume was brought to the mark with MeOH with toxin concentrations
ranging from 2.5–280 ng/mL for OA and 0.8–92 ng/mL for AZA1.
Spiked tissue samples were prepared for the following tissues: C. gigas, O. edulis, E. siliqua,
P. maximus meat and P. maximus gonad. For the spiked tissue samples 1 mL of stock
standard solution was added to the flasks and the volume brought to the mark with MeOH
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such that the final concentration was 10 ng/mL and 6 ng/mL for OA and AZA1 (equivalent to
125 µg/kg and 75 µg/kg in tissue) respectively.
For all the matrix matched standards a sample to solvent ratio (SSR) of 12.5 was obtained
which reflects the routine monitoring extraction method.

2.3.8. Statistical analysis
Statistical calculations were carried out using Sigmastat 3.0. The significance test used to
compare varieties and methods was the two-way analysis of variance Holm-Sidak test. Alpha
was set at 0.05 (95% confidence) for all experiments.

2.4.

Results and discussion

2.4.1. Assessment of matrix effects using the acidic gradient method
The average concentrations and standard deviations shown in Table 2.1 were calculated from
five batches acquired over several months. The accuracy of AZA1 measurements on the TSQ
in the different varieties of shellfish ranged from 64.2 to 83.1%. Signal suppression was
consistently observed and was significantly different between the shellfish varieties (p =
0.009). When the same method was performed on the QToF the accuracy ranged from 97.1 to
104.6% without significant differences between varieties (p = 0.467).
The accuracy observed for OA using the acidic method also greatly varied between the two
instruments (Table 2.1). Acceptable accuracies were achieved on the TSQ which ranged from
94.3 to 110.9%. The two-way ANOVA test revealed that the accuracy was statistically
different between the shellfish varieties (p<0.001). The pairwise multiple comparison
procedure results demonstrated that the accuracy obtained for OA in O. edulis (110.9%) and
for M. edulis (108.0%) were not significantly different (p = 0.343) but were significantly
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different when compared to the other shellfish varieties (p values ranging from <0.001 to
0.041). The accuracy obtained for OA analysis on the QToF with the acidic method was
affected by signal enhancement and ranged from 114.6 to 130.9% with a significant
difference between the shellfish varieties (p = 0.008).

Table 2.1. Accuracy and precision data (expressed as percentages) obtained on QToF and
TSQ with the acidic method (average ± SD; n = no of injections, p = no of concentration
points).
Acidic

OA

AZA1

Analyte

Shellfish variety
TSQ

QToF

M. edulis (p=7)

82.6 (n=18)

± 7.8

102.7 (n=15)

± 11.3

C. gigas (p=1)

83.1 (n=13)

± 4.5

104.6 (n=21)

± 7.8

O. edulis (p=1)

69.8 (n=13)

± 6.8

101.2 (n=18)

± 3.6

E. siliqua (p=1)

73.5 (n=12)

± 7.3

101.1 (n=21)

± 5.4

P. max meat (p=1)

79.3 (n=13)

± 13.6

103.3 (n=21)

± 5.5

P. max gonad (p=1)

64.2 (n=13)

± 3.6

97.1 (n=21)

± 3.1

M. edulis (p=7)

108.0 (n=18)

± 8.4

130.9 (n=18)

± 7.7

C. gigas (p=1)

102.4 (n=13)

± 3.2

114.6 (n=18)

± 16.4

O. edulis (p=1)

110.9 (n=13)

± 8.3

130.5 (n=18)

± 18.1

E. siliqua (p=1)

94.3 (n=12)

± 6.7

119.3 (n=18)

± 12.7

P. max meat (p=1)

98.3 (n=13)

± 3.5

119.7 (n=15)

± 23.3

P. max gonad (p=1)

101.3 (n=13)

± 5.1

125.9 (n=18)

± 11.0

Comparison of the results between instruments show that the apparent recoveries observed on
the QToF were always higher than on the TSQ regardless of the shellfish variety and the
method used.
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During analysis of AZA1 on the TSQ it was noted that the injection of a standard after the
injection of a number of tissue extracts led to a lower response than when injected after a
calibration curve. The degree of suppression was dependent on the type of tissue extract. This
phenomenon is illustrated in Figure 2.1 which shows the response of three consecutive
injections of an AZA1 standard (104 ng/mL) after three injections of three shellfish extracts
prepared from five different varieties. A six point calibration curve was systematically run
after the three injections of the AZA1 standard and used to calculate the concentrations
reported in Figure 2.1. Depending on the tissue type the degree of suppression ranged from
15 to 70%. In this instance P. maximus gonad tissue appeared to be the worst offender while
the clams (T. philippinarium) had the least effect. Injections of the AZA1 standard after the
oyster, mussel and scallop extracts have shown that the first injections are equally affected by
signal suppression while the third injection led to a significantly higher response.
120.0

AZA1 conc (ng/ml)

100.0

80.0
1st
2nd

60.0

3rd
40.0

20.0

0.0
T.
philippinarium

C. gigas

P. maximus
meat

M. edulis

P. maximus
scallop gonad

Figure 2.1. Concentration obtained for three consecutive injections of a standard of AZA1
(104 ng/mL shown as the bold line) on the TSQ using gradient elution following three
injections of various shellfish tissue extracts. The error bars show the standard deviations
obtained from the mean (n=3).
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These results suggest that either later eluting compounds, or compounds lingering in the
source are responsible for the signal suppression observed. This phenomenon is not observed
for the analysis of OA on the QToF.
It was also noted that the results for the suppression obtained for the shellfish extracts in
Figure 2.1 were dissimilar to those obtained in Table 2.1. This may be due to the fact that
although some of the extracts used in the two separate experiments were from the same
variety, they were harvested at different locations and times. This would suggest that the use
of matrix matched standards from extracts other than the sample, can lead to erroneous
results.
The within-day precision obtained with the acidic method for OA ranged from 1 to 10 % on
both instruments while the between-day precision over at least five days was 8% on both the
QToF and the TSQ (Table 2.2). The analysis of AZA1 using the acidic method on the QToF
demonstrated excellent precision as the within-day precision ranged from 2 to 5% and a
between-day precision of 11% (Table 2.2). The results obtained for AZA1 with the acidic
method on the TSQ were not as good, with within-day precision ranging from 3 to 16%. The
high variation on day five was due to a lower response of the first set of solutions that was
injected compared to the second and the third replicate set (Table 2.2). A between-day
precision of 8% was observed over five days.
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Table 2.2. Within and between days precision obtained with the acidic method calculated on
the percentage of difference in response factor between a set of spiked solutions of M. edulis
extracts and MeOH. A set of seven solutions equivalent to 0.063 to 3.5 mg/kg for OA and
0.010 to 1.150 mg/kg for AZA1 was injected in triplicate on each day.
Days
1

2

3

4

5

6

n=3

OA QToF

OA TSQ

AZA QToF

AZA1 TSQ

135.6

100.8

105.7

81.5

5.3

8.9

3.2

5.5

132.0

108.1

86.0

82.0

7.2

4.1

2.8

7.8

137.8

113.1

96.8

85.8

4.5

4.4

4.1

3.3

129.5

100.6

108.5

86.3

9.9

7.4

4.9

4.4

120.2

117.3

116.6

77.6

3.2

0.8

3.9

15.1

130.5

-

-

-

3.9

-

-

-

Average

130.9

108.0

102.7

82.6

Stdev

7.7

8.4

11.3

7.8

Average
Stdev
Average
Stdev
Average
Stdev
Average
Stdev
Average
Stdev
Average
Stdev

2.4.2. Methods to address matrix effects
2.4.2.1.

Partitioning with hexane

The LRM was extracted following the same procedure used for the other shellfish as
described in the experimental section.
As part of our experiment we investigated the recoveries of OA and AZA1 (analysis of OA
on TSQ and AZA1 on QToF) in the methanolic (and hexane) fraction after the hexane
partitioning (data not shown). The recoveries were satisfactory for both compounds (> 95%).
Hexane did not appear to have any effect on matrix suppression for the AZAs on the TSQ
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with no significant differences being observed between the partitioned (hexane) LRM and the
crude LRM (Figure 2.2). The suppression is still observed for the subsequent LRM and
standard injections for both partitioned and non partitioned samples and reflects what was
observed for the different tissue types (Figure 2.1).
Furthermore, the signal suppression effect observed in AZA1 standards after the injection of
shellfish extracts presented in Figure 2.1 was also examined. The results from Figure 2.2 D
show that the two injections of a methanolic standard of AZA1 (104 ng/mL) that followed
three injections of the LRM were affected by signal suppression as the average
concentrations were measured as 78.0 ± 5.6 and 79.4 ± 7.1 ng/mL for the first and second
injections respectively. It is only on the third injection of the standard that the concentration
measured (102.7 ± 4.1 ng/mL) returned within the expected theoretical concentration.
The effect of hexane partitioning on the signal enhancement effect observed for OA on the
QToF instrument was also evaluated. Similarly to the above results, the hexane partitioning
did not eliminate the matrix effects observed (data not shown).
These findings are in agreement with the results reported by Ito and Tsukada.24 In this study
the partitioning of scallop extracts with hexane and chloroform was evaluated for the
reduction of signal suppression observed by LC-MS when the analysis of OA, DTX1,
yessotoxin and pectenotoxin-6 was attempted. This clean-up procedure had no effect on the
matrix effects observed. The LC-MS method from McNabb et al. (2005) also included a
hexane partitioning step prior to injection but there is no information regarding the potential
benefits of this clean-up step on matrix effects.28 Although the partitioning step does not
eliminate matrix effects, its application enables a higher degree of cleanliness in the source
and in the system without detrimental effect on the accuracy.
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B

A

C

D

Figure 2.2. Average concentrations of AZAs (n=3) obtained by injection of three successive
LRM extracts and three successive LRM extracts after hexane partitioning on the TSQ. Each
series of three injections were separated by the injection of three successive standard
solutions. A) Concentration of AZA1 in partitioned and non-partitioned LRM. B)
Concentration of AZA2 in partitioned and non-partitioned LRM. C) Concentration of AZA3
in partitioned and non-partitioned LRM. D) Concentration of AZA1 standard (104 ng/mL)
after the injection of three LRMs and three partitioned LRMs.

2.4.2.2.

Alkaline method

Changing the selectivity of the method may help to overcome matrix interferences. The use
of an alkaline method for the separation of lipophilic toxins was reported to increase the
sensitivity for the OA group of toxins and enable better separation of the DSP (including
PTX2) and AZA group of toxins. This separation allows analysis of both groups of toxins in
the one run without having to alternate the mass spectrometer polarity.26 An additional study
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found that SPE on polymeric sorbents combined with an alkaline method can significantly
reduce matrix interferences for both OA and AZA1.22
The alkaline method was run on both the QToF and TSQ instruments without any sample
pre-treatment to determine any impact on matrix interferences. To assess the matrix effects
MeOH standards were run with matrix matched standards in triplicate and the slopes
compared (Table 2.3).
Excellent results were obtained when the analyses were performed on the TSQ using the
alkaline method with accuracies of 90.9 to 108.1 % for AZA1 and 97.2 to 104.4 % for OA
(Table 2.3). There was no statistically significant difference between the varieties (p = 0.083
and 0.278 for AZA1 and OA, respectively). Signal enhancement was systematically observed
for both OA and AZA1 when the QToF was used with the alkaline method. For AZA1 the
accuracy ranged from 107.7 to 135.5% with a significant difference observed between
varieties (p<0.01) while the accuracy for OA ranged from 122.8 to 127.4 % without
significant difference between varieties (p = 0.928).
By using the alkaline method the AZA1 suppression effect on the TSQ was overcome
without any sample pre-treatment; analysis of three injections of a P. maximus gonad extract
followed by three standard injections yielded 98% ± 1.1 recovery for the AZA1 (and OA) in
the standard compared with 38% ± 12 recovery for AZA1 using the acidic method.
The precision of OA measurements using the alkaline method ranged from 0.4 to 11% on
both instruments (Table 2.4). Between-day precision was 9.5 and 8.3% on the QToF and the
TSQ, respectively. The precision obtained for AZA1 using the alkaline method was also
acceptable with within-day precisions ranging from 2 to 14% on both instruments and
between-day precisions of 9.2 and 16.6% on the QToF and TSQ, respectively.
The accuracies for OA and AZA1 using the acidic and the alkaline methods were reported in
extracts of mussels (M. edulis), scallops (P. maximus) and oysters (C. gigas).22 The crude
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extracts spiked with OA (equivalent to 160 μg/kg) using a SSR of 10 showed that, with the
acidic method and analysis of OA in the negative ESI mode, signal enhancement was
observed in scallops and oysters (128.8 and 123.6%, respectively) while an acceptable
accuracy was obtained in mussels (104.7%). The use of alkaline method led to excellent
accuracies in crude extracts of mussels and in scallops (99.3 and 98.9%) while signal
suppression was observed in oysters (79.6%). Therefore, a systematic decrease in the
response (>20%) was observed when the alkaline method was used.

Table 2.3. Accuracy and precision data (%) obtained on QToF and TSQ with alkaline

OA

AZA1

Analyte

method (average ± SD; n = no of injections, p = no of concentration points).
Shellfish variety

Alkaline
TSQ

QToF

M. edulis (p=7)

103.2 (n=12)

± 16.6

135.5 (n=12)

± 9.2

C. gigas (p=1)

108.1 (n=9)

± 9.5

118.7 (n=12)

± 13.2

O. edulis (p=1)

101.1 (n=9)

± 3.2

131.3 (n=12)

± 13.0

E. siliqua (p=1)

90.9 (n=9)

± 4.5

107.7 (n=12)

± 11.2

P. max meat (p=1)

102.1 (n=9)

± 4.3

107.9 (n=12)

± 7.3

P. max gonad (p=1)

97.9 (n=9)

± 2.9

125.7 (n=12)

± 20.6

M. edulis (p=7)

103.9 (n=12)

± 8.3

122.8 (n=15)

± 9.5

C. gigas (p=1)

106.2 (n=9)

± 3.6

123.4 (n=12)

± 13.2

O. edulis (p=1)

97.2 (n=9)

± 4.8

127.4 (n=12)

± 7.2

E. siliqua (p=1)

99.5 (n=9)

± 3.2

126.0 (n=12)

± 15.9

P. max meat (p=1)

101.6 (n=9)

± 8.0

124.3 (n=12)

± 17.8

P. max gonad (p=1)

99.2 (n=9)

± 6.4

126.7 (n=12)

± 13.5
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This trend was not observed in our study. In the past, signal enhancement (50%) was
observed when the analysis of OA in crude extracts of mussels was performed on the same
instrument and using the same acidic method.23 Although the same variety of mussels were
used (M. edulis), the flesh composition may have been different enough than in the present
study to induce differences in the degree of matrix effects observed.
In the study by Gerssen et al.,22 the crude extracts spiked with AZA1 (equivalent to
100 μg/kg) using a SSR of 10 showed that, with the acidic method, signal suppression was
observed in mussel, scallops and oysters (accuracies of 84.3, 59.1 and 73.6%, respectively).
The use of alkaline method systematically led to better accuracies (88.1, 89.0 and 83.5% in
the crude extracts of mussels, scallops and oysters, respectively). The results we obtained on
the TSQ (same instrument as in Gerssen et al.) are in agreement with these observations and
the suppression effect observed for AZA1 using the acidic method was eliminated when the
alkaline method was used. The suppression effect in the analysis of AZA1 has been reported
for numerous shellfish varieties on different instruments with various chromatographic
methods.23,26,29,30 The results we obtained for AZA1 on the QToF with the acidic method are
consistent with a previous study performed on this instrument31 and within acceptable
accuracies. However, signal enhancement was observed when the alkaline method was used.
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Table 2.4. Within and between days precision obtained with the alkaline method calculated
on the percentage of difference in response factor between a set of spiked solutions of M.
edulis extracts and MeOH. A set of seven solutions equivalent to 0.063 to 3.5 mg/kg for OA
and 0.010 to 1.150 mg/kg for AZA1 was injected in triplicate on each day.
Days
1

2

3

4

5

2.4.2.3.

Replicates

OA QToF

OA TSQ

AZA QToF

AZA1 TSQ

130.6

109.8

141.1

120.7

9.3

4.9

9.0

5.8

114.5

111.8

134.9

114.2

4.9

3.2

13.7

9.1

Average

127.8

93.1

134.6

80.5

Stdev

11.1

2.9

2.8

8.3

Average

115.2

107.6

131.6

95.5

7.5

0.4

10.7

9.8

125.7

97.1

-

105.2

4.2

6.6

-

3.6

Average

122.8

103.9

135.5

103.2

Stdev

9.5

8.3

9.2

16.6

Average
Stdev
Average
Stdev

Stdev
Average
Stdev

Modified acidic gradient method with 100% organic solvent flush

Standards and matrix matched standards were run in triplicate in each batch to assess the
impact on matrix enhancement for OA on the QToF and matrix suppression for AZA on the
TSQ. Four batches were run over a one-month period. The average and standard deviations
(n=12) for the six shellfish varieties are shown in Table 2.5.
The introduction of the 100% CH3CN flush for the analysis of AZA1 on the TSQ resulted in
improved accuracies (Table 2.5) when compared to the results shown in Table 2.1. The
suppression effect observed previously was eliminated and the accuracies ranged from 89.3
to 103.7%. Interestingly the highest bias was observed for P. maximus gonad which was also
the case with the short acidic gradient method. The two-way ANOVA indicated that the
differences in the mean values between shellfish varieties were significant (p<0.001). The
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analysis of OA in the different shellfish varieties on the TSQ led to excellent accuracies,
ranging from 98.2 to 105.8%. Although the analysis of OA using the short acidic gradient on
the TSQ demonstrated acceptable accuracies, the method with the 100% CH3CN flush
provided more consistent results between varieties. After allowing for the effect of the days
of analysis, the two-way ANOVA indicated that the difference between the mean values
obtained for the different shellfish varieties was not significant (p = 0.496).
The signal enhancement observed in the analysis of OA with the QToF remained critical with
the ‘flushing’ method. The accuracies ranged between 117.3 to 171.4%. A significant
statistical difference was observed between varieties (p<0.001). Investigations showed that
the pronounced enhancement effect was not related to the flushing step as the same results
were obtained when using the shorter acidic method and with a new analytical column (data
not shown).
Our results indicated that the suppression of AZA1 on the TSQ was caused either by late
eluting compounds or due to compounds lingering in the source from previous injections. In
order to determine which was the case, an experiment was performed using the acidic method
which consisted of two injections of an O. edulis extract followed by the injection of an
AZA1 standard in triplicate. The above procedure was then repeated with modifications. The
flow going through the column was stopped after the injections of the O. edulis extract, the
column was replaced with a union and the mobile phase B set at a flow rate of 0.4 mL/min
for 5 min (as is the case with the acidic flush method). After 5 min the column was installed
on the system and allowed to equilibrate for 3 min before the next injection of AZA1
standard. The experiment was repeated in triplicate.
As observed previously the AZA1 standard was suppressed by 17 ± 3% after two injections
of the O. edulis extract using the acidic method. The suppression was still observed even after
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the source was flushed (18 ± 5%) indicating that the interfering compounds were strongly
retained on the column.

Table 2.5. Accuracy and precision data (expressed as percentages) obtained on QToF and
TSQ (n=12) with the modified acidic gradient method with 100% organic solvent flush
(average ± SD; p = no of concentration points).
Shellfish variety

AZA1

OA

TSQ

TSQ

QToF

M. edulis (p=7)

103.7

± 7.7

100.7

± 10.3

162.4

± 11.6

C. gigas (p=1)

103.4

± 7.1

102.8

± 13.6

150.6

± 21.5

O. edulis (p=1)

94.8

± 8.8

105.8

± 12.1

164.4

± 13.1

E. siliqua (p=1)

94.9

± 6.8

100.4

± 9.3

134.9

± 11.8

P. max meat (p=1)

97.4

± 5.4

98.2

± 8.0

117.3

± 10.2

P. max gonad (p=1)

89.3

±10.8

100.3

± 11.2

171.4

± 15.2

2.4.2.4.

On-line SPE

The use of two columns for the separation of compounds from complex mixtures such as
shellfish provides another dimension to conventional liquid chromatography. This approach
has been successfully used for both single laboratory and collaborative study validations for
the determination of low level agricultural residues in soft drinks by LC-MS/MS.32,33
The performance of a combination of two columns was evaluated for OA analyses on the
QToF using the acidic method. An Oasis HLB column was used as the initial column to trap
OA from the matrix. The column was then back flushed onto the analytical column, the BDS
Hypersil C8 for further separation. The approach was adapted from a method used for the
analysis of phycotoxins in plankton cells.34 The accuracy of the method was evaluated using
the same approach as that for OA and AZA1 using the acidic and the alkaline methods. All
solutions were injected in triplicate on five separate days over a five month period.
Acceptable accuracies were obtained in all shellfish varieties which ranged from 86.5 to
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102.6% (Table 2.6). Comparison of these results with those obtained using the acidic method
on the QToF (Table 2.1) demonstrates that the use of a second column significantly reduced
the matrix effects that were associated with OA analysis in shellfish varieties.
The between-day precision obtained using the column switching method was acceptable for
all shellfish varieties with relative standard deviations ranging from 5.7 to 11.4% (Table 2.6).
The sensitivity of the column switching method was comparable to the acidic method on the
same instrument with a limit of detection (LOD) equivalent to 16 µg/kg tissue (Table 2.7).
Attempts to shorten the run time (from 43 min) by adjusting the gradient conditions and/or
flow rates were unsuccessful.

Table 2.6. Accuracy (expressed as a percentage) of the column switching method on the
QToF (acidic mobile phase) for OA in different shellfish varieties (average ± SD; n = no of
injections, p = no of concentration points).
Shellfish variety

Average OA recovery ± SD (n=15)

M. edulis (p=7)

95.1 ± 11.4

C. gigas (p=1)

101.4 ± 10.2

O. edulis (p=1)

90.4 ± 5.7

E. siliqua (p=1)

86.5 ± 8.6

P. max meat (p=1)

93.5 ± 6.7

P. max gonad (p=1)

102.6 ± 10.9

2.4.3. Method performances
A fit for the purpose analytical method should meet the minimum performances for specific
parameters set by international organizations.35–37 The validation parameters include
selectivity, accuracy, precision, range, sensitivity and ruggedness (the FDA and ICH
guidelines also include the assessment of the stability of the analytes). When LC-MS/MS
methods are used the selectivity of the method is generally excellent and the absence of
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response in several blank samples is usually sufficient to demonstrate the specificity of a
given method.

2.4.3.1.

Sensitivity

The LOD observed for OA and AZA1 on both instruments and using the acidic and alkaline
methods are shown in Table 2.7. The alkaline method allowed for a two-fold improvement in
sensitivity compared to the acidic method. The LOD achieved for AZA1 was better with the
acidic method than with the alkaline method by a factor of 1.7 on both instruments. The TSQ
was 10 times more sensitive than the QToF for AZA1.

Table 2.7. LODs (signal to noise ≥ 3≤10) for AZA1 and OA on the TSQ and the QToF with
the acidic and alkaline method determined in mussel extracts.
Acidic (µg/kg)

Alkaline (µg/kg)

TSQ

QToF

TSQ

QToF

AZA1

0.3

3

0.5

5

OA

10

20

5

10

2.4.3.2.

Accuracy

In the AOAC guidelines, acceptable accuracy is a function of the concentration and the
purpose of the analysis. An accuracy of 75%–125% is considered acceptable for methods of
quantitation at ppb levels, as in this study. The FDA guidelines37 define an acceptable
accuracy as being within 15% of the actual value except at the lower limit of quantitation
(LOQ) at which 20% is acceptable. Therefore, the accuracy that we obtained for OA on the
TSQ and for AZA on the QToF with the acidic method, as well as for both OA and AZA1 on
the TSQ with the alkaline method, meet the requirements of the AOAC and the FDA
guidelines.
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2.4.3.3.

Precision

According to the AOAC guidelines, repeatability is defined as the degree of agreement of
results when conditions are maintained as constant as possible with the same analyst,
reagents, equipment, and instruments performed within a short period of time. The
repeatability varies with concentration and a theoretical calculated value can be obtained
from the Horwitz equation (1) where c is the concentration of the analyte expressed as mass
fraction.
-0.15

(1) RSDr= C
The HORRAT formula (equation 2) allows for the calculation of a ratio that should fall
between 0.5 and 2 in order to consider the repeatability as satisfactory.
(2)

HORRATr



RSDr ( found )
RSDr ( calculated

)

Therefore, acceptable precisions for the extracts spiked with OA should have relative
standard deviations ranging from 2.8 and 11.2 while acceptable precisions for AZA1 should
range from 3.0 to 12.1. Almost all the standard deviations of the analyses carried out with
both instruments were within the acceptable range. The FDA guidelines define acceptable
precision as a RSD obtained from five measurements being less than 15% and less than 20%
at the lower LOQ. Therefore, according to the FDA guidelines, acceptable precisions were
obtained for OA and AZA1 using both acidic and alkaline methods for all shellfish varieties
on the TSQ, except for M. edulis, using the alkaline method for which 16.6% RSD was
observed.
We demonstrated that the within-day precision is greatly affected by a suppression effect for
the AZAs. The injection of several shellfish extracts strongly suppressed the response in the
samples analysed after the shellfish extracts. When the alkaline and modified acidic methods
were evaluated this phenomenon was not observed.
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2.5.

Conclusions

We demonstrated the impact of matrix interference in the LC-MS/MS analysis of low-level
toxins in molluscan shellfish, and strategies to overcome this. Contrasting results were
obtained on two different LC-MS/MS instruments, using an acidic method, even with the
same source type (ESI), using the same LC conditions (and samples) and the analyses
performed by a single analyst. Significant differences were observed between shellfish
varieties. Partitioning the sample with hexane proved unsuccessful in overcoming the
interferences observed for OA on the QToF and AZAs on the TSQ.
Matrix suppression for AZA1 was overcome using an acidic method with an organic solvent
flush and alternatively by an alkaline method. Matrix enhancement observed for OA on the
QToF was eliminated only by an on-line SPE method.
In the author’s lab the alkaline method is the method of choice for the TSQ while the acidic
method (using on-line SPE for OA analysis) is the preferred procedure for the QToF.
Introduction of LC-MS/MS as the primary method for the regulatory monitoring of biotoxins
in shellfish will be quite challenging, considering the variety of instrumentation and
techniques available.
This study clearly demonstrates that different LC-MS/MS instruments can produce very
dissimilar results due to matrix interferences and that it is necessary to initially evaluate
matrix effects and where present implement procedures to eliminate and/or correct for them.
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3.1.

Abstract

Azaspiracids (AZAs) are a group of lipophilic polyether toxins produced by the small
dinoflagellate Azadinium spinosum. They may accumulate in shellfish and can result in
illnesses when consumed by humans. Research into analytical methods, chemistry,
metabolism and toxicology of AZAs has been severely constrained by the scarcity of highpurity AZAs. Consequently, since their discovery in 1995, considerable efforts have been
made to develop methods for isolation of AZAs in sufficient amounts and purities for
toxicological studies, in addition to the preparation of standard reference materials. A 7-step
procedure was improved for the isolation of AZA1–3, increasing recoveries two-fold
compared to previous methods and leading to isolation of sufficiently purified AZA6 for
structural determination by NMR spectroscopy. The procedure, which involved a series of
partitioning and column chromatography steps, was performed on 500 g of Mytilus edulis
hepatopancreas tissue containing ~ 14 mg of AZA1. Overall yields of AZA1 (52%), AZA2
(43%), AZA3 (43%) and AZA6 (38%) were good, and purities were confirmed by NMR
spectroscopy. The structure of AZA6 was determined by 1- and 2-dimensional NMR
spectroscopy and mass spectrometry. The stability of AZA6 relative to AZA1 was also
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assessed in three solvents in a short-term study that demonstrated greatest stability in aqueous
CH3CN.

3.2.

Introduction

Azaspiracids (AZAs) were discovered after 8 people in the Netherlands became ill in 1995
after consuming mussels harvested off the west coast of Ireland.1 Contaminated mussels
from this incident were sent to Tohoku University in Japan, where the primary causative
agents (AZA1–3) were isolated and characterized.2,3 The illness caused by the consumption
of AZAs was named azaspiracid shellfish poisoning (AZP), and severe acute symptoms
include nausea, vomiting, diarrhoea, and stomach cramps.4 The AZA group now includes
more than 20 analogues that are either produced by phytoplankton, through biotransformation
in shellfish, or as by-products formed as a result of storage of the toxin.5,6 However, only
AZA1–3 are currently regulated by the European Union.7 The other analogues had initially
been found at lower concentrations and were therefore not deemed to be significant, but little
is known about these additional analogues and to date only AZA1–5 have been isolated and
fully characterized.
The Irish national biotoxin monitoring program was set up in 2001 and since that time the
detection of AZAs in shellfish samples has resulted in significant shellfish farm closures.8
AZAs have since been found in other European countries, Morocco, Eastern North America,
Japan and more recently Chile.9–13 The EU has set maximum levels of 160 μg/kg of toxins
from the AZA group (defined as the sum of AZA1–3, corrected for their estimated toxic
equivalence factors) for shellfish to be placed on the market.7 Until recently, the mouse
bioassay (MBA) was the EU reference method for the detection of marine biotoxins in
shellfish. However, there were problems with this method in terms of sensitivity, accuracy,
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false positives and ethics.14 Although the current regulatory limit for AZAs may be detected
by both MBA or LC-MS/MS methods, the MBA is not capable of detecting lower levels and
the non-specific character of the assay has prevented its effective use in routine
monitoring.15,16 The MBA has now been replaced with liquid chromatography coupled to
mass spectrometry (LC-MS/MS) as the reference method for the detection of lipophilic
marine biotoxins in shellfish.7
Considerable efforts were made to try to identify the biological source of AZAs, and in 2002
James et al. reported Protoperidinium crassipes as the causative organism.17 However, this
species was not found to produce AZAs in culture (Tillmann and Krock, unpublished data).
Furthermore, analysis of picked cells of P. crassipes in Norway showed no presence of
AZAs.18 As P. crassipes is a heterotrophic dinoflagellate; it is possible that it might feed on
AZA-producing phytoplankton. In 2007, during an oceanographic survey in the North Sea, a
small (5 µm in width) photosynthetic thecate dinoflagellate was identified (subsequently
named Azadinium spinosum) that was abundant in water samples that also contained AZAs
by LC-MS/MS. A. spinosum was subsequently found to produce AZA1 and AZA2 in
culture.19,20 It is believed that most of the other AZA analogues are produced as a result of
metabolic processes in shellfish or as a result of storage.6,21 This belief was corroborated by a
study in which an Irish strain of A. spinosum was fed directly to shellfish resulting in the
formation of the analogues AZA3, AZA6, AZA17 and AZA19.22
A number of toxicological studies have been performed showing AZAs to be teratogenic to
fish,23 damaging to the gastrointestinal tract in mice,24,25 and potential lung-tumor
promoters.26 However, more detailed toxicological studies need to be performed on as many
AZA analogues as is possible in order to establish more accurate regulatory limits and to
identify all analogues that are relevant for public health protection. A recent study,
investigating an increase in AZA3 concentration in shellfish tissue upon heating, showed that
64

Chapter 3 - Improved Isolation procedure for AZAs from shellfish
AZA3 is produced as a result of decarboxylation of AZA17,6 which in turn is a metabolic
product of AZA1.27 The same phenomenon was observed for AZA6 (i.e., decarboxylation of
AZA19, which similarly appears to be a metabolic product of AZA2).6 AZA2 was found to
be the predominant toxin detected in Portugal, Morocco, Japan, and in scallops in
Chile,10,12,28,29 so it would not be surprising if the ratio of AZA6 to AZA3 was higher in
samples from these countries than in profiles observed in European shellfish.
Isolation of AZAs has been reported previously,3,30–33 however in three of these studies the
purity was not assessed by NMR.30–32 In this paper we describe the isolation of AZA1–3 and
AZA6 from shellfish using a modified procedure with improved recoveries and purities. This
enabled the confirmation, by NMR spectroscopy, of the structure for AZA6 (Figure 3.1) that
had previously been proposed based on MS fragmentation studies and analogy with AZA3.
We also assess the relative stabilities of AZA1 and AZA6 in three solvents.

3.3.

Experimental section

3.3.1. Chemicals
All solvents (pestican grade) were purchased from Labscan (Dublin, Ireland). Sodium
chloride (99+%), triethylamine (99%), ammonium acetate (97+%), ammonium formate
(reagent grade), formic acid (>98%), and silica gel (10–40 µm, type H) were purchased from
Sigma Aldrich (Steinheim, Germany). Sephadex LH-20 was from GE Healthcare (Uppsala,
Sweden), LiChroprep RP C8 (25–40 µm) was from Merck (Darmstadt, Germany), Luna
Phenyl-Hexyl (15 µm) was from Phenomenex (Cheshire, UK), and MeOH-d3 (CD3OH,
99.5%) was from Cambridge Isotope Laboratories (MA, USA). AZA1–3 certified reference
materials (CRMs) were obtained from the NRC, Certified Reference Material Program
(Halifax, NS, Canada).
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3.3.2. Extraction and clean up efficiency from freeze dried and wet tissue
Three 10 g (W1) hepatopancreas samples were freeze-dried and extracted three times (Ultra
turrax, IKA-Werke T25 at 11,000 rpm) for 1 min with EtOH (15 mL) in parallel with three
wet samples. Extracts were centrifuged (3,950 x g) for 5 min and the supernatant decanted
into 20 mL volumetric flasks which were brought to volume with EtOH. Prior to analysis by
LC-MS/MS (method A) the samples were filtered (Whatman, 0.2 µm, cellulose acetate
filter). The clean-up efficiency ((W1-W2)/W1 x 100) was assessed by combining the relevant
extracts, evaporating the solvent in vacuo and determining the weight of the remaining
residue (W2).

3.3.3. Isolation from shellfish
Cooked whole-mussel tissue (2.5 kg) from M. edulis collected in 2005 from Bruckless,
Donegal, Ireland, was dissected to yield 500 g of hepatopancreas, which was homogenized
with a Waring blender and freeze-dried (final weight 130 g). The freeze-dried hepatopancreas
was extracted with EtOH (5 × 500 mL) using a Waring blender. The extracts were combined,
evaporated in vacuo, and partitioned between EtOAc (150 mL) and aqueous NaCl (1 M, 50
mL). The EtOAc fraction was evaporated to dryness in vacuo and the oily residue was
partitioned between hexane (200 mL) and MeOH–H2O (9:1, 200 mL). The MeOH fraction
was evaporated to dryness in vacuo, dissolved in EtOAc (20 mL), and ~ 4 g of silica gel was
added. The sample was then carefully evaporated to dryness in vacuo, mixed to a fine powder
and loaded onto a silica gel (55 g) column (19.5 × 5 cm). Vacuum assisted elution was
performed successively with hexane, EtOAc, EtOAc–MeOH (9:1), (7:3), (1:1), and MeOH
(300 mL of each, all containing 0.1% acetic acid except for hexane). The 7:3 EtOAc–MeOH
fraction which FIA-MS/MS (method C) was shown to contain the AZAs, was evaporated in
vacuo, loaded in MeOH onto a Sephadex LH-20 column (150 × 1.5 cm, packed in MeOH)
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and eluted by gravity (~ 1 mL/min) with MeOH. The first 20 min of eluate was collected
separately, with 3-min fractions collected thereafter. Fractions containing AZAs (fractions 8–
15), as determined by FIA-MS/MS, were combined, evaporated to dryness in vacuo, and the
sample loaded in CH3CN–H2O (6:4, plus 0.1% triethylamine) onto a column packed with
Phenyl-Hexyl (19.9 × 2 cm). The sample was eluted with CH3CN–H2O (3:7, plus 0.1%
triethylamine) at 4 mL/min, and 5 mL fractions were collected. Appropriate fractions were
combined (AZA3, fractions 10–15; AZA6, fractions 16–23; AZA1, fractions 24–34 and
AZA2, fractions 35–45) based on FIA-MS/MS analysis.
Final purification of AZA1 was achieved by semi-preparative LC (Agilent 1200) with
photodiode array (PDA) detection (210 nm) using a Luna C8 (5 µm, 250 × 10 mm,
Phenomenex) column eluted with CH3CN–H2O (1:1, plus 2 mM ammonium acetate) at
4 mL/min. The column temperature was 30 °C. AZA2, AZA3 and AZA6 were purified using
the similar conditions as for AZA1, but with a narrower-bore column (Cosmosil C18, 5µm,
250 × 4.6 mm, Nacalai tesque) eluted with CH3CN–H2O (1:1, plus 2 mM ammonium acetate)
at 1 mL/min. Purified AZAs were recovered by diluting the fractions with H2O (to 20%
CH3CN), loading on to solid-phase extraction (SPE) cartridges (Oasis HLB, 200 mg),
washing with MeOH–H2O (1:9, 10 mL) to remove the buffer and eluting with MeOH–H2O
(9:1, 20 mL).
Purified samples were tested for phthalates (method E) which, if present, were removed by
partitioning the sample in MeOH–H2O (4:1, 20 mL) with 20 mL of hexane. Removal of
solvent by evaporation in vacuo afforded purified AZAs as white solids.

3.3.4. Comparison of flash chromagraphy stationary phases
Two stationary phases (LiChroprep RP-8 and Luna Phenyl-Hexyl) were assessed for
separation, clean-up and recovery efficiencies. Each stationary phase (packed in a 19.9 ×
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2 cm column) was loaded with 200 µg of residue in CH3CN–H2O (6:4, plus 0.1%
triethylamine), which had been brought through the first 5 steps of the isolation procedure,
and eluted with CH3CN–H2O (3:7, plus 0.1% triethylamine) at 4 mL/min. Fractions
containing AZAs, as determined by flow injection analysis with mass spectrometry detection
(FIA–MS/MS, method C), were combined and analyzed by LC-MS/MS (method A).

3.3.5. Mass spectrometry
Two LC-MS/MS systems were used in positive ion mode, both of which were equipped with
a z-spray ESI source.
Method A. Recoveries were determined by quantitative analysis of fractions on a Waters 2695
LC coupled to a Micromass triple-stage quadrupole (TSQ) Ultima operated in selected
reaction monitoring (SRM) mode, with the following transitions: AZA1 m/z 842.5654.4
and 842.5672.4, AZA2 856.5654.4 and 856.5672.4, AZA3 828.5640.4 and
828.5658.4, AZA6 842.5640.5 and 842.5658.4. The cone voltage was 60 V and the
collision voltage was 40 V, the cone and desolvation gas flows were set at 100 and 800 L/h,
respectively, and the source temperature was 150 °C.
Binary gradient elution was used, with phase A consisting of H2O and phase B of 95%
CH3CN in H2O (both containing 2 mM ammonium formate and 50 mM formic acid) in a
minor modification to the method of Quilliam et al.34 Chromatography was performed with a
Hypersil BDS C8 column (50 × 2.1 mm, 3 µm, with a 10 × 2.1 mm guard column of the same
stationary phase) (Thermo Scientific). The gradient was from 30% B, to 90% B over 8 min at
0.25 mL/min, held for 5 min, then held at 100% B at 0.4 mL/min for 5 min, and returned to
the initial conditions and held for 4 min to equilibrate the system. The injection volume was
5 µL and the column and sample temperatures were 25 °C and 6 °C, respectively.
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Method B. Purity was initially assessed on a Micromass time-of-flight (QToF) Ultima
coupled to a Waters 2795 LC by running MS scans (m/z 100–1000) using the same
chromatographic conditions as above. Identification of other contaminant AZA analogues
was also determined by performing product ion scans, where the precursor ions were selected
and then fragmented, for all the known AZA analogues.
Method C. Qualitative analysis of fractions for AZAs was performed by FIA-MS/MS using a
Micromass QToF Ultima coupled to a Waters 2795 LC. Samples (2 µL) were injected, using
the 2795 autosampler, directly (no column) into the mass spectrometer monitoring for the
precursor ions.

3.3.6. LC-PDA purity analysis
Method D. A concentrated sample (~500 µg/mL) was injected (1 µL) onto the analytical
system (Shimadzu 10AVp) with photodiode array (PDA) detection (210 nm) using a
Cosmosil C18 column, 5 µm, 250 × 4.6 mm eluted with CH3CN–H2O (1:1, plus 2 mM
ammonium acetate) at 1 mL/min. The column temperature was 30 °C.
Method E. An additional method employed to detect any strongly retained compounds (e.g.,
phthalates) used an analytical LC system (Shimadzu LC 10AVp) with PDA detection at
210 nm. The sample collected after the SPE step was injected (5 µL) onto a Vydac C18,
column (10 µm, 250 × 4.6 mm, Grace) and eluted with MeOH–H2O (9:1) at 1 mL/min,
maintaining the column temperature at 30 °C.

3.3.7. NMR spectroscopy
NMR-purity was assessed by 1H NMR using a Bruker DRX-500 spectrometer. The structure
of AZA6 was determined by analysis of 1H, COSY, TOCSY, NOESY, ROESY, HSQC and
HMBC spectra using a Bruker Avance III 700 spectrometer fitted with a 1.7 mm proton69
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detect micro-cryoprobe. Approximately 50 μg of AZA6 were dissolved in 30 μL CD3OH, and
proton-detected spectra were acquired with pre-saturation of the OH peak. The TOCSY
spectrum was recorded using an MLEV sequence with a 120 ms mixing time. The ROESY
spectrum was acquired with a spin-lock pulse of 200 ms and a spin-lock field of
approximately 3 kHz. Two HMBC spectra were recorded, optimized for long-range
couplings of 8.33 Hz and 5.56 Hz (60 ms and 90 ms evolution times, respectively). All
samples were tuned and matched to 50 Ω resistive impedance. Chemical shifts were
referenced to internal CHD2OH (3.31 ppm) or CD3OH (49.15 ppm).

3.3.8. Stability studies
A side-fraction from the final step in the isolation procedure, containing both AZA6 and
AZA1, was used to assess stability. Aliquots of the fraction were evaporated under a stream
of N2 and taken up in three solvents (MeOH, EtOH, and 4:1 CH3CN–H2O) and stored in
flame-sealed ampoules (under nitrogen) at −18 °C, 4 °C and 40 °C for a 4-week period.
Samples were ampouled in triplicate for each of the temperature and time points. The study
was performed isochronously, and samples were analyzed simultaneously by LC-MS/MS
(method A) with specimens stored at −80 °C used as the control.

3.3.9. Methylation with diazomethane
To identify whether the degradation products formed during the stability study were methyl
esters or other methyl derivatives, AZA6 methyl-ester was synthesized. A purified sample (~
60 ng) of AZA6 was added to the outside tube of an Aldrich diazomethane generator with
System 45 connection, and 1 mL MeOH and 1.5 mL Et2O were added. Diazomethane was
generated in the inner tube of the apparatus and allowed to react in situ with the extract.
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After reacting for 45 min at 0 °C with occasional swirling, the extract was transferred to a
glass vial, evaporated to dryness under a stream of N2, and the residue dissolved in MeOH
(1 mL) for LC-MS/MS analysis (method B).

3.3.10. Cleavage with sodium periodate
Aliquots (50 µL) of 0.2 M solution of sodium periodate were added to 50 µL of purified
AZA6 and AZA3 (~ 80 ng/mL in MeOH) in insert vials, vortex mixed for 20 s and analysed
after ca. 2 h by LC-MS/MS (method B).
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Figure 3.1 Structures of azaspiracids with substitution points for analogues. Note that only
AZA1–6 have their structures unambiguously established by NMR spectroscopy, while the
remaining structures are tentative, based on MS fragmentations, biosynthetic and metabolic
considerations, and analogy with known analogues.
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3.4.

Results and discussion

3.4.1. Extraction and partitioning
An exhaustive trial extraction was performed on 130 g of freeze-dried hepatopancreas
sample resulting in a 95% clean up (Table 3.1). The use of EtOH as an extraction solvent for
the purification of AZAs has previously been reported.33 Small scale tests with MeOH and
EtOH as extraction solvents showed that both solvents were equivalent in terms of extraction
efficiency. EtOH was chosen as the extraction solvent primarily to minimize the formation of
side products, which can be significant when MeOH is used as extractant.5
Freeze-drying of shellfish prior to extraction has been successfully employed previously in
the isolation of pinnatoxins from Australian oysters.35 This has many advantages, including
avoiding the necessity of using H2O miscible extraction solvents, complete control of
extractant composition, and low H2O content in the extract (thus avoiding difficulties during
evaporation and potentially toxin stability problems). The effect of freeze-drying the mussel
hepatopancreas prior to extraction of AZAs was therefore explored. Higher extraction
efficiencies were achieved for the freeze-dried samples after the first and second extractions
with 12% and 2% more AZAs being extracted respectively. No difference was observed in
clean up efficiency (94.2% for both freeze-dried and wet tissues), but the extracts from the
freeze-dried samples evaporated more quickly with little or no foaming in the subsequent
vacuum-evaporation step. The two subsequent liquid–liquid partitioning steps resulted in
only minor losses of toxin (~ 95% recovery) with an overall clean up efficiency of 67%
(Table 3.1).

3.4.2. Silica gel
The sample was eluted from the silica gel column with step gradients of hexane, EtOAc,
EtOAc–MeOH and MeOH. AZAs eluted in 7:3 EtOAc–MeOH, with only small losses of
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toxin. The EtOAc–MeOH mixtures contained 0.1% acetic acid. Previous studies have shown
that AZAs are unstable in acidic environments, but that shellfish tissue appears to have a
protective effect.36 As the sample at this stage of the isolation was still quite crude, and there
appeared to be no degradation of the AZAs during small-scale trials, it was deemed to be safe
to use acetic acid in the eluent at this point of the procedure. Attempts to replace the acetic
acid with 0.1% triethylamine were unsuccessful, with the toxins eluting over three of the
mobile-phase compositions, thereby reducing the clean-up efficiency significantly. Of all the
steps in the procedure, silica gel chromatography (step 4) gave the greatest efficiency in
terms of clean up (93%) and recovery (~ 95%) (Table 3.1).

3.4.3. Sephadex LH-20 chromatography
AZAs eluted together after ca. 64 min and were collected in 11 fractions. The clean-up
efficiency of 66% was achieved with a recovery of 85%.

3.4.4. Phenyl-hexyl flash chromatography
Acidic mobile phases have previously been used for reverse-phase flash chromatographic
purification,33 but bring with them an inherent risk of acid-promoted degradation of AZAs
during storage or evaporation. We found the use of triethylamine to be a safer alternative,
with the toxins being stable whilst stored in the freezer as a dry sample (after evaporation of
the mobile phase containing 0.1% triethylamine) for at least one month (data not shown).
Both the RP-8 and Phenyl-Hexyl stationary phases performed similarly in terms of clean-up
efficiency and recovery however, with respect to resolution, the Phenyl-Hexyl proved to be
much more efficient at separating the AZA analogues than the RP-8 stationary phase (Table
3.1). Separation of the AZA analogues at this stage in the procedure improved recoveries and
purities in the final semi-preparative LC step (step 7), so the Phenyl-Hexyl stationary phase
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was chosen as the stationary phase for flash chromatography. This step resulted in a clean-up
of 64% (assessed after the RP-8 vs Phenyl-Hexyl experiment, see experimental section) and a
recovery of ~ 90% (Table 3.1).

3.4.5. Preparative HPLC
An acidic mobile phase was used for semi-preparative LC purification in preliminary studies,
but AZAs were very unstable when evaporated to dryness from the acidic eluent
(unpublished information) confirming the results of Alfonso et al.36 Therefore, a neutral
mobile phase was chosen to prevent AZA degradation. Acceptable chromatography was
obtained for AZA1 and AZA2 using the neutral mobile phase, but broad, fronting peaks were
observed for AZA3 and AZA6. Similar chromatography for AZA3 was also observed using
alkaline conditions on an analytical scale.37 This is presumably related to the fact that both
AZA3 and AZA6 lack a methyl group at the R3 position (Figure 3.1, p 74) which somehow
affects their chromatographic behavior. All fractions were collected based on UV detection at
210 nm to minimize contamination with non-AZA analytes.
Most (80%) of the AZA6 from the flash chromatography (step 6) was recovered in the AZA6
fraction, and 20% came from the AZA3 fraction. The recovery of AZA6 from the semipreparative LC (61%) was slightly less than for the other AZA analogues (all ~ 85%),
probably because co-eluting compounds necessitated significant heart cutting.

3.4.6. SPE recovery of AZAs from eluent
Fractions from the semi-preparative LC purification were diluted with H2O and recovered on
SPE cartridges in order to remove any buffer remaining in the sample, but also to reduce the
H2O content in, and volume of, the AZA fractions prior to evaporation, and as an additional
final clean-up step to remove trace contaminants introduced via the LC eluents. This SPE
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recovery resulted in very little loss of toxin, with recoveries of >95% being achieved, and
greatly facilitated evaporation of the purified AZA-fractions to dryness.

3.4.7. Overall recoveries
7.3 mg of AZA1 was purified along with 1.6 mg of AZA2, 2.0 mg of AZA3 and 300 µg of
AZA6. Overall recoveries (steps 1–7) were 52% for AZA1, 43% for AZA2 and -3, and 38%
for AZA6, and represent a two-fold increase in recovery compared to previous isolations
carried out as part of the ASTOX project.33,38 Furthermore, the improved procedure is
significantly easier to perform and less labor intensive.

Table 3.1. Batch summary table for purification of AZA1–3 and AZA6.
Step

Step

AZA1

AZA2

AZA3

AZA6

Weight

(mg)

(mg)

(mg)

(mg)

(g)

Subsampling

14.1

4.0

4.8

0.78

505.0

1

1st crude extract

14.0

3.9

4.7

0.77

26.9

2

1st partitioning

13.3

3.7

4.4

0.73

23.9

3

2nd partitioning

12.6

3.5

4.2

0.69

8.9

4

Silica gel

11.9

3.3

4.0

0.65

0.6

5

LH20

10.1

2.8

3.4

0.55

0.2

6

Flash (phenyl-

9.2

2.5

2.4

0.49

-

Prep HPLC (C8/C18)

7.3

1.7

2.0

0.30

-

% Recovery

52

43

43

38

% Purity

>95

>95

>95

>95

No

hexyl)*
7

3.4.8. Purity testing by MS, UV and NMR
The purity of the samples was first determined by mass spectrometry. An LC-MS scan was
performed in the range m/z 100–1000, followed by LC-MS/MS analysis for all the known
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AZA analogues as well as for any additional masses picked up in the MS scan (method B).
The sample was also analyzed using the LC-PDA semi-preparative method (method D) to
ensure that no additional peaks were observed in the UV trace. To determine whether
strongly retained compounds, such as phthalates, were present in the sample, isocratic LCPDA was performed (method E). Previous NMR analysis had shown the presence of a
phthalate in some fractions which was detectable by LC-PDA (max 205, 225 and 275 nm).
This contaminant was conveniently removed by partitioning with hexane. Once samples were
deemed to be sufficiently pure (LC-MS/MS and LC-PDA), they were prepared for NMR
spectroscopy. The 1H NMR spectra of AZA1–3 were compared to published NMR data and
found to be essentially identical, and examination of the spectra indicated purities of >95%.

3.4.9. AZA6 structural elucidation by NMR

NMR data for AZA6 have not been published, and its proposed structure was based only on
MS/MS fragmentation and on analogy with the structure of AZA3. AZA6 was therefore
subjected to a more thorough series of 1- and 2D NMR experiments to verify its presumed
structure. NMR analysis confirmed the previously postulated structure of AZA6, a methyl
group at the R2 position (C-8) and a methylene at C-22 (R3 = H), see Figure 3.1 and Table
3.2. Structural elucidation of AZA6 was done using 1- and 2-dimensional homonuclear 1H
and heteronuclear 1H{13C} NMR spectroscopy to assign the 1H and

13

C resonances, the

chemical shifts of which were then compared with published data for AZA1–3.2,3 One77
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dimensional 1H NMR and edited HSQC spectra showed that AZA6 had 6 methyl, 16
methylene, and 17 methine groups. Chemical shifts for eight quaternary carbons were
ascertained from HMBC correlations (2.20,2.31/181.6, C-1; 5.71,5.32/72.29, C-6;
1.67,1.96/130.8, C-8; 1.93,0.91/106.9, C-10; 1.93,0.91/110.9, C-13; 2.13/98.1, C-21;
3.93/146.6, C-26; 2.14/97.6, C-28; and 0.83/95.6, C-36). Chemical shifts reported in Table
3.2 are from the HSQC (for 1H and protonated 13C atoms) and HMBC (for quaternary carbon
atoms) spectra. Analysis of the COSY and TOCSY spectra led to the identification of 9 spinsystems based on protons and methyl groups attached to C-2–C-7; 8-CH3; C-9; C-11–C-12;
C-14–C-20; C-22–C-25; 26=CH2; C-27; C-29–C-35; and C-37–C-40 (Figure 3.1). The
following HMBC correlations defined the connections of the spin systems: C-6 to H-7; C-7 to
8- CH3; C-8 to 8- CH3 and H-9a,b; C-9 to 8- CH3; C-10 to H-9; C-10 to H-11b; C-13 to H12b; C-13 to H-14; C-13 to 14- CH3; C-21 to H-22a,b; C-25 to 26=CH2; 26=CH2 to H-27b;
C-26 to H-27a,b; C-28 to H-27a,b; C-38 to 37-CH3; and C-36 to H-40b. Periodate treatment
of AZA6 yielded the same C-20–C-21-cleavage product as was obtained by treatment of
AZA3, thereby establishing the presence of a 20,21-diol in AZA6 and a link between the C14–C-20 and C-22–C-25 spin-systems.
The presence of a resonance at 1.67 ppm (8-Me) was consistent with the vinylic methyl group
such as present in AZA2. The olefinic resonance at 5.32 ppm (H-7) showed more complex
coupling than could be accounted for by its original assignment as H-9. When the 1H
spectrum was observed with resolution enhancement (Gaussian window function, LB =
−2.0 Hz, GB = 0.25) the resonance at 5.32 ppm (8-Me) showed splitting into a multiplet (J ≈
1.4 Hz) implying coupling to more than 3 protons. In addition there was a weak COSY
correlation from 5.32 ppm (H-7) to 4.70 ppm (H-6) and an HMBC correlation from C-6
(72.3 ppm) to 5.32 ppm (H-7). This leads to the assignment of this vinylic proton resonance
(5.32 ppm) to H-7 and it defines the double bond as between C-7 and C-8 in AZA6,
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consistent with the structural revision of AZA1 by Nicolaou et al.39 A detailed analysis of
NMR data for AZA1 and AZA2 (C. O. Miles, A. L. Wilkins, F. Rise and J. Kilcoyne,
unpublished) gave essentially identical results, so the original assignments2,3 for AZA1–3 for
C-7–C-9 and their attached protons and methyl groups are revised accordingly in Table 3.2.
Analysis of the TOCSY spectrum of AZA6 corresponding to the C-22 to C-25 spin system
indicated that there was only one methyl group, and an additional methylene group, in ring-E
compared to AZA1 and AZA2. This, along with COSY correlations, led to the conclusion
that there is no methyl at C-22 of AZA6, analogous to AZA3.
ROESY NMR data confirmed that the relative stereochemistry of AZA6 was the same as that
published for AZA1.39 ROESY correlations were observed between H-30 and H-34, H-32
and H-33, and H-3 and H-34, consistent with the stereochemistry around rings F, G and H
having H-32, H-33 and H-34 as equatorial, equatorial, and axial, respectively, with the 30-Me
equatorial. In addition, ROESY correlations between the 37-Me and both H-33 and H-35a
place the NH in ring-I on the β-face of ring-H. ROESY correlations between the 14-Me and
both H-6 and H-11b support C-12 being axial to ring-C and the absence of a correlation
between H-14 and H-16, were consistent with 14-Me being equatorial, and confirms the
stereochemistry in this section of AZA6 as being that assigned to AZA1–3 by Nicolaou et
al.39–41 The ROESY correlation between H-16 and H-17, and H-16 and H18b, supports the
cis-fusion of the 5-membered ring-D to ring-C. All the NMR data is thus consistent with the
structure shown for AZA6 in Figure 3.1, as is the MS/MS fragmentation reported previously
and used to propose the original tentative structure for this compound.42 The periodate
cleavage established that AZA6 had the same structure and relative stereochemistry as for
AZA3 in the C-21–C-40 moiety. Furthermore, AZA6 is a metabolite produced by oxidative
decarboxylation of the 22-Me group of AZA2 in shellfish,6 so it must have the same absolute
stereochemistry as AZA.
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Table 3.2. NMR assignments for AZA6 (in CD3OH) and AZA1–3 (in CD3OD)a,b.

1
2
3
4
5
6
7c
8
8-Me
9c
10
11
12
13
14
14-Me (41)
15
16
17
18
19
20
21
22
22-Me (42)
23
24
24-Me (43)
25
26
26-CH2
(44)
27
28
29
30
30-Me (45)
31
32
33
34
35
36
37
37-Me (46)
38
39
39-Me (47)
40
a

AZA-6
13
1
C
H
181.6
38.2
2.2
34.5
2.31
130.7
5.71
133.2
5.39
72.3
4.7
122.7
5.32
130.8
22.64
1.67
40.05
1.94
106.9
32.9
1.62
37.1
1.93
110.9
30.5
1.98
16.3
0.91
32.3
1.71
77.5
3.89
72.7
4.13
38.1
1.98
79.3
4.39
80.0
3.26
98.1
39.0
2.13

2.2
2.31

2.39
2.29
2.14

1.79

2.04

2.13

29.0
39.0
17.8
80.1
146.6
115.5

1.56
1.3
0.79
3.93

1.56

5.1

5.19

48.1
97.6
43.9
26.3
23.5
35.4
72.3
78.9
75.3
42.8
95.6
31.5
15.8
39.8
37.6
19.2
47.46

2.14

2.33

1.3
2.23
0.9
1.45
4.21
3.68
4.76
1.86

1.96

1.63
0.83
1.1
1.71
0.82
2.46
3 b

1.75

2.36

1.51

2.52

AZA-1
13
1
C
H
180.3
37.4
2.31
30.3
2.33
133.8
5.74
131.8
5.46
73.2
4.81
130.1
5.65
124.1
5.76

2.31
2.33

36.5
107.9
33.9
38.3
112.1
31.7
17.4
33.4
79.1
74.2
37.8
79.9
77.6
101.1
37.6
17.2
38.9
43.1
18.8
80.4
149.1
117.2

2.15

2.49

1.68
1.97

2.33
2.16

5.18

5.36

50.4
99.5
44.9
27.2
24.3
36.1
73.6
82.3
75.6
42.5
97.4
36.4
16.2
38.4
30.2
19.3
46.9

2.26

2.43

1.37
2.23
0.96
1.54
4.38
4.08
5.02
2.5

2.05

2.02
0.94
1.77
3.89
4.25
2
4.44
3.94
2.09
0.91
1.44
1.35
0.84
4

1.99
0.98
1.31
1.89
0.95
2.84
2 c

1.85

2.01

1.44

1.84

2.64

1.7

2.91

AZA-2
13
1
C
H
177.8
35.6
2.34
29.5
2.31
132.8
5.68
132.1
5.42
73.3
4.72
123.6
5.32
132.8
23.8
1.67
41.1
1.97
108.3
34
1.65
38.3
1.96
112.1
31.7
2
17.4
0.93
33.4
1.73
79
3.87
74.2
4.2
37.7
1.98
79.9
4.42
77.6
3.93
101
37.6
2.07
17.2
0.89
39
1.43
43.1
1.33
18.9
0.83
80.4
3.97
149.1
118.1
5.17
50.1
99.5
44.9
27.2
24.1
36.1
73.6
82.4
75.6
42.4
97.4
36.5
16.2
38.4
30.2
19.3
46.9

2.34
2.31

2.42
2.33
2.16

1.83

1.98

1.43

5.35

2.24

2.42

1.36
2.22
0.93
1.51
4.35
4.06
5
2.49

2.03

1.97
0.97
1.29
1.86
0.94
2.83

1.82

2.62

1.68

2.91

AZA-3
13
1
C
H
177.8
35.4
2.37
29.4
2.33
133
5.73
132.4
5.47
73.1
4.81
130
5.63
124.2
5.75
36.5
108
34
38.3
112.1
31.7
17.3
33.4
79
74
38.2
80.3
80.6
98.7
33.4

2.13

2.48

1.66
1.96

2.34
2.15

1.55

2.07

30.1
42.3
18.9
80.7
149.2
118

1.61
1.28
0.86
4.08

1.61

5.18

5.35

50.2
99.5
44.9
27.2
24.3
36.1
73.6
82.4
75.6
42.3
97.4
36.5
16.2
38.3
30.1
19.3
46.9

2.26

2.43

1.37
2.24
0.96
1.53
4.37
4.07
5.03
2.54

2.05

2.02
0.95
1.75
3.91
4.23
1.98
4.43
3.63

1.84

1.98

1.83

2.64

1.99
0.98
1.31
1.9
0.95
2.84

Data from Satake et al. Data from Ofuji et al. Published assignments for positions 7 and 9 of AZA1–3
interchanged as a consequence of the revised position of the olefin in ring A. 39
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2.37
2.33

1.68

2.92
2,3
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3.4.10. AZA6 stability
The stability of AZA6 was compared with that of AZA1. Figure 3.2 shows that AZA6 is
significantly less stable (p<0.05, Student’s t-test) than AZA1 when stored in MeOH at 40 °C.
These results parallel the observations of Perez et al.,33 who showed that AZA3 was less
stable than AZA1 under these conditions and confirms the results of McCarron et al.43
showing that AZA6 exhibited similar instability to AZA3 in tissue CRM extracts. AZA6, like
AZA3, but unlike AZA1 and AZA2, has no methyl group on the C-22 position. The
mechanism responsible for this reduced stability is as yet unclear.
In this study the stability of AZA6 was determined in three solvents. Figure 3.2 shows that
AZA6 is significantly more stable (p<0.05, Student’s t-test) in 4:1 CH3CN–H2O than in
MeOH or EtOH. The appearance of additional LC-MS/MS peaks at m/z 856.5 and 870.5 after
storage in MeOH and EtOH, respectively, indicated that these solvents were reacting with
AZA6 to produce methyl and ethyl derivatives. The formation of AZA methyl esters after
storage in MeOH has previously been reported, however, little evidence was provided to
suggest these compounds were in fact methyl esters.5 Methylation may occur at C-1 to
produce the methyl ester or, alternatively, at C-21 to produce the methyl ketal. A purified
sample of AZA6 was reacted with diazomethane to produce AZA6 methyl ester. The semisynthetic methyl ester differed from the derivative observed during the stability study in both
LC-MS/MS retention time and fragmentation pattern. The mass spectrum of the methyl ester
showed a loss of 18 amu (m/z 838.5) from the parent ion, while the derivative showed a loss
of 32 amu (m/z 824.5) from the parent ion, suggesting that the AZA6 is being methylated at
the C-21 position to form a methyl ketal during storage in MeOH (Figure 3.3). The methyl
ester of AZA6 also shows a different retention time to that of the methyl ketal, with the
methyl ester being retained longer on the column. Furthermore, when the sample containing
the methyl derivative was treated with sodium periodate, the compound remained intact
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consistent with the proposition that the AZA6-derivative is methylated at the 21-position (i.e.,
AZA6 21-methyl ketal). These results support observations reported by Jauffrais et al.44
which showed the formation of AZA1 and AZA2 methyl ketals in A. spinosum methanolic
extracts.

A

B

Figure 3.2. A) Stability of AZA1 and -6 stored in MeOH at −18 °C, 4 °C, and 40 °C and B)
stability of AZA6 stored at 40 °C in MeOH, EtOH and 20% aqueous CH3CN.
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Figure 3.3. Mass spectra of a) AZA6, b) AZA6 methyl ester and c) AZA6 methyl ketal.

3.5.

Conclusions

A method was optimized for the isolation of AZAs from highly contaminated M. edulis
hepatopancreas. A seven-step procedure involving extraction, two partitioning, and four
chromatography steps was employed. The method was adapted to limit degradation of sample
by replacing acidic mobile phases with slightly basic and neutral mobile phases in two of the
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chromatography steps. Improved separation of the AZAs during the penultimate step (flash
chromatography; step 6) was achieved by using a Phenyl-Hexyl stationary phase, leading to a
more efficient final clean up step by semi-preparative LC. Overall recoveries of ~40–50%
were achieved for AZA1–3 and AZA6. Sufficient AZA6 was isolated for structural
elucidation by NMR which confirmed the previously postulated5 structure (Figure 3.1). A
short-term stability study showed that AZA6 is significantly more stable in aqueous CH3CN
than in MeOH (the usual storage solvent) at 40 °C. The isolated AZAs are of sufficient purity
for toxicological research and for the preparation of analytical standards.
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4.1.

Abstract

Since azaspiracid-1 (AZA1) was identified in 1998, the number of AZA analogues has
increased to over 30. The development of an LC-MS method using a neutral mobile phase led
to the discovery of isomers of AZA1, AZA2 and AZA3, present at ~ 2–16% of the parent
analogues in phytoplankton and shellfish samples. Under acidic mobile phase conditions,
isomers and their parents are not separated. Stability studies showed that these isomers were
spontaneous epimerization products whose formation is accelerated with the application of
heat.
An AZA1 isomer was isolated from contaminated shellfish and identified as 37-epi-AZA1 by
nuclear magnetic resonance (NMR) spectroscopy and chemical analyses. Similar analysis
indicated that the isomers of AZA2 and AZA3 corresponded to 37-epi-AZA2 and 37-epiAZA3, respectively. The 37-epimers were found to exist in equilibrium with the parent
compounds in solution. 37-epi-AZA1 was quantitated by NMR and relative molar response
studies were performed to determine potential differences in LC-MS response of AZA1 and
37-epi-AZA1.
Toxicological effects were determined using Jurkat T lymphocyte cells as an in vitro cell
model. Cytotoxicity experiments employing a metabolically-based dye (i.e., MTS) indicated
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that 37-epi-AZA1 elicited a lethal response that was both concentration- and time-dependent,
with EC50 values in the sub-nanomolar range. Based on EC50 comparisons, 37-epi-AZA1 was
5.1-fold more potent than AZA1. This data suggests the presence of these epimers in seafood
products should be considered in the analysis of AZAs for regulatory purposes.

4.2.

Introduction

Azaspiracids (AZAs) are marine biotoxins (Figure 4.1) that originate from the phytoplankton
Azadinium1 and Amphidoma2 spp. and that can accumulate in shellfish. The consumption of
AZA-contaminated shellfish can lead to a human poisoning called azaspiracid shellfish
poisoining.3 A. spinosum has been shown to produce AZA1 and AZA2,4 while many of the
other analogues are produced as a result of metabolism within the shellfish.5,6 The number of
known AZA analogues in this group has increased considerably7 since they were first
discovered in 1998.3 However, only AZA1, AZA2 and AZA3 are regulated by the EU.8 To
date, only AZA1–6 have been isolated and fully characterized.3,9–11
AZAs have been responsible for seven confirmed shellfish poisoning events.12 Symptoms
generally include gastrointestinal illness, such as nausea, vomiting, severe diarrhoea, and
stomach cramps.13 In animals, they can elicit similar diarrhetic effects14 with severe intestinal
pathology15 but extracts given via intraperitoneal injection exhibited “neurotoxin-like”
symptoms characterized by sluggishness, respiratory difficulties, spasms, progressive
paralysis, and death within 20–90 minutes.16,17 In feeding studies, the AZAs have been shown
to be absorbed and systemically distributed with some microscopic pathology associated with
the small intestine.18–20 In vitro, the AZAs are also highly cytotoxic to various cell types, with
cell death via apoptosis21 occurring in low nanomolar concentrations.22–25 Structure–activity
relationship studies have shown that there are distinct differences in the potencies of the AZA
analogues. AZA2 is the most potent, followed by AZA3, AZA1, and then the hydroxylated
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AZA4 and AZA5.9,16,26 The only target conclusively demonstrated for the AZAs has been the
hERG potassium channel.27

Figure 4.1. Structures of AZA1−3, -6 and their 37-epimers, and AZA4 and -5.

Liquid chromatography–mass spectrometry (LC-MS) is the reference method for the analysis
of lipophilic marine biotoxins in shellfish.8 Considerable efforts were made to produce
certified reference materials (CRMs) for AZAs,28–31 which are now available.32,33 The
availability of CRMs is necessary to ensure accuracy of analytical results. A number of LCMS methods for the analysis of AZAs have been published employing acidic34–36 and basic37
mobile phases. More recently, an LC-MS method for lipophilic toxin analysis was reported
that used a neutral mobile phase.38 This method revealed the presence of unidentified isomers
of AZA1, AZA2 and AZA3 in tissue and calibrant CRMs. These isomers were resolved using
a neutral eluent but co-eluted with the parent toxin in an acidic eluent.33 The proportion of
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these isomers for AZA1–3 in the tissue CRM ranged from 2–16% of their parent analogues.
This finding is significant due to the potential of these isomers to interfere with the accuracy
of analytical results. Although these isomers are not typically resolved using acidic and
basic37 methods, they may lead to discrepancies in analytical results depending on the amount
present and their relative response factors. Isomers of AZAs have been reported previously
but these were produced as a result of acid-catalyzed degradation of the main analogues, and
the isomers were resolved from the parent compounds by LC using acidic eluents.7,39
In this paper we identify a group of epimerized AZA analogues found naturally in shellfish
and phytoplankton, and report on their origin, stability, toxicity and relative response factors
in LC-MS analysis. The potential consequences of AZA-epimerization for shellfish
consumers are also briefly discussed.

4.3.

Experimental section

4.3.1. Chemicals
All solvents (pestican grade) were purchased from Labscan (Dublin, Ireland) and Caledon
(Georgetown, ON, Canada). Distilled H2O was further purified using a Barnstead nanopure
diamond UV purification system (Thermo Scientific, Iowa, USA). Sodium chloride (99+%),
triethylamine (99%), ammonium acetate (97+%), ammonium formate (reagent grade), formic
acid (>98%), and silica gel (10–40 µm, type H), were purchased from Sigma–Aldrich
(Steinheim, Germany). Sodium chloride (99+%) and sodium periodate were purchased from
Sigma Aldrich (St Louis, USA). Sephadex LH-20 was from GE Healthcare (Uppsala,
Sweden), LiChroprep RP C8 (25–40 µm) was from Merck (Darmstadt, Germany), Luna
phenyl-hexyl (15 µm) was from Phenomenex (Cheshire, UK), CD3OH (99.5 atom-% D) was
from Cambridge Isotope Laboratories (MA, USA), and CD3OD and CD3OH (100.0 and 99.8
95

Chapter 4 - Isolation of 37-epi-AZA1 from shellfish
atom-% D, respectively) were from Sigma–Aldrich (Steinheim, Germany). AZA CRMs were
obtained from the National Research Council of Canada (Halifax, NS, Canada).

4.3.2. Culture toxin extraction
A sample (10 mL) of a culture of the Irish strain of A. spinosum5 was transferred into a 15 mL
centrifuge tube and centrifuged at 4,500 g for 5 min. The supernatant was decanted and the
pellet was extracted with 1 mL of MeOH by vortex mixing for 1 min followed by
centrifugation for 5 min at 10,500 g. The extract was filtered through a glass Pasteur pipette
plugged with cotton wool into an HPLC vial, for LC-MS analysis (method A).

4.3.3. Analysis of raw shellfish tissues
AZA-contaminated raw shellfish samples, tested as part of the routine monitoring programme
in Ireland, were selected for analysis of epimers. The shellfish were shucked and
homogenised using a Warring blender before extraction. Tissue samples (2 g) were extracted
by vortex mixing for 1 min with 9 mL of MeOH, centrifuged at (3,950 g) for 5 min, and the
supernatant decanted into a 25 mL volumetric flask. The remaining pellet was further
extracted using an Ultra turrax homogenizer (IKA-Werke T25 at 11,000 rpm) for 1 min with
an additional 9 mL of MeOH, centrifuged at (3,950 g) for 5 min, and the supernatant
decanted into the same 25 mL volumetric flask which was brought to volume with MeOH.
The extracts were analysed by LC-MS (method A).

4.3.4. Heat treatment of raw AZA-contaminated shellfish and extracts
The extracts from above were transferred into centrifuge tubes and placed in a H2O bath
(Grant Ltd, Cambridge, UK) at 90 °C for 10 min, removed, allowed to cool and transferred
into HPLC vials for LC-MS analysis (method A). Aliquots (6 × 2 g) of whole tissue
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homogenate were weighed into centrifuge tubes, three of which were capped and placed in a
H2O bath at 90 °C for 10 min, removed, allowed to cool and extracted (using the above
extraction method) in parallel with the three unheated samples. The extracts were analyzed by
LC-MS (method B).

4.3.5. Stability studies
Dilutions of fractions collected from the final step in the isolation of AZAs,11 containing
AZA1–3 and their epimers, were dissolved in CH3CN–H2O (8:2) or in CH3CN–H2O (8:2) to
which 0.1% v/v formic acid or triethylamine had been added. Aliquots of the solutions were
transferred to amber ampoules, flame-sealed under nitrogen, and stored at −18 °C, 20 °C and
40 °C for up to 7 days. The study was performed using a reverse isochronous strategy40 and
samples were analyzed under reproducibility conditions by LC-MS (method A) with samples
stored at −80 °C used as the control. An analogous study was performed in parallel using
MeOH (instead of CH3CN–H2O) as solvent.

4.3.6. Isolation of 37-epi-AZA1 from shellfish
The isolation method employed is described in detail elsewhere.11 Final separation of AZA1
from its epimer was achieved by semi-preparative HPLC (Shimadzu 10AVp) with
photodiode array (PDA) detection at 210 nm using a Luna C8 column (5 µm, 250 × 10 mm)
eluted with CH3CN–H2O (11:9, plus 2 mM ammonium acetate) at 4 mL/min with a column
temperature of 30 °C. AZA2, AZA3 and their 37-epimers were purified using the same
system as for AZA1, but with a narrower-bore column (Cosmosil C18, 5 µm, 250 × 4.6 mm)
eluted with CH3CN–H2O (1:1, plus 2 mM ammonium acetate) at 1 mL/min. Purified AZAs
were recovered by diluting the fractions with H2O (to 20% CH3CN), loading on to solidphase extraction (SPE) cartridges (Oasis HLB, 200 mg), washing with MeOH–H2O (1:9,
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10 mL) to remove the buffer, and eluting with MeOH–H2O (9:1, 20 mL). However, the
epimers were not sufficiently pure at this stage and there was some conversion (~ 8%) of the
epimers back to the parent compound during the SPE step. Samples were therefore passed
through semi preparative HPLC a second time, the CH3CN was removed on a rotary
evaporator at 20 °C, the AZAs extracted from the buffer with an equal volume of EtOAc, and
the solvent was removed on a rotary evaporator at 20 °C to give the epimers as colorless
solids.

4.3.7. Periodate cleavage
Dilutions of fractions collected from the final step in the isolation procedure, containing both
parent analogue and its epimer, were dissolved in MeOH. To 100 µL of sample was added
50 µL of 0.2 M sodium periodate solution, and the reaction analyzed immediately by LC-MS
(method A) and again at intervals over a 2 h period, but including traces at m/z 448.4 (for the
AZA1 and AZA2 oxidation product) and at m/z 434.4 (for the AZA3 oxidation product). As a
control, the sodium periodate solution was replaced by H2O.

4.3.8. Incorporation of deuterium from CH3OD
An aliquot (0.5 mL) from the final step in the isolation procedure, containing both AZA1 and
37-epi-AZA1, was evaporated under nitrogen, taken up in 0.5 mL CH3OD, stored at 40 °C,
and aliquots analyzed periodically over 10 days by LC-MS (method A) for m/z 842.5, m/z
843.5 and m/z 844.5 to monitor deuterium incorporation. An aliquot (0.2 mL) of the partially
deuterated sample was evaporated under nitrogen, dissolved in MeOH (40 µL) and added to
1 M phosphate buffered saline (PBS) (160 µL). The sample was stored at 40 °C and analyzed
periodically over 4 days by LC-MS (method A) for m/z 842.5, m/z 843.5 and m/z 844.5 to
monitor loss of deuterium.
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4.3.9. LC-MS analysis
Method A. A Micromass Ultima time-of-flight (QToF) mass spectrometer equipped with a zspray ESI source and coupled to a Waters 2795 LC was used for this method. Separation was
performed on a 5 μm, 150 × 2 mm Luna C18 (2) column (Phenomenex, UK) operated at
30 °C, injecting 5 µL samples. A binary mobile phase of H2O (A) and CH3CN–H2O (95:5)
(B), each containing 5 mM ammonium acetate (pH 6.8), was used isocratically (A:B, 35:65)
at a flow rate of 0.35 mL/min. The QToF was operated in product ion scan mode, where the
precursor ions selected were: m/z 842.5 (AZA1 and AZA6); 856.5 (AZA2); and 828.5
(AZA3), in positive ionization mode. The cone voltage was 40 V and the collision voltage
was 50 V, the cone and desolvation gas flows were set at 100 and 750 L/h, respectively, and
the source temperature was 150 °C.
Method B. An Agilent 1200 LC system (Agilent Inc., Palo Alta, CA, USA) connected to an
API4000 QTRAP mass spectrometer (AB Sciex, Concord, ON, Canada) equipped with a
Turbospray ionization source was used for this method. Separation was performed on a
2.5 µm, 2.1 × 50 mm, Luna C18 (2) HST column (Phenomenex, Torrance, CA, USA)
operated at 15 °C, injecting 1–5 µL samples. A binary mobile phase of H2O (A) and CH3CN–
H2O (95:5) (B), each containing 5 mM ammonium acetate (pH 6.8), was used, with a
gradient from 25 to 100% B over 5 min at 0.35 mL/min and held at 100% B for 2 min before
re-equilibration for the next run. The MS was operated in positive ion selected reaction
monitoring (SRM) mode for the following transitions: m/z 842.5→672.5 (AZA1); m/z
856.5→672.5 (AZA2); m/z 828.5→658.5 (AZA3) and m/z 842.5→658.5 (AZA6) with
collision energy 70 V. Typical parameters were electrospray voltage 5500 V, source
temperature 400 °C, and declustering potential 70 V.
Method C. For the relative molar response study on AZA1 and 37-epi-AZA1, samples were
analysed using a number of LC-MS/MS methods. Analyses were performed on an Agilent
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1200 LC system (Agilent Inc., Palo Alta, CA, USA) connected to an API4000 QTRAP mass
spectrometer (AB Sciex, Concord, ON, Canada) equipped with a Turbospray ionization
source. The MS was operated in positive ion mode and SRM for the following transitions:
m/z 842.5→824.5/806.5/672.4/654.4/462.3/362.3 (AZA1 and 37-epi-AZA1), with collision
energies of 45 to 70 V. For selected ion monitoring (SIM) experiments, m/z 842.5 ([M+H]+)
was analyzed.
Method C(i) Gradient elution with a neutral mobile phase was run as described for method B.
Method C(ii) Isocratic elution with a neutral mobile phase was run on the same Luna column
using 60% B at 0.3 mL/min.
Method C(iii) Gradient elution with acidic mobile phase was run on the same Luna column
but eluting with H2O (A) and CH3CN–H2O (95:5) (B), each containing 50 mM formic acid
and 2 mM ammonium formate. Linear gradient elution was run from 25 to 100% B over
5 min at 0.3 mL/min and held at 100% B for 2 min, before re-equilibration for the next run.
Method C(iv) Isocratic elution with the acidic mobile phase was run on the same Luna
column using 55% B at 0.3 mL/min.
High resolution MS/MS spectra. Aliquots (~ 5 μL) of AZA1 and -2 after NMR analysis in
CD3OH and CD3OD, respectively, were diluted with 500 µL MeOH to remove rapidly
exchangeable OD- and ND-groups, evaporated to dryness under N2, and dissolved in 1 mL
CH3CN for analysis. High resolution MS/MS spectra of the [MH+1] + ions (m/z 843.5 and
857.5, respectively) of AZA1 and -2 during infusion of the solutions into a Q Exactive mass
spectrometer (Thermo Scientific) using ESI in positive ion mode with mass-selection width
set to m/z 0.4 and scan range m/z 150–900. The normalized collision energy was 30 V,
resolution was set to 140 K, with capillary temperature 320 °C, S-lens RF level 50, spray
voltage 3.8 kV, and sheath gas and auxiliary gas at 45 and 10 units respectively.
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4.3.10. NMR spectroscopy
Structural Elucidation. Structural determinations were performed by analysis of 1H, COSY,
TOCSY, SELTOCSY, NOESY, ROESY, SELROESY,

13

C, DEPT135, HSQC and HMBC

spectra using Bruker Avance I or Avance II 600 MHz spectrometers equipped with a TCI
cryoprobe and Z-gradient coils. Samples of AZA1 (1 mg), 37-epi-AZA1 (0.1 mg) and AZA2
(1 mg) were dissolved in ~ 0.5 mL CD3OD or CD3OH at 30 °C, and chemical shifts were
referenced to internal CHD2OD or CHD2OH (both 3.31 ppm), or CD3OD or CD3OH
(49.0 ppm). Single- or double-frequency pre-saturation of solvent resonances was performed
using continuous wave and/or excitation sculpting as required.
Quantitative NMR (qNMR). Quantitation of AZA1 and 37-epi-AZA1 by NMR was
performed on a Bruker Avance II 600 spectrometer using a BBI probe (5 mm) and operating
at room temperature. Purified samples dissolved in CD3OH were measured against external
standards of caffeine dissolved in H2O (4.10 mM) as described previously for AZA CRMs32
using techniques described previously by Burton et al.41

4.3.11. Toxicology
Cell Culturing. Non-adherent human Jurkat E6-1 T lymphocyte cells (American Type
Culture Collection TIB-152; Manassas, VA, USA) were grown as described by Twiner et
al.22,26 Briefly, cells were grown in RPMI medium (cat. #11875-093, Invitrogen, CA, USA)
supplemented with 10% (v/v) fetal bovine serum (FBS; cat. #26140, Invitrogen, CA, USA)
and maintained in a humidified incubator (Sanyo 18AIC-UV) with 5% CO2 in air at 37 °C.
Cells were subcultured with fresh medium at an inoculum ratio of 1:4 every 3 to 4 days by
transferring 2.5 mL of cells to 7.5 mL of fresh supplemented medium in 75 cm 3 screw cap
culture flasks.
Cytotoxicity assay. The effect of AZA1 and 37-epi-AZA1 on viability of Jurkat T lymphocyte
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cells was determined. Jurkat T lymphocytes were selected based on initial in vivo
observations,15 cell sensitivity following extensive in vitro cytotoxicity screening
experiments,22 and for comparative purposes to other AZA analogues for which potencies
have been determined using this assay.26,29 The Jurkat T lymphocyte cell line was grown as
described above and cells were seeded in 100 L of the supplemented medium at 35,000 cells
per well in black, sterile, 96-well culture plates for 24 h to allow for recovery and settling.
The AZA analogues were added at various concentrations for 24, 48, and 72 h of continuous
exposure prior to assessment of cytotoxicity. The final concentrations of AZA1 ranged from
9.5 × 10−8 to 5 × 10−12 M, and the final concentrations of 37-epi-AZA1 ranged from 7.6 ×
10−7 to 5 × 10−12 M. Parallel controls of equivalent amounts of MeOH/PBS were used to
normalize the viability data for each treatment. Following exposure of the cells to the AZA
analogues for the specified period of time, cellular viability/cytotoxicity was assessed using
the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium) assay (Promega Biosciences, San Luis Obispo, CA, USA; cat. no. G5421). Each
well received 10 μL of the MTS solution, the cells were incubated for 4 h at 37 °C, and
absorbance at 485 nm was measured (FluoStar microplate reader, BMG Lab Technologies).
Data are presented as means ± standard error of three separate experiments (n=3). In addition,
each cytotoxicity experiment was performed using duplicate wells. Cytotoxicity data were
blank-corrected and normalized to the control (% viability) and plotted using GraphPad Prism
(ver. 5.0c, San Diego, USA).
Collection of Samples for Metabolites. Samples were taken throughout the course of the
toxicology experiments to determine AZA analogue stability and/or metabolite composition.
In parallel with the cytotoxicity experiments outlined above, these experiments were
conducted using AZA1 and 37-epi-AZA1 with initial concentrations in each well of 94.8 and
767 nM, respectively. Samples were taken directly from the 96-well plates containing T
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lymphocyte cells at 0, 24, 48, and 72 h following the addition of the AZAs. The experiments
were conducted in triplicate and also repeated in the absence of cells. At the given time, the
entire volume (100 L) of the well contents were transferred to a glass vial and then
immediately frozen at −70 °C. Direct analysis of the samples was performed by LC-MS
(method B).

4.4.

Results and discussion

4.4.1. Observation and formation
The AZA isomers were first observed during the development of analytical methods for the
measurement of a mussel tissue matrix CRM for AZAs. When LC conditions were switched
from using an acidic mobile phase to a neutral one, additional isomeric peaks were resolved
(Figure 4.2). Analysis of a fresh A. spinosum culture showed no detectable AZA1 and AZA2
isomers, while extracts of raw shellfish (M. edulis and C. gigas) contaminated with AZAs
(0.08–4.8 µg/g) showed the presence of only minor amounts (< 2%). However, when the
extracts were heated to 90 °C for 10 min, the concentration of isomers increased to 6–15% of
the parent compounds (Figure 4.3).

103

Chapter 4 - Isolation of 37-epi-AZA1 from shellfish
(A)

(B)

AZA1 + 37-epi-AZA1

AZA1

AZA2

AZA2 + 37-epi-AZA2

AZA3 + 37-epi-AZA3

AZA3

37-epi-AZA1

m/z > m/z
856.5 > 672.5

37-epi-AZA2

842.5 > 672.5
37-epi-AZA3

828.5 > 658.5
3

4

5
6
Retention Time (min)

7

8

3

4

5
6
Retention Time (min)

7

8

Figure 4.2. LC-MS analysis of CRM-AZA-Mus33 with (A) acidic pH and (B) neutral pH
mobile phases, showing co-elution and resolution of the 37-epi-AZAs, respectively.
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Figure 4.3. LC-MS/MS analysis of raw (A) and cooked (B) mussel samples using method B.
37-epimers are marked with *. The increase in AZA3 after cooking is due to heat induced
decarboxylation of AZA17.6
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These results strongly suggested that the isomers are heat-promoted conversion products and
further highlights the fact that the chemical profile of these toxins in shellfish can change
significantly during cooking. Previous studies have shown that levels of certain AZAs (e.g.,
AZA3) increased dramatically upon cooking as a result of other AZA analogues undergoing
decarboxylation.6

4.4.2. Stability
Short-term stability studies were performed for the isomers of AZA1–3 using dilutions of
fractions collected from the isolation step for AZAs,11 at −18 °C, ~ 20 °C and 40 °C in two
solvents and under weakly acidic and basic conditions over a 7 day period. The results
showed that the isomers were stable at freezer and room temperatures, while at higher
temperatures (40 °C) they converted back to the parent analogues (Figure 4.4). Greatest
stability is observed under weakly basic conditions while the weakly acidic conditions
increased instability. The isomers were significantly more stable in aqueous CH3CN than in
MeOH, with the rate of conversion being twice as fast in MeOH (Figure 4.4). Isomerization
of AZA2 was observed during NMR analysis in CD3OD, but appeared to cease upon addition
of 0.1% v/v d5-pyridine.
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Figure 4.4. Stability of 37-epi-AZA1 in aqueous CH3CN, in aqueous CH3CN containing
0.1% TEA, in aqueous CH3CN containing 0.1% FA at -18 °C, ~ +20 °C and at +40 °C and in
MeOH at 40 °C, with −80 °C being used as a control. Lines show data fitted to exponential
decay to 16% epimer at equilibrium.

The stability data indicated that equilibrium is reached at ~ 16% isomer (Table 4.1).
Conversion of the isomer to the parent analogue was faster for AZA3 relative to AZA1 and
AZA2 (Table 4.1). In the presence of MeOH, methyl ketals11 were also formed at the higher
temperatures, particularly so for AZA3 and under the acidic conditions.

Table 4.1. Half-life (days)a for 37-epi-AZA1, AZA2 and AZA3 in aqueous CH3CN at 40 °C.
Treatment

a

37-epi-AZA1

37-epi-AZA2

37-epi-AZA3

0.1% Formic acid

7.5

7.0

2.1

Neutral

11

11

4.5

0.1 % TEA

38

32

28

From LC-MS data fitted to exponential decay curve with 16% epimer at equilibrium, using SigmaPlot 12.0.
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The stability studies provided valuable information with respect to handling of the samples.
The fact that the isomers were relatively stable at room temperature over a number of days
meant that there was no conversion whilst performing the semi preparative HPLC step.
Procedures that are normally performed at higher temperatures (evaporation of solvents and
NMR spectroscopy) could be performed at lower temperatures to deal with this instability.
Thus, evaporation steps were carried out at ≤ 20 °C and qNMR was performed at 20 °C.
Previous studies on AZAs showed that the stability of AZA1 and AZA6 was significantly
improved when stored in CH3CN–H2O (8:2) when compared to MeOH.11 Experiments
performed in this study confirm these findings. Not only was there faster conversion of
isomers to the parent analogues in MeOH, but the formation of methyl ketals11 was observed
in MeOH and was promoted under the acidic conditions.

4.4.3. Purification
AZAs were isolated from mussels to obtain sufficient quantities for the preparation of
reference materials and for toxicological studies.11 During the semi-preparative HPLC
purification (7th step) of the isolation procedure, peaks eluting close to the main AZA1–3
peaks were collected separately, and through LC-MS analysis shown to be mixtures of the
parent analogue and its isomer. A purified sample of the AZA1 isomer was obtained by
performing an additional HPLC separation step. Analysis of the isomer fraction collected
immediately after the semi preparative step showed that < 1% of the parent analogue was
present. However, after the sample was passed through the SPE cartridge to remove the
buffer, significant conversion to the parent compound had occurred (~ 8%). The use of other
SPE stationary phases (C18 and C8) also had the same effect. Evaporation of the organic
solvent from the sample at ≤ 20 °C and subsequent extraction of the sample with EtOAc
proved to be effective at maintaining the stability of the isomer with no conversion being
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observed. Sufficient AZA1 isomer (~ 150 µg) with adequate purity (containing ≤ 1.5%
AZA1) was isolated for analysis by NMR (both structural and quantitative). Small amounts
of the AZA2 and AZA3 isomers were also isolated but not in sufficient quantities for NMR
analyses. Nevertheless, sufficient levels of isomers were present in stored NMR samples of
AZAs 1–3 to permit partial NMR signal assignments.
Previous AZA purification procedures employed an acidic mobile phase in the final
purification step.29,32 Therefore, any isomer present would have been collected as part of the
parent analogue peak. The procedure used in the present study employed a neutral mobile
phase, which enabled the isomers to be resolved from the parent analogue peaks and
permitted their purification. In addition to the AZA1–3 isomers, a fraction containing the
equivalent isomer of AZA6 was also collected which suggests these isomers exist for all the
known AZA analogues.

4.4.4. Structure determination
LC-MS. The only clear differences in the LC-MS spectra between the parent analogue and its
isomer were changes to the ratio of the H2O loss, retro Diels–Alder (RDA) (m/z 672/654) and
the relative intensity of the m/z 462 fragment ions (Figure 4.5).

Periodate cleavage. Periodate cleaves the diol moiety of AZAs at C-20/21 to produce a
lactone.6,7,11 In MeOH, AZA1 and its isomer were both cleaved by periodate at essentially the
same rate, giving products with the same mass but having different retention times. This
shows that the isomer cannot simply be the 21-epi-AZA1, because C-21 is oxidized to a
carbonyl group during cleavage and could not therefore give rise to isomeric oxidation
products. Rather, the isomer of AZA1 must result from structural modification in C-22–C-40.
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Figure 4.5. Mass spectra of A) AZA1 and B) 37-epi-AZA1 (method A), showing different
ratios for the m/z 654/672 ions.

NMR spectroscopy. The structure determination of AZAs and their isomers is complicated by
the known, but hitherto poorly defined, pH dependency of the majority of the proton and
carbon atoms of the penultimate six membered nitrogen-containing ring and the five
membered furanosyl ring attached to it.11 For example, Ofuji et al.9 have reported shifts of
2.83 ppm and 2.91 ppm for the H-40 methylene resonances of AZA2 in CD3OD, whereas we
observed chemical shifts ranging between 2.54 and 2.80 ppm for these protons in the NMR
spectra of two samples of AZA2 (Table 4.2) and in the spectra of other AZAs examined in
our laboratory. The NMR spectral data originally reported for AZA1–53,9,10 were obtained
from CD3OD containing 0.5% v/v CD3CO2D in order to sharpen some of the resonances in
the region around the amino group (M. Satake, University of Tokyo, Japan, personal
communication). However, given that we found the isomerization of AZAs in MeOH to be
catalyzed by dilute acetic acid, structural NMR analysis of the AZA-isomers in this CD3OD
109

Chapter 4 - Isolation of 37-epi-AZA1 from shellfish
containing CD3CO2D was not considered appropriate. We therefore used CD3OD without
added acid, although as a consequence of this some of the chemical shifts varied significantly
from sample-to-sample, presumably because the degree of protonation of the amino group
varied slightly from isolation-to-isolation.
A further complication in the structural analysis of AZAs is that the chemical shift of H-20 is
also sensitive to the extent to which the terminal ring nitrogen atom is protonated. We have
observed shifts for this proton in the range 3.55 to 3.86 ppm in specimens of AZA1 and
AZA2, and some other AZAs examined in our laboratory whereas Ofuji et al.9,10 have
reported shifts in the vicinity of 3.94 ppm for the mildly acidified solutions of AZAs that they
examined. Notwithstanding the varying H-20 chemical shifts, an identical series of ROESY
correlations, indicative of a common C-20 stereochemistry, was observed between H-20 and
the nearby H-18a, H-19, H-22 and 22-CH3 protons.
The sensitivity of H-20 chemical shifts to the varying extent of N-protonation can be
interpreted as indicating the preferred solution conformation of AZAs as one in which the
proton (or protons) attached to the terminal ring N-atom are positioned towards the central C20 atom. Detailed analyses of 1D-SELROESY and 2D-ROESY data verified this proposal. In
particular, irrespective of the chemical shift of the H-20 signal and of protons attached to
carbon atoms in the C-31−C-40 portion of AZAs (which vary from specimen to specimen),
moderate to strong inter-ring ROESY correlations were observed from H-40eq to H-19, and to
the pro-Z 26=CH2 proton, together with ROESY correlations arising from suitably oriented
terminal-ring protons. These correlations are consistent with a preferred solution of AZAs
amino group and H-40 protons orientated towards H-19. The known pH sensitivity of some
of the protons in close proximity to the terminal ring N-atom, and remote from it (H-20), can
now be rationalized, since variations in the degree of protonation of the nitrogen atom will
also influence the chemical shift of the H-20 proton. The resulting steric hindrance of the
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amino group in this conformation may also explain its observed lack of reactivity towards
alkylation and acylation.42
Because LC-MS studies had shown that AZAs underwent slow isomerization in MeOH,
preliminary NMR investigations of the isomers were able to be performed on samples in
deutero-MeOH containing both the parent analogue and its isomer (Table 4.3). This has the
advantage that chemical shifts for both the parent AZA and its isomer can be directly
compared, despite the sensitivity of some of the chemical shifts towards pH. However,
signals from the parent compound were often greater than 20-fold more intense than those of
the isomer, and many of these signals overlapped signals from the isomer, making structural
analysis challenging and only partial assignment of isomer resonances was possible via
analysis of 1D and 2D NMR spectra. The stability data obtained during this work eventually
allowed isolation of the isomer of AZA1 in sufficient amounts (~ 150 μg) and purity (> 95%)
for structure elucidation by NMR spectroscopy.
The chemical shifts established for the ring-A–D carbons and protons for the AZA1 and
AZA2 isomers were essentially identical to those which we determined for AZA1 or AZA2,
respectively, in CD3OD, CD3OH or d6-DMSO, and in accordance with those reported by
Ofuji et al.9 However, the assignments for resonances from the 7- and 9- positions were
reversed11 due to the revision of the position of the ring-A double bond from the 8(9)-position
to the 7(8)-position as established by synthesis.43–45 In addition, the original assignments for
the 11- and 12-positions9 were reversed based on HMBC correlations observed for the
methylene protons of AZA2 that resonate at 2.33 and 2.16 ppm. HSQC data showed that
those protons were attached to the methylene carbons resonating at 33.2 and 37.4 ppm,
respectively. In the HMBC spectrum of AZA2, the proton signal at 2.33 ppm exhibited an
HMBC correlation to the C-14 methine carbon signal, which resonated at 31.0 ppm, while the
proton signal at 2.16 ppm exhibited an HMBC correlation to the C-9 methylene carbon at
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40.4 ppm (mistakenly assigned as the C-7 resonance by Ofuji et al.9 due to the incorrect
position of the ring-A double bond). These correlations are consistent with methylene proton
signals at 2.33 ppm and 2.16 ppm showing 3J correlations to C-14 (31.0 ppm) and C-9
(40.3 ppm), respectively, rather than 4J correlations (rarely seen in HMBC spectra). Thus,
these HMBC correlations indicated that the proton signal at 2.33 ppm is from H-12, and that
the signal at 2.16 ppm is from H-11, and consequently that their carbon signals at 33.2 and
37.4 ppm arise from C-12 and C-11, respectively. The equivalent HMBC correlations were
also observed for AZA1 and its isomer, indicating that this re-assignment applies to other
AZAs. Other than for the reversal of the Ofuji et al.’s assignments for the 11- and 12methylene groups, proton and carbon chemical shifts, 1H coupling constants observed in 1H
NMR or SELTOCSY experiments, together with TOCSY and ROESY correlations observed
for the isomers of AZA1 and AZA2 (where resolved from those of AZA2), were consistent
with ring-A–D portions the structures of the isomers being the same as that reported for
AZA1 and AZA2, respectively.
Knowledge of both the pH dependency of some of the chemical shifts and the preferred
solution confirmation of AZAs, as revealed by inter ring ROESY correlations, facilitated the
structure determination of the AZA1 isomer. In particular, the AZA1 isomer exhibited a
series of ROESY correlations (e.g. H-20 (3.50 ppm) to H-19 (4.45 ppm), H-16 (3.91 ppm),
H-22 (2.30 ppm), H-18a (2.07 ppm), and 22-Me (0.82 ppm); and H-40eq (2.62 ppm) to the
pro-Z 26=CH2 proton (5.28 ppm), H-19 (4.43 ppm) and 39-Me (0.88 ppm)) similar to those
observed for AZA1 and AZA2. However there were ROESY correlations shown by other
terminal ring protons, most notably between the 37-Me (1.06 ppm) and H-39 (1.84 ppm), H38a (1.44 ppm) and H-35a/b (2.11 ppm)) which were consistent with axial orientation of the
37-Me group in the AZA1 isomer rather than the equatorial orientation in AZA1 and all other
known AZAs (Figure 4.1).
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Table 4.2. NMR assignments for AZA2 and 37-epi-AZA2 from a partially epimerized
sample in CD3OD.
AZA2
37-epi-AZA2
13
1
13
1
Atom
C
H
C
H
1
181.3
n.r.
2
38.3
2.24, 2.24
n.r.
n.r.
3
30.3
2.32, 2.32
n.r.
n.r.
4
133.5
5.73
n.r.
n.r.
5
131.2
5.41
n.r.
n.r.
6
72.7
4.72
n.r.
n.r.
7
123.1
5.34
n.r.
n.r.
8
131.0
n.r.
9
40.4
1.98, 2.43
n.r.
n.r.
10
107.5
n.r.
11
37.4
1.97, 2.16
n.r.
n.r.
12
33.2
1.66, 2.33
n.r.
n.r.
13
111.3
n.r.
14
31.0
2.01
n.r.
2.01
15
32.6
1.74, 1.84
n.r.
1.75, 1.82
16
78.2
3.89
78.1
3.91
17
73.3
4.20
73.0
4.17
18
37.4
2.01, 2.01
n.r.
2.00, 2.06
19
79.2
4.43
n.r.
4.43
20
77.0
3.82
77.0
3.50
21
100.1
99.8
22
36.6
2.13
35.9
2.30
23
38.5
1.43, 1.43
n.r.
1.41, 1.41
24
42.2
1.36
n.r.
1.35
25
79.7
3.97
79.8
3.88
26
148.2
148.1
27
49.5
2.23, 2.41
49.2
2.14, 2.37
28
98.5
n.r.
29
44.3
1.35, 2.03
44.1
1.32, 2.00
30
26.5
2.24
n.r.
2.26
31
35.5
1.51, 1.82
n.r.
1.50, 1.78
32
72.8
4.33
72.7
4.24
33
81.0
3.97
79.0
3.81
34
75.0
4.95
75.4
4.82
35
42.1
2.34a, 2.56
n.r., 2.13
36
96.5
96.6
37
36.2
1.93
37.3
n.r.
38
38.3
1.26, 1.65
38.9
1.45, 1.73
39
30.1
1.82
n.r.
1.84
40
46.5
2.75, 2.80
47.9
2.62, 2.67
8-Me
23.0
1.69
n.r.
n.r.
14-Me
16.7
0.94
n.r.
0.94
22-Me
16.4
0.91
16.5
0.90
24-Me
18.1
0.83
18.1
0.82
26=CH2
116.6
5.16, 5.33
115.7
5.13, 5.28
30-Me
23.6
0.95
23.9
0.94
37-Me
15.6
0.95
15.9
1.06
39-Me
18.8
0.93
19.3
0.88
a
Exchanges deuterium. n.r., not resolved from AZA2 signals.
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Table 4.3. NMR assignments for AZA1 and 37-epi-AZA1.
AZA1 in CD3OD
Atom
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34

13

C
181.2
38.1
30.2
133.7
130.7
72.5
129.4
123.2
35.7
107.2
37.5
33.2
111.3
31.0
32.6
78.2
73.3
37.3
79.2
76.9
100.2
36.6
38.3
42.3
79.6
148.3
49.5
98.6
44.3
26.4
35.4
72.8
81.2
74.9

1

H

2.25, 2.25
2.33, 2.33
5.75
5.44
4.79
5.63
5.73
2.12, 2.46
1.97, 2.14
1.66, 2.33
2.02
1.76, 1.85
3.88
4.23
1.99, 2.01
4.43
3.86
2.12
1.43, 1.43
1.35
3.98
2.24, 2.42
1.36, 2.03
2.23
1.52, 1.83
4.35
4.01
4.98

AZA1 in CD3OH
13

C
180.6
37.6
29.9
133.4
130.6
72.3
129.3
123.1
35.6
107.1
37.4
33.1
111.2
80.8
32.5
78.1
73.2
37.1
79.1
76.8
100.2
36.6
38.1
42.1
79.5
148.2
49.6
98.5
44.1
26.3
35.2
72.7
81.2
74.8

1

H

2.25, 2.25
2.33, 2.33
5.74
5.43
4.78
5.63
5.72
2.12, 2.47
1.95, 2.13
1.65, 2.32
2.01
1.75, 1.84
3.88
4.22
1.95, 1.99
4.42
3.88
2.09
1.42, 1.42
1.34
3.97
2.23, 2.41
1.35, 2.03
2.22
1.51, 1.82
4.34
4.02
4.98

AZA1 in CD3OD +
0.5% CD3CO2Da
13
1
C
H
180.3
37.4
2.31, 2.31
30.3
2.33, 2.33
133.8
5.74
131.8
5.46
73.2
4.81
130.1
5.65
124.1
5.76
36.5
2.15, 2.49
107.9
38.3
1.97, 2.16
33.9
1.68, 2.33
112.1
31.7
2.02
33.4
1.77, 1.85
79.1
3.89
74.2
4.25
37.8
2.00, 2.01
79.9
4.44
77.6
3.94
101.1
37.6
2.09
38.9
1.44, 1.44
43.1
1.35
80.4
4.00
149.1
50.4
2.26, 2.43
99.5
44.9
1.37, 2.05
27.2
2.23
36.1
1.54, 1.84
73.6
4.38
82.3
4.08
75.6
5.02
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AZA1 in d6-DMSO
13

C
n.r.
n.r.
27.3
128.1
129.5
70.2
122.4
122.4
34.4
105.0
36.2
31.9
109.2
29.3
31.3
75.6
71.1
37.7
77.7
74.8
97.8
34.3
37.3
40.4
77.5
146.7
47.5
95.9
43.4
24.8
34.3
70.8
76.9
73.7

1

H
n.r.
n.r.
2.21
5.63
5.39
4.71
5.61
5.71
2.03, 2.43
1.89, 2.02
1.54, 2.19
1.89
1.60, 1.71
3.84
4.05
1.86, 1.98
4.26
3.25
2.17
1.31, 1.31
1.22
3.81
2.04, 2.25
1.20, 1.9
2.17
1.33, 1.71
4.13
3.61
4.68

37-epi-AZA1 in
CD3OD
13
1
C
H
181.3
38.4
2.25, 2.25
30.3
2.33, 2.33
133.7
5.75
130.7
5.44
72.5
4.80
129.4
5.64
123.3
5.73
35.8
2.12, 2.48
107.3
37.6
1.95, 2.14
33.3
1.65, 2.33
111.4
31.1
2.03
32.7
1.76, 1.83
78.1
3.91
73.0
4.20
39.0
2.00, 2.07
79.2
4.43
77.0
3.50
99.9
35.9
2.30
38.6
1.42, 1.42
42.2
1.36
79.9
3.87
148.1
49.0
2.14, 2.37
98.3
44.6
1.32, 2.00
26.7
2.26
35.5
1.50, 1.78
72.2
4.24
78.8
3.81
75.4
4.83
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35
41.9
2.41, 2.59
47.7
2.43, 2.59
42.5
2.50c
41.7
36
96.6
96.5
97.4
93.9
37
36.0
1.95
35.8
36.4
1.99
36.4
38
38.0
1.28, 1.67
37.8
1.28, 1.66
38.4
1.31, 1.70
38.8
39
29.8
1.85
29.6
1.85
30.2
1.89
30.4
40
46.4
2.79, 2.84
46.3
2.79, 2.86
46.9
2.84, 2.91
46.3
14-Me
16.6
0.95
16.5
0.94
17.4
0.95
15.9
22-Me
16.4
0.91
16.3
0.90
17.2
0.91
16.3
24-Me
18.1
0.84
17.9
0.83
18.8
0.84
17.5
26=CH2
116.8
5.16, 5.34
116.8
5.16, 5.33
117.2
5.18, 5.36
113.4
30-Me
23.5
0.95
23.4
0.95
24.3
0.96
23.3
37-Me
15.5
0.96
15.4
0.96
16.2
0.98
15.7
39-Me
18.6
0.94
18.4
0.94
19.3
0.95
19.0
a
3
NMR data from Satake et al. ; solvent composition, personal communication from M. Satake.
b
One of the H-35 signals not identified due to exchange.
n.r., not resolved from AZA1 signals.
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1.76, 2.21
1.58
1.00, 1.45
1.53
2.33, 2.38
0.86
0.789
0.738
4.96, 5.11
0.84
0.75
0.76

45.1
96.8
39.1
36.8
25.0
47.8
16.7
16.6
18.1
115.5
23.9
15.8
19.3

2.11b
1.78
1.45, 1.73
1.84
2.62, 2.67
0.95
0.90
0.82
5.13, 5.28
0.94
1.06
0.88
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This deduction was supported by the occurrence of the C-39 methine carbon signal of the
AZA1 isomer at 25.0 ppm compared to 29.8 ppm in AZA1 (Table 4.3). The upfield shift
observed for C39 is reminiscent of that exhibited by C-37 of DTX2 (21.0 ppm), which
possesses an axial 35-methyl group relative to that of C-37 in DTX1 (27.5 ppm) which
possesses an equatorial 35-methyl group.46
Confirmation of 37-epimerization (Figure 4.6), and the identification of the axial and
equatorial H-38 and H-40 methylene protons of the epimer of AZA1 (and AZA2), was
obtained via analyses of the coupling constants exhibited by the H-38 and H-40 methylene
protons, revealed in contour plots and slices extracted from 2D-HSQC and TOSCY spectra,
the resolution of which for protons in 6-membered rings was sufficient to resolve large 2Jgem
and 3Jax–ax couplings (~ 10–12 Hz) but not the smaller 3Jax–eq or 3Jeq–eq couplings (typically 3–
4 Hz or less). In a 1D-SELTOCSY spectrum of epimerized AZA1 obtained at the resonance
frequency of the 37-Me of 37-epi-AZA1 (1.06 ppm) (Figure 4.1), H-38ax appeared as a welldefined triplet of doublets due to 2JH-38ax–H-38eq and 3JH-38ax–H-39ax couplings of 10–12 Hz. In
contrast, H-38ax appeared as a quartet-like signal in the 2D-HSQC, TOCSY and 1DSELTOCSY spectra of AZA1 and AZA2 due to 2JH-38ax–H-38eq, 3JH-38ax–H-39ax and 3JH-38ax–H-37ax
couplings of ~ 10–12 Hz. The H-38eq signal of each the compounds appeared as a doublet
since only the large 2JH-38ax–H-38eq coupling of ~ 10–12 Hz and not smaller 3Jax–eq or 3Jeq–eq
couplings were resolved in HSQC or TOCSY slices (Figure 4.1). Similar observations were
made for epimerized samples of AZA2 (Table 4.2) as well as for all other AZAs studied
(unpublished observations).
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Figure 4.6. Top, 1D SELTOCSY NMR spectrum of 37-epi-AZA1 determined at the
resonance frequency of its axial 37-methyl group (1.06 ppm); Bottom, 1D-SELTOCSY NMR
spectrum of AZA1 at the frequency of its equatorial 37-methyl group (0.96 ppm). Both
spectra were acquired from the same specimen of partially epimerized AZA1 in CD3OH.
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The axially and equatorially oriented H-40 protons of AZAs were identified similarly, since
in the 2D-HSQC and TOCSY spectra H-40ax appeared as a triplet-like signal due to well
resolved 2JH-40ax–H-40eq and 3JH-40ax–H-39ax couplings while the H-40eq appeared as a doublet
signal due to resolution in HSQC spectra of only the larger 2JH-40ax–H-40eq coupling and not the
smaller 3JH-40eq–H-39ax coupling (Figure 4.1). These observations were supported by NoE
correlations observed in the ROESY and SELROESY spectra of AZA1, 37-epi-AZA1
(Figure 4.7), and in a mixed sample of AZA2 and its epimer (data not shown).

Figure 4.7. NoE correlations observed for the F–I rings of AZA1 (top) and 37-epi-AZA1
(bottom) in ROESY and SELROESY spectra from CD3OH and/or CD3OD.
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It was apparent from the inter-ring ROESY correlations that the H-40eq protons in AZA1 and
37-epi-AZA1 exhibited to H-19 to the pro-Z 26=CH2, that the C-36 configuration of 37-epiAZA1 was as in AZA1 since the foregoing pair of ROESY correlations would not have been
observed for 37-epi-AZA1 had it also been epimerized at C-36.
The analyses of stereochemically definitive H-38 and H-40 coupling constants was enhanced
by the acquisition of NMR spectral data for AZA1 and 37-epi-AZA1 in CD3OH, including
1

H, 2D-COSY, TOCSY, ROESY and HSQC data, with pre-saturation of the protonated

CD3OH/HOD signals. This appreciably sharpened the H-40 methylene protons of the
respective compounds by preventing the NH proton (or the protonated variant of it) from
exchanging deuterium with the solvent and the consequent line broadening effect due to 3JD–
C–C–H

coupling(s) between the N–D (or N–D2+) and H-40 methylene protons. Essentially

identical 1H (to within 0.01 ppm) and 13C shifts (to within 0.1 ppm) were obtained in CD3OD
and CD3OH. On the other hand, a significant difference (and in some cases beneficial
resolution of overlapped methylene proton signals) was observed when d6-DMSO was
substituted for CD3OD or CD3OH (Table 4.3).
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Scheme 1. Possible mechanism for 37-epimerisation of AZAs.
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Epimerization at C-37 presumably proceeds as shown in Scheme 1. Consistent with this was
the observation that deuterium was rapidly incorporated at C-37 of the epimer formed during
isomerisation of AZA1 and AZA2 in CD3OD, together with a slower incorporation of
deuterium at the pro-S position at C-35 (2.34 ppm in AZA2). Examination of AZA2 after
NMR in CD3OD using high resolution MS/MS of the m/z 857.5 ion confirmed the presence
of deuterium (as well as 13C) in the C-33–C-40 fragment.
To verify this finding, a sample containing 37-epi-AZA1 and AZA1 was stored in CH3OD at
40 °C and analyzed periodically by LC-MS. The incorporation of deuterium was observed
via the appearance of fragment peaks with extra mass. Intensity changes observed in HSQC
spectra indicated rapid uptake of a first deuterium and a somewhat slower incorporation of a
second at H-37 and H-35S, respectively, with a very slow (possibly due to steric effects)
incorporation of a third deuterium at H-35R.
After 10 days of storage in CH3OD, the deuterated sample was evaporated, taken up in PBS
(with 20% MeOH), and stored at 40 °C to assess the rate of deuterium loss from the structure
in this medium. Deuterium was washed out fairly rapidly, with ~ 60% of the original
deuterium remaining after 4 days. In addition, it was observed that the AZA epimer converted
back to AZA1 at a much faster rate in the PBS solution after 24 h (80% conversion) than in
MeOH (14% conversion). These findings are significant as they could enable the production
of stable isotope-labelled internal standards that could be used to compensate for matrix
effects and increase the accuracy of LC-MS quantitation. Furthermore, it might be possible to
produce tritium-labelled AZAs for biochemical investigations.
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4.4.5. Relative molar response study
37-epi-AZA1 that had been isolated and purified for structural elucidation was
quantitated by qNMR. The molar response of the epimer was assessed against purified
AZA111 that had also been quantitated by qNMR. Accurate working standards were
then prepared by diluting the qNMR stock solutions in high purity degassed MeOH.
The concentrations of the working solutions were 1.3 µM for AZA1, and 1.2 µM for
37-epi-AZA1. The anthryldiazomethane (ADAM) derivatization method for LC-FLD of
AZAs42 was applied to the AZA1 and 37-epi-AZA1 standards to provide supporting
information for the qNMR data. However, due to instability of 37-epi-AZA1, a
significant proportion of it converted back to AZA1 under the derivatization conditions
and the ADAM results for the epimer would therefore not be reliable quantitatively.
A number of mass spectrometric experiments were carried out (LC-MS method C) in
order to determine the molar response of 37-epi-AZA1 relative to AZA1. The results are
summarized in Table 4.4. Although the proportion of epimer present in samples is
approximately 2–16%, and may be considered relatively low, it is still important to
understand any potential differences in response in the MS detection of the epimers
when compared to the parent AZA analogues. When establishing the relative molar
responses of different compounds in LC-MS the mobile phase composition can
influence the ionization efficiency, therefore it is important to test under isocratic
conditions if possible. Differences can also arise due to the MS detection mode. While
SIM detection depends only on the ionization efficiency of the compounds in the ESI
source, and the transport of the ions through to the quadrupole, detection in SRM can
also be affected by differences in the fragmentation of compounds. Therefore, to
establish baseline response factors initial analyses were done using isocratic elution
with detection in SIM mode. SRM is more commonly used in routine/regulatory LC122
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MS/MS analysis of lipophilic toxins, therefore the standards were also analysed in SRM
mode.

Table 4.4. Relative molar response factors (with standard deviation of the last
significant

figure

in

parenthesis)

of

37-epi-AZA1

in

relation

to

AZA1

(AZA1(area/concentration)/37-epi-AZA1(area/concentration))a.
Neutral
MS mode

Gradientb

Isocraticc

Acidic
Gradientd

Isocratice

(ion/transition)
SIM (842.5)

0.94 (3)

0.93 (3)

SRM (842→824)

0.912 (4)

0.883 (3)

0.860 (4)

0.882 (4)

SRM (842→806)

1.016 (7)

0.995 (5)

0.977 (5)

0.971 (3)

SRM (842→672)

0.968 (3)

0.920 (3)

0.913 (5)

0.912 (5)

SRM (842→654)

0.588 (4)

0.580 (2)

0.554 (3)

0.554 (1)

SRM (842→462)

0.801 (4)

0.763 (3)

0.745 (4)

0.746 (2)

SRM (842→362)

1.106 (6)

1.105 (4)

1.091 (7)

1.097 (2)

a

Determined by SIM and SRM LC-MS experiments using gradient and isocratic LC elution with neutral
and acidic mobile phases. Propagated standard deviations (of the last significant figure) from LC-MS/MS
analyses are shown in parentheses. bMethod C(i). cMethod C(ii). dMethod C(iii). eMethod C(iv).

In most cases the response factor of the 37-epi-AZA1 was not considerably different
from that of AZA1. The isocratic elution SIM data obtained for AZA1 and
37-epi-AZA1 was consistent between acidic and neutral pH mobile phases and the
results suggest that 37-epi-AZA1 has a slightly lower response than AZA1 when
analysed under these conditions (0.94 relative to AZA1). In all SRM transitions m/z
842.5 was selected in Q1, and following fragmentation a variety of ions were selected in
Q3. The data shows that the SRM transition selected for analysis of 37-epi-AZA1 could
have a significant impact on quantitation when using an AZA1 standard (Table 4.4).
Although the initial collision induced H2O losses (m/z 824 and 806) are not ideal
transitions for confirmatory purposes, due to the higher probability of interferences
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from isobaric compounds, they both show response factors for 37-epi-AZA1 within
10% of those observed when using the same transitions for AZA1. The m/z 672
fragment that results from RDA cleavage of the A-ring also gave a similar response
factor. However, the subsequent H2O loss from this RDA fragment (m/z 654) gave a
much lower response for 37-epi-AZA1 relative to AZA1 (~ 0.57). This difference
correlates to one of the major differences observed in the product ion spectrum of both
compounds (Figure 4.5). The intensity of the m/z 654 ion is much reduced in the
product ion spectrum of 37-epi-AZA1, which is probably due to this H2O loss occurring
near C-21, Figure 4.5. Therefore, the 842→654 transition is not ideal for quantitation of
AZA1 and 37-epi-AZA1 under conditions where they are not resolved. A lower
response factor was also observed when using m/z 462 as the Q3 ion in SRM (0.76
relative to AZA1), which correlates with the reduced intensity of this ion in the product
ion spectrum of 37-epi-AZA1 (Figure 4.5). The m/z 362 ion is frequently used as a
confirmatory transition in SRM analysis of regulated AZAs and a slightly higher
response factor was observed when using this as the Q3 ion in SRM analysis of
37-epi-AZA1. With an acidic mobile phase (pH 2.3) the use of gradient or isocratic
elution had no impact on the relative response of 37-epi-AZA1. This is because AZA1
and 37-epi-AZA1 co-elute at this pH, and are being ionized in the ESI source at the
same mobile phase strength. However, it can be seen that on average the relative molar
response of 37-epi-AZA1 relative to AZA1 was slightly higher when using neutral
mobile phase compared to acidic. This is because 37-epi-AZA1 is resolved from AZA1
at the neutral pH, eluting later. The increased organic content of the mobile phase when
37-epi-AZA1 elutes conceivably causes the slightly higher response observed.
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4.4.6. Toxicology
Of all the functional assays developed for AZAs, the Jurkat T lymphocyte cell assay
was found to be the most sensitive,29 and was therefore chosen to assess the toxicity of
37-epi-AZA1. In this assay, cells initially respond to AZAs by a reduction in membrane
integrity, organelle protrusion concurrent with flattening of cells, the retraction of their
pseudopodia or lamellipodia, followed by protracted cell lysis.22
In a manner not unlike many other AZA analogues 37-epi-AZA1 was cytotoxic to
Jurkat T lymphocyte cells in a time- and concentration-dependent manner (Figure 4.8).
The 37-epi-AZA1 was shown to be 5.1-fold more potent than the parent AZA1 (Table
4.5) making it comparable in potency (in vitro) to AZA2 and AZA3 (8.3- and 4.5-fold
more potent than AZA1, respectively).26 However, this work has shown the epimer to
be highly unstable, rapidly converting back to its parent analogue at temperatures >
20 °C, and since all of the cytotoxicity experiments were run for a protracted period of
time (up to 72 h) at 37 °C, it was anticipated that there could be significant conversion
of the epimer back to AZA1. As such, samples were taken frequently throughout the
course of the study and subsequently analysed by LC-MS to assess for these (or other)
structural changes.

Table 4.5. Calculated EC50 values (nM) with 95% confidence intervals (CI) and relative
potencies (Rel. Pot.) for AZA analogues based on T lymphocyte cytotoxicity.
AZA

24 h

48 h

72 h

Mean

Rel.

analogue

EC50

95% CI

EC50

95% CI

EC50

95% CI

EC50

Pot.

AZA1

1.0

0.2–4.9

1.1

0.5–2.5

1.3

0.6–3.0

1.1

1.0

37-epi-AZA1

0.2

0.05–0.4

0.3

0.1–0.5

0.2

0.1–0.5

0.2

5.1
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Figure 4.8. Effect of AZA1 and 37-epi-AZA1 on T lymphocyte cell viability. Jurkat T cells
were exposed to various concentrations of A) AZA1 and B) 37-epi-AZA1 for 24, 48, or
72 h and viability was assessed using the MTS assay. All data (mean ± SE; n = 3) were
normalized to the control (10% MeOH vehicle). Non-linear, three-parameter dose–response
(variable slope) analysis was performed and EC50 values were calculated (Table 4.5).
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The analysis showed that the samples taken immediately after injection (i.e., t = 0 h)
consisted of 94% 37-epi-AZA1 and 6% AZA1. After 24 h, considerable conversion of
the epimer to AZA1 had taken place (73% AZA1), with nearly full equilibration
between 48 and 72 h (~ 12% isomer). Similar conversion rates were observed in the
stability study in which the deuterated AZA epimer mix was stored in a MeOH:PBS
solution at 40 °C. In parallel, analysis of the AZA1 sample at t = 0 showed that 3% of
the isomer was present while after 24 h the amount increased to 11% with apparent
equilibration being achieved after 48 h at 12% (Table 4.5). Assuming the total AZAs
remain constant over the course of the experiment, we have shown that there was little
to no metabolism or irreversible binding (e.g., to protein or plastic) of the AZAs (Table
4.6).

Table 4.6. Proportions of 37-epi-AZA1 and AZA1 following exposure to the Jurkat T
lymphocyte cell assay (37 °C) and in the absence of cells in aqueous CH3CN at 40 °C
(n=3).

Time

Jurkat T lymphocyte

Jurkat T lymphocyte

cells (37-epi-AZA1)

cells (AZA1)

% 37-epi-

% AZA1

% 37-epi-

AZA1

% AZA1

AZA1

Aqueous CH3CN

% 37-epi-

% AZA1

AZA1

0

94 ± 1

6±1

4±1

96 ± 1

96 ± 1

4±1

24

27 ± 5

73 ± 1

11 ± 1

89 ± 1

89 ± 1

11 ± 1

48

14 ± 2

86 ± 1

12 ± 1

88 ± 1

86 ± 1

14 ± 1

72

12 ± 1

88 ± 1

12 ± 1

88 ± 1

76 ± 1

24 ± 1

The conversion of 37-epi-AZA1 to the parent compound at 24 h (~ 75% AZA1) was
surprising given the significantly higher potency determined for the epimer. However,
previous experiments using this assay13 and other in vitro methods by various
investigators25,47,48 indicate that the toxic effects of AZAs are immediately elicited and
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irreversible, which could explain the increased potency of the 37-epi-AZA1 despite its
instability under the conditions tested. Although these laboratory findings suggest that
the epimeric forms of AZA may present more of a toxicological hazard than the parent
molecules and may be important from a monitoring perspective, we do not yet know the
stability and/or contribution of these analogues in situ, nor whether a similar structure–
activity relationship applies in vivo.

4.5.

Conclusions

37-Epimers of AZA1–3 and AZA6 were detected in tissue CRMs using a neutral mobile
phase with LC-MS detection. The proportion of the epimers ranged from 2–16%, with
proportions increasing following the application of heat. Stability studies showed that
the epimers convert at higher temperatures back to the parent analogue and that
equilibrium in solution is reached at ~ 16%. Sufficient amounts of 37-epi-AZA1 were
isolated to enable full structural elucidation by NMR showing it to differ from AZA1 in
the orientation of the methyl group at the C-37 position. Although only 37-epi-AZA1
was fully characterized it is highly likely that the epimers of AZA2, AZA3 and AZA6
have the same stereochemistry. Work currently being undertaken suggests that these
epimers exist for all AZAs. Relative molar response factor studies by LC-MS revealed
no major difference in response factors between the two compounds when analysed by
SIM or SRM when the typical transitions are used (842→824, 842→672 and
842→362), but a significant difference was observed for the 842→654 transition and
this is therefore not recommended for quantitative analysis of AZAs. 37-epi-AZA1 was
5.1 times more cytotoxic to Jurkat T lymphocyte cells than AZA1. Consequently, full
equilibration (to 16% 37-epi-AZA1) of a sample containing AZA1 could be expected to
increase the sample’s toxicity in this assay by ~ 1.7-fold, assuming that the epimer has
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the same toxicological mechanism of action as AZA1. Furthermore, the observation that
the rate of epimerization is increased in weakly acidic solutions may be of relevance to
toxicity via oral exposure. This and previous6 studies thus highlight the importance of
assessing toxin profiles in cooked shellfish (typically shellfish are cooked before
consumption) due to toxin conversions, as well as the need for further toxicological
studies (in vitro and in vivo) to be performed on the conversion products such as these
AZA-epimers.
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CHAPTER 5 – ISOLATION, STRUCTURE ELUCIDATION,
RELATIVE LC-MS RESPONSE, AND IN VITRO TOXICITY OF
AZASPIRACIDS FROM THE DINOFLAGELLATE AZADINIUM
SPINOSUM.
Kilcoyne, J., Nulty, C., Jauffrais, T., McCarron, P., Herve, F., Foley, B., Rise, F., Crain,
S., Wilkins, A. L., Twiner, M., Hess, P., Miles, C. O. 2014. Isolation, structure
elucidation, relative LC-MS response, and in vitro toxicity of azaspiracids from the
dinoflagellate Azadinium spinosum. Journal of Natural Products, 2014, 77, 2465–2474.

5.1.

Abstract

We identified three new azaspiracids (AZAs) with molecular weights of 715, 815 and
829 Da (AZA33 (3), AZA34 (4) and AZA35, respectively) in mussels, seawater and
Azadinium spinosum culture. Approximately 700 µg of 3 and 250 µg of 4 were isolated
from a bulk culture of A. spinosum and their structures determined by MS and NMR
spectroscopy. These compounds differ significantly at the carboxyl end of the molecule
from known AZA analogues, and therefore provide valuable information on structure–
activity relationships. Initial toxicological assessment was performed using an in vitro
model system based on Jurkat T lymphocyte cytotoxicity, and the potencies of 3 and 4
were found to be 0.22- and 5.5-fold that of AZA1 (1), respectively. Thus, major changes
in the carboxyl end of 1 resulted in significant changes in toxicity. In mussel extracts, 3
was detected at low levels, whereas 4 and AZA35 were detected only at extremely low
levels or not at all. The structures of 3 and 4 are consistent with AZAs being
biosynthetically assembled from the amino end.
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5.2.

Introduction

Numerous azaspiracid (AZA) analogues have been identified in shellfish,1,2 however,
only AZA1 (1), AZA2 (2) and AZA3 are currently regulated by the European Union.3
Compounds 1 and 2 are produced by the dinoflagellate Azadinium spinosum,4 while the
majority of the other reported analogues are due to shellfish metabolism.5−7
A number of toxicological studies have shown AZAs to be teratogenic in fish,8
damaging to the gastrointestinal tract in mice,9,10 and potential lung tumour promoters.11
A recent in vitro study on 1, 2 and AZA3 confirmed the high potency of AZAs and
suggested multiple molecular targets for these compounds which are differentially
affected by the various AZA analogues.12,13 However, further toxicological studies need
to be performed on as many AZA analogues as possible to establish more accurate
regulatory limits and to identify all analogues that are relevant for public health
protection.
The isolation and structure elucidation of 1, 2, AZA3–614−17 and 37-epi-AZA118 from
shellfish have been reported. Purification of these compounds is necessary: 1) to enable
the preparation of certified reference materials (CRMs), which are essential for the
successful implementation of monitoring programs; 2) for use in toxicology studies, so
that regulators can implement appropriate closure limits, and; 3) for structure
elucidation by NMR, enabling a better understanding of the chemistry involved.
Isolation of AZAs from shellfish is a labour intensive procedure requiring up to eight
steps involving extraction, partitioning and column chromatography.17,19 Such
compounds are ideally isolated from cultures of the producing organisms due to the
initial extract being significantly cleaner than from shellfish, and therefore requiring
fewer purification steps.20−22 Isolation of AZAs from a marine sponge23 and cultures of
A. spinosum24 have been reported.
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More recently, the presence of unidentified AZAs in the dinoflagellates Amphidoma
languida (with molecular weights of 815 and 829 Da) and Azadinium poporum (with
molecular weights of 845 and 857 Da) were reported.25 All of the AZAs identified
previously give a characteristic LC-MS/MS fragment at m/z 362, whereas these
compounds gave an m/z 348 fragment, suggesting the lack of a methyl or methylene
group in rings E–I (Figure 5.1). AZAs were also detected in isolates of A. poporum
from Chinese coastal waters.26 Although one strain did not produce detectable AZAs,
three other strains produced exclusively 2.26 Furthermore, AZAs (with molecular
weights of 827, 857 and 829 Da) were present in a newly discovered strain Azadinium
dexteroporum, all of which produced the characteristic m/z 362 LC-MS/MS
fragments.27
Here we report the identification of three new AZAs – AZA33 (3), AZA34 (4) and
AZA35 from a bulk culture of A. spinosum, two of which were isolated in sufficient
quantities for structure elucidation by NMR spectroscopy. We additionally report on
their stability, toxicity and relative response factors in LC-MS/MS analysis, and assess
their relevance in terms of human health protection.
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Figure 5.1. Structures of AZA1 (1), AZA2 (2), AZA33 (3) and AZA34 (4) including
atom numbering. Note that atom numbering for 3 and 4 starts at C-6 and C-3,
respectively, so that structurally related atoms in 3 (C-16–C-40) and 4 (C-6–C-40)
retain the same atom numbering as their corresponding atoms in 1 in Table 5.2. Also
shown are the major MS/MS fragmentation pathways for 1 and 2. Compounds 3, 4 and
AZA35 showed fragmentations (b) and (c), whereas 4 and AZA35 also exhibited the
RDA fragmentation pathway (a) but 3 did not (Figure 5.2).
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5.3.

Experimental section

5.3.1. General experimental procedures
NMR experiments for structure elucidation were run using Bruker Avance I and
Avance II 600 MHz spectrometers equipped with TCI cryoprobes and Z-gradient coils,
at 30 °C and a Bruker DRX-500 spectrometer was used for qNMR.
Mass spectrometric studies were performed using a Waters 2695 LC coupled to a
Micromass triple-stage quadrupole (TSQ) Ultima, a Waters 2795 LC coupled to a
Micromass quadrupole time of flight (QToF) Ultima and an Agilent 1200 LC system
connected to an API4000 QTRAP mass spectrometer equipped with a Turbospray
ionization source.

5.3.2. Biological material
A. spinosum strains were collected from the West coast of Ireland (SM26) and the North
Sea (3D936). Mytilus edulis samples contaminated with AZAs were obtained from
shellfish harvesting sites along the West coast of Ireland. SPATT extracts generated in
studies carried out by Fux et al.28,37 were used for analysis. The SPATTs were deployed
along the Northwest (Bruckless, Donegal) and Southwest coasts of Ireland (Bantry Bay)
at different depths (0, 5 and 10 m) during an AZA toxic event.

5.3.3. Culture extraction
Samples (10 mL) of cultures of an Irish strain (SM26) and a North Sea strain (3D936) of
A. spinosum were loaded onto solid-phase extraction (SPE) cartridges (Oasis HLB,
100 mg), washed with MeOH/H2O (1:9, 5 mL), and eluted with MeOH (3 mL). The
eluate was evaporated under a stream of nitrogen, taken up in 250 µL MeOH, and
analysed by LC-MS/MS (method A).
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5.3.4. Shellfish extraction
Samples were prepared as described in Kilcoyne et al.18 The extracts were analysed by
LC-MS/MS (method A).

5.3.5. Isolation and purification
Initial isolation steps were performed from bulk cultures of the 3D9 strain of A.
spinosum as described by Jauffrais et al.24 HP-20 resin extracts were combined,
evaporated in vacuo, and partitioned between EtOAc (150 mL) and aqueous NaCl (1 M,
50 mL). The EtOAc fraction was evaporated to dryness in vacuo, the residue dissolved
in EtOAc (20 mL), and 4 g of silica gel added. The sample was then carefully
evaporated to dryness in vacuo, mixed to a fine powder, and loaded onto a silica gel
(6 g) column (with dimensions of 3 × 5 cm). Vacuum-assisted elution was performed
successively with hexane, EtOAc, EtOAc/MeOH (9:1, 7:3, and 1:1), and MeOH (30 mL
of each, all containing 0.1% acetic acid except for hexane). The 7:3 EtOAc/MeOH
fraction, which flow-injection analysis (FIA)-MS/MS (method B) showed to contain the
AZAs, was evaporated in vacuo, and the sample loaded in CH3CN/H2O (6:4, plus 0.1%
triethylamine) onto a column packed with Phenyl-Hexyl (19.9 × 2 cm). The sample was
eluted with CH3CN/H2O (7:13, plus 0.1% triethylamine) at 4 mL/min, and 5 mL
fractions were collected. Appropriate fractions were combined (4 and 1, fractions 15–
18; and 2 and 3, fractions 19–25) based on FIA-MS/MS analysis (method B).
Final purification of 3 and 4 was achieved by semi-preparative LC (Agilent 1200) with
photodiode array (PDA) detection (210 nm) using a Cosmosil C18, 5µm, 250 × 4.6 mm,
Nacalai tesque column at 30 °C eluted with CH3CN/H2O (13:7, plus 2 mM ammonium
acetate) at 1 mL/min. Purified 3 and 4 were recovered by evaporation to ~ 20% CH3CN,
loading onto SPE cartridges (Oasis HLB, 200 mg), washing with MeOH/H2O (1:9,
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10 mL) to remove the buffer, and eluting step-wise with MeOH/H2O (4:6, 6:4, 8:2,
10:0, 20 mL each) with > 95% of 3 and 4 recovered in the 8:2 MeOH/H2O. Removal of
solvent by evaporation in vacuo afforded purified 3 and 4 as white solids (700 µg and
250 µg respectively).
AZA33 (3). white, amorphous solid; 1H and

13

C data (CD3OD, 600 MHz), see Table

5.1; HRESIMS m/z 716.4759 [M+H]+ (calcd for C41H66NO9, 716.4738).
AZA34 (4). white, amorphous solid; 1H and

13

C data (CD3OD, 600 MHz), see Table

5.1; HRESIMS m/z 816.4900 [M+H]+ (calcd for C45H70NO12, 816.4898).

5.3.6. LC-MS experiments
Method A. Recoveries were determined by quantitative analysis of fractions on a Waters
2695 LC coupled to a Micromass TSQ Ultima operated in SRM mode for the following
transitions:

m/z

842.5→824.5/362.3

(1);

m/z

856.5→838.5/362.3

(2);

m/z

716.5→698.5/362.3 (3); m/z 816.5→798.5/362.3 (4); and m/z 830.5→812.5/362.5
(AZA35). The cone voltage was 60 V, collision energy was 50 V, the cone and
desolvation gas flows were set at 100 and 800 L/h, respectively, and the source
temperature was 150 °C.
Binary gradient elution was used, with mobile phase A consisting of H2O and mobile
phase B of 95% CH3CN in H2O (both containing 2 mM ammonium formate and 50 mM
formic acid). Chromatography was performed with a Hypersil BDS C8 column (50 ×
2.1 mm, 3 µm, with a 10 × 2.1 mm guard column of the same stationary phase)
(Thermo Scientific). The gradient was from 30–90% B over 8 min at 0.25 mL/min, held
for 5 min, then held at 100% B at 0.4 mL/min for 5 min, returned to the initial
conditions and held for 4 min to equilibrate the system. The injection volume was 5 µL
and the column and sample temperatures were 25 °C and 6 °C, respectively.
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Method B. Qualitative analysis of fractions for AZAs was performed by FIA-MS/MS
using a Micromass QToF Ultima coupled to a Waters 2795 LC. Samples (2 µL) were
injected directly (no column) into the mass spectrometer, monitoring for the precursor
ions.
Method C. Purity was assessed on a Micromass QToF Ultima coupled to a Waters 2795
LC by running MS scans (m/z 100–1000) using the same chromatographic conditions as
method B. Structure analysis of AZA analogues was performed via product ion scans,
where the precursor ions were selected and then fragmented, for all the known AZA
analogues.
Method D. Accurate mass measurements were performed on a Waters Acquity UPLC
coupled to a Xevo G2-S QToF operated in MSe mode, scanning from 100−1200 m/z and
using leucine enkephalin as the reference compound. The cone voltage was 40 V,
collision energy was 50 V, the cone and desolvation gas flows were set at 100 and
1000 L/h, respectively, and the source temperature was 120 °C.
Chromatography was performed with an Acquity UPLC BEH C18 (50 × 2.1 mm,
1.7 µm) column (Waters), using the same mobile phase described in method A. The
gradient was from 30–90% B over 2 min at 0.4 mL/min, held for 2 min, and returned to
the initial conditions and held for 1 min to equilibrate the system. The injection volume
was 5 µL and the column and sample temperatures were 25 °C and 6 °C, respectively.
Method E. The samples were analysed using a neutral eluent to enable the separation of
37-epimers18 of 3 and 4. Separation was performed using a 2.5 µm, 2.1 × 50 mm, Luna
C18(2) HST column (Phenomenex) and the mobile phase was H2O (A) and
CH3CN/H2O (95:5) (B), each containing 5 mM ammonium acetate (pH 6.8).
Method F. For the relative molar response study, accurate AZA working standards
(1.3 µM for 1, 1.6 µM for 3, and 1.3 µM for 4) were prepared by diluting purified AZAs
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in high purity degassed MeOH and quantitating by qNMR. Samples were analysed
using gradient and isocratic LC-MS/MS methods with acidic eluents (method A).
Analysis was performed on an Agilent 1200 LC system with the same Luna column
described in method E, eluted at 0.3 mL/min, connected to an API4000 QTRAP mass
spectrometer (AB Sciex) equipped with a Turbospray ionization source. The MS was
operated in positive ion mode and SRM transitions were as follows: m/z
842.5→824.5/672.5/462.3/362.3 (1); m/z 716.5→698.5/462.3/362.3 (3) and m/z
816.5→798.5/672.5/362.3 (4). For SIM experiments, m/z 842.5, 716.5 and 816.5
([M+H]+) were analysed. Typical parameters were 5500 V electrospray voltage, 400 °C
source temperature, 70 V declustering potential and collision energies of 45 to 70 V
(where applicable). The injection volume was 1–5 µL and the column and sample
temperatures were 25 °C and 6 °C, respectively. Method F(i). Gradient elution used a
linear gradient from 25–100% B over 5 min and held at 100% B for 2 min before reequilibration for the next run. Method F(ii). Used isocratic elution with 60% B.

5.3.7. Stability studies
Purified samples of 1, 3 and 4 were combined and aliquots (in MeOH) were stored in
flame-sealed ampoules (under nitrogen) at −18 °C, +20 °C and +40 °C for up to 7 days.
The study was performed isochronously,38 and samples were analyzed simultaneously
by LC-MS/MS (method A) with specimens stored at −80 °C used as controls.

5.3.8. Periodate cleavage
Aliquots (100 µL) of purified and diluted samples (~ 100 ng/mL) of 1, 3 and 4 were
oxidised by adding 50 µL of 0.2 M NaIO4. The samples were analysed immediately by
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LC-MS/MS (method C) but with an additional trace for the oxidised AZA product (m/z
448.3).

5.3.9. Methylation with diazomethane
To determine whether a carboxylic acid group was present, purified 3 and 4 (~ 60 ng)
samples were reacted with diazomethane. The samples were added to the outside tube of
an Aldrich diazomethane generator with System 45 connection, and 1 mL MeOH and
1.5 mL Et2O were added. Diazomethane was generated in the inner tube of the
apparatus and allowed to react in situ with the extract. After reacting for 45 min at 0 °C
with occasional swirling, the extracts were transferred to a glass vial, evaporated to
dryness under a stream of N2, and residues dissolved in MeOH (1 mL) for LC-MS/MS
(method C).

5.3.10. NMR experiments
Structural determinations were performed by analysis of
SELTOCSY, NOESY, ROESY, SELROESY,

1

H, COSY, TOCSY,

13

C, DEPT135, HSQC and HMBC

spectra. Samples of 1 (1 mg), 3 (0.1 mg) and 4 (0.1 mg) were dissolved in ~ 0.5 mL
CD3OD and chemical shifts were referenced to internal CHD2OD (3.31 ppm), or
CD3OD (49.0 ppm). Single- or double-frequency pre-saturation of solvent resonances
was performed using continuous wave and/or excitation sculpting as required.
Quantitation of pure 3 and 4 was performed on aliquots in CD3OH. The sample was run
against external standards of caffeine in H2O (4.01 mM) as described previously.39
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5.3.11. Toxins and other materials
All solvents (pesticide analysis grade) were from Labscan and Caledon. Distilled H2O
was further purified using a Barnstead nanopure diamond UV purification system
(Thermo Scientific). Sodium chloride (99+%), triethylamine (99%), ammonium acetate
(97+%), ammonium formate (reagent grade), formic acid (>98%), silica gel (10–40 µm,
type H), sodium periodate and CD3OD (100.0 atom-% D) were from Sigma–Aldrich.
Sephadex LH-20 was from GE Healthcare, LiChroprep RP C8 (25–40 µm) was from
Merck, Luna Phenyl-Hexyl (15 µm) was from Phenomenex, CD3OH (99.5 atom-% D)
for qNMR was from Cambridge Isotope Laboratories. AZA CRMs were obtained from
the National Research Council of Canada.

5.3.12. Toxicology
Cell Culturing. Human Jurkat E6-1 T lymphocyte cells (American Type Culture
Collection TIB-152) were grown as described by Twiner et al.40 Briefly, cells were
grown in RPMI-1640 medium (cat. #11875-093, Invitrogen) supplemented with 10%
(v/v) fetal bovine serum (FBS; cat. #26140, Invitrogen) and maintained in a humidified
incubator (Sanyo 18AIC-UV) with 5% CO2 in air at 37 °C. Cells were subcultured with
fresh medium at an inoculum ratio of 1:4 every 3 to 4 days by transferring 2.5 mL of
cells to 7.5 mL of fresh supplemented medium in 75 cm3 screw cap culture flasks.
Cytotoxicity Assay. The effect of the AZA analogues on the viability of Jurkat T
lymphocyte cells was determined. Exponentially growing cells were seeded in 100 L
of the supplemented medium at a density of 30,000 cells per well in black, sterile, 96well culture plates for 12–18 h to allow for recovery and settling. AZA analogues were
added at various concentrations and assessed for cytotoxicity after 24, 48, or 72 h of
exposure. Parallel controls of equivalent amounts of PBS/MeOH were used to
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normalize the viability data for each treatment. Cellular viability/cytotoxicity was
assessed using the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2(4-sulfophenyl)-2H-tetrazolium) assay (Promega Biosciences, cat. no. G5421). Like
other tetrazolium-based assays, MTS in the presence of an electron coupling reagent
(phenazine methosulfate; PMS) measures cellular viability by determining the activity
of mitochondrial dehydrogenases.41 As a substrate for dehydrogenases, MTS becomes
reduced into a soluble, purple dye that can be quantitated colorimetrically to determine
the relative level of cellular viability/cytotoxicity per well. Following exposure of the
cells to the AZA analogues for the specified time, each well received 10 μL of a
PMS/MTS (1:20) solution (final concentrations of 7.9 and 158.5 g/mL, respectively).
Cells were incubated for 4 h, after which absorbance readings at 485 nm were obtained
using a FluoStar microplate reader (BMG Lab Technologies). Data are presented as
means ± SE of three separate experiments (n=3). In addition, each cytotoxicity
experiment was performed using duplicate wells. Cytotoxicity data were blankcorrected and normalized to the control (% viability). EC50 and 95% confidence
intervals were calculated using three-parameter, variable slope, non-linear regression
analysis (GraphPad Prism, ver. 5.0c).
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5.4.

Results and discussion

5.4.1. Analysis
In 2009, preliminary analysis (data not shown) of SPATT (Solid Phase Adsorption
Toxin Tracking) disks deployed at Bruckless, Ireland, in 200528 during a major AZA
event (where levels in mussels reached ~ 9 µg/g AZA equivalents29), showed the
presence of numerous candidate AZAs, including new analogues with m/z 716.4745,
816.4909, and 830.5069. Subsequent analysis of extracts from a culture of A. spinosum
by LC-MS/MS showed the presence of three new AZAs showing accurate masses of
m/z 716.4759 (3), 816.4900 (4) and 830.5046 (AZA35). Compound 3 was also
subsequently detected in an A. spinosum (SHETF6) extract collected from the Shetland
Islands by Tillmann et al.30 The three compounds all had fragmentations characteristic
of AZAs (Figure 5.2). The ratios of 2 and 3, relative to 1 were both 0.3 in cells of A.
spinosum cultures (SM2 and 3D9 strains). Compounds 4 and AZA35 were much less
abundant with ratios of 0.15, and 0.02 relative to 1, respectively, found in the culture
medium of the 3D9 strain (Figure 5.3).
Analysis of shellfish samples contaminated with 1, 2 and AZA3 (0.08–8.0 µg/g AZA
equivalents), tested as part of the routine biotoxin monitoring programme at the Marine
Institute, were also analysed for 3, 4 and AZA35. Compound 3 was detected in all
samples tested, 4 was only detected (<0.04 µg/g) in samples with > 4.0 µg/g AZA
equivalents, while AZA35 was not detected in any of the samples. The levels of 3,
relative to 1 and 2, in the SPATTs and shellfish were significantly lower than in the
cultures (SM2 and 3D9 strains) (Figure 5.3), suggesting that 3 might be chemically
transformed in seawater and shellfish.
After tangential flow filtration of a bulk culture of A. spinosum into retentate and
permeate,24 4 and AZA35 were detected only in the permeate (Figures 5.3 and 5.4).
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Similarly, higher levels of 4 were detected in the SPATT extracts relative to the A.
spinosum culture extracts suggesting that these compounds may be extracellular,
perhaps being produced within the cell and excreted. Alternatively, they may simply be
released after cellular lysis or mechanical stress on the cellular membranes during
pumping and filtration. In any case, shellfish have been shown to be capable of
absorbing AZAs from both the algal cells and the dissolved phase.31
Epimers of 1, 2, AZA3 and AZA6 at C-37 have previously been reported using LC-MS
with a neutral eluent.18,32 LC-MS analysis of A. spinosum extracts and purified samples
of 3 and 4 using a neutral eluent showed the presence of additional peaks (ranging from
~ 5−12% relative to the parent peak) which were not observed using an acidic eluent.
The spectra of these peaks differed from those of the parent compounds only in their
fragment ion ratios, as was observed for 37-epi-AZA1.18 It is likely that these peaks
correspond to the 37-epimers of 3 and 4.
Compounds 3 (700 µg) and 4 (150 µg) were isolated from the culture extract of A.
spinosum (3D9) used for the isolation of 1 and 2 that has been described previously.24
The stabilities of 3 and 4 were compared with that of 1 over a period of 7 days at −18
°C, +20 °C and +40 °C in MeOH. Both compounds exhibited similar stability to 1; each
being stable at the freezer and room temperatures over 7 days with minor degradation (<
5%) after 7 days of storage at 40 °C.
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Figure 5.2. Mass spectra of A) AZA1 (1), B) AZA33 (3), C) AZA34 (4) and D) AZA35
at a collision energy of 50 V.
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A. spinosum (SM2 strain)
A. spinosum (3D9 strain)
A. spinosum (3D9 strain) permeate
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Figure 5.3. Ratios of AZA2 (2), -33 (3) and -34 (4) relative to AZA1 (1) detected by
LC-MS/MS in A. spinosum SM2 (n=10), A. spinosum 3D9 (n=36), A. spinosum
permeate (n=3), SPATTs (n=7) and shellfish (Mytilus edulis, n=20).
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Figure 5.4. LC-MS chromatogram (method D) of a HP-20 resin permeate extract from
a bulk culture of A. spinosum showing peaks for AZA34 (4), AZA1 (1), AZA35, AZA2
(2) and AZA33 (3). Peak marked with * corresponds to AZA1 methyl ester.42
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5.4.2. Structure determination
LC-MS. High Resolution MS data were consistent with 3, 4 and AZA35 possessing the
molecular formulae shown in Table 5.1, indicating that 3, 4 and AZA35 possess six,
two, and one fewer carbon atoms than 1, respectively.
The mass spectrum of 3 (Figure 5.2) showed typical AZA-type H2O loss fragments (m/z
698 and 680). Additionally, fragments at m/z 362 and 462 suggested that the amino end
(i.e., C-21–C-40 and substituents) of 1 was also present in 3. No retro Diels–Alder
(RDA) fragment was present, however, suggesting that the A/B/C ring-system of 3
differed from that of 1. Thus, the carboxyl end of 3 (i.e., C-1−C-19) differed from that
of 1 by the absence of C6H6O3 and by the presence of four instead of seven rings/double
bonds.
Compound 4 also displayed H2O loss fragments (m/z 798 and 780), but also showed an
RDA fragment at m/z 672, in addition to fragments at m/z 362 and 462 that are
characteristic of the C-21–C-40 moiety of 1 (Figure 5.2). The MS data therefore
suggested that the structure of 4 was very similar to that of 1, including an intact A-ring,
and that 4 differed from 1 by loss of C2H4 from the side chain attached to the A-ring.
The mass spectrometric data for AZA35 (Figure 5.2 and Table 5.1) are consistent with
an additional CH2 group in the structure of 4 between C-3 and C-9, possibly in the form
of a methyl group at C-8 (as in 2). NMR data will be required to confirm this proposal.
LC-MS analysis showed that treatment of 3 and 4 with periodate yielded the same C20–C-21-cleavage product (m/z 448) as was obtained by treatment of 1. This establishes
not only the presence of a 20,21-diol in both 3 and 4, but confirms that the same C-21–
C-40 moiety that is present in 1 is also present in 3 and 4.
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Purified 3 and 4 were treated with diazomethane. LC-MS/MS analysis confirmed
conversion to the corresponding methyl esters, thus establishing the presence of a
carboxyl group in the side-chain attached at C-16 or C-6, respectively, of 3 and 4.

Table 5.1. Exact masses of [M+H]+ ions and calculated molecular formulae for AZA1
(1), -2 (2), -33 (3), -34 (4) and -35 in an A. spinosum (3D9) HP-20 permeate extract.
AZA

Molecular Formula
+

Measured m/z
+

Rings +

Δ

double bonds

(ppm)

([M+H] )

[M+H]

AZA1 (1)

C47H72NO12

842.5052

13

0.4

AZA2 (2)

C48H74NO12

856.5195

13

−1.2

AZA33 (3)

C41H66NO9

716.4759

10

3.8

AZA34 (4)

C45H70NO12

816.4900

12

0.9

AZA35

C46H72NO12

830.5046

12

-0.4

NMR spectroscopy—AZA33 (3).

Detailed analysis of 1H,

13

C, DEPT135, COSY, TOCSY, SELTOCSY, HSQC and

HMBC spectra of 3 showed the presence of the pentacyclic C-20−C-40 ring system,
present in all other known AZAs, consistent with results of the periodate cleavage
experiment. During NMR analysis of both 3 and 4, a series of minor peaks (~ 3–10%)
were also observed which were attributable to the corresponding 37-epimers, due to
susceptibility of AZAs to epimerization in MeOH under neutral and weakly acidic
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conditions.18 The presence of these epimers is noted, but is not discussed further as
these minor peaks did not interfere with NMR analysis of the parent compounds.
AZAs are characterized by a distinctive doublet-of-triplet-like signal, akin to a quartet,
at 4.41−4.43 ppm (H-19). The corresponding signal of 3 appeared at 4.08 ppm (dt, J =
8.2, 6.7 Hz). This indicated modification in 3 of the normal AZA structure in the
vicinity of C-19, with the retention of three adjacent coupled protons (H-18 and H-20).
Correlations in the COSY spectrum confirmed that the H-19 signal (4.08 ppm) was
coupled to H-20 (3.34 ppm) and a pair of methylene proton signals (H-18a/b) at 1.95
and 2.00 ppm. In the TOCSY spectrum, H-19 showed additional correlations to a pair of
methylene protons centered at 1.92 and 1.55 ppm (H-17), and an oxygenated methine
signal at 3.907 ppm (H-16), the chemical shift of which differed marginally from that of
the H-25 (3.911 ppm). In the HSQC spectrum, the foregoing protons showed
correlations to carbons at 30.5 (C-18), 30.9 (C-17) and 81.5 ppm (C-16). These
observations are consistent with the attachment to C-20 (77.4 ppm), via C-19
(80.3 ppm), of a tetrahydrofuran ring (two methylene carbons at 30.5 (C-18) and 30.9
ppm (C-17) and an oxygenated methine carbon at 81.5 ppm (C-16)), as in all other
known AZAs.33 The structure of this tetrahydrofuran ring differs, however, from known
AZAs in that it possesses two methylene carbons, indicating that it is not cis-fused to a
six-membered pyran ring as is the case for all other AZAs. It follows that the remaining
C10H15O2 portion of 3 (not accounted for by the proposed C-16 to C-40 substructure
(C31H50NO7)) must be attached to the oxygenated C-16 atom at 81.5 ppm. Moreover, it
follows from the C10H15O2 formulation, that the residue attached to C-16 must possess a
total of three rings and/or double bonds. The presence in this residue of a carboxyl
group (also consistent with the diazomethane reactivity), two olefinic double bonds, and
five methylene carbons was indicated by the occurrence of signals at 181.9 ppm
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(COOH), 127.8, 130.8, 131.5 and 133.4 ppm (2 × CH=CH groups), and at 30.9, 33.9,
34.1, 39.7 and 40.5 ppm (5 × CH2 groups), precluding the presence of rings in C-6–C15.
Notwithstanding the appreciable overlap of the four olefinic proton signals (5.40–
5.53 ppm, Figure 5.5C), the resolution of the COSY spectrum was such that the
connectivities depicted in Figure 5.1 could be established, and were supported by
TOCSY and SELTOCSY spectra run with a range of mixing times. The resonances of
the

13

C atoms to which these protons were attached were established by correlations

observed in the HSQC spectrum.
H-16 (3.907 ppm) showed COSY correlations to the H-17 methylene protons (1.55 and
1.92 ppm) and to the pair of diastereotopic side chain protons at 2.17 and 2.24 ppm (H15). These protons show a COSY correlation to the least shifted of the four olefinic
protons at 5.43 ppm (H-14). In the HSQC spectrum, this proton exhibited a correlation
to the olefinic carbon signal at 127.8 ppm (C-14). In the HMBC spectrum, H-16
(3.907 ppm) showed a correlation to the olefinic C-14 carbon (127.8 ppm), and the
protons at 5.43 (H-14) and 2.17 (H-15) also showed correlations to 133.4 ppm (C-13).
C-13 in turn showed an HSQC correlation to a methine signal at 5.50 ppm (H-13).
These observations defined the location of the first of the two double bonds in the 10carbon side chain attached to C-16.
The two pairs of methylene protons at 2.03 ppm (4H, br s, H-11 and H-12) were not
overlapped in the 1H NMR spectrum by other signals, and showed COSY correlations
only to the olefinic proton signals centered at 5.45 (H-10) and 5.50 ppm (H-13). In the
HMBC spectrum, the protons at 2.04 ppm showed correlations to the four olefinic
carbons (127.8, 130.8, 131.5 and 133.4 ppm) and adjacent partner methylene carbons
(33.9 and 34.1 ppm, C-11 and C-12). The resolution of the processed HMBC spectrum
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was such that while the four olefinic carbon correlations were resolved, the methylene
carbon resonances, which differed by 0.2 ppm, were not. The foregoing COSY and
HMBC observations demonstrated that the methylene carbons (C-11and C-12) with
superimposed proton signals at 2.03 ppm must be located between the C-9(10) and C13(14) double bonds.
The remaining pair of methylene carbons at 30.9 and 39.7 ppm, which showed HSQC
correlations to pairs of protons at 2.26 (2H) and 2.18 (2H) ppm, respectively, and a
terminal carboxyl group (181.9 ppm), must be attached to C-9. Consistent with this, the
olefinic proton signal at 5.48 (H-9) ppm showed a COSY correlation to 2.26 ppm (H8a/b), while HMBC correlations were observed between the proton signal at 2.18 ppm
(H-7a/b) and the carboxyl carbon (C-6, 181.9 ppm) and a methylene carbon (C-8,
30.9 ppm).
Homonuclear decoupling experiments were also consistent with the attachment to C-16
of a 10 carbon side-chain (Figure 5.1). In particular, homonuclear decoupling at
2.04 ppm under standard conditions collapsed the lines attributable to the H-10 and H13 olefinic protons (5.45 ppm and 5.50 ppm, respectively) to 15.3 Hz doublets (Figure
5.5B). These couplings demonstrate that the 9(10)- and 13(14)-double bonds are both
trans-substituted. Similarly, homonuclear decoupling at 2.21 ppm (between the
frequencies of the H-7 and H-8 methylene protons) using a higher power level that was
also effective at decoupling the nearby H-15 methylene protons (at 2.17 and 2.24 ppm),
resulted in the H-9 (5.48 ppm) and H-14 (5.43 ppm) olefinic protons appearing as welldefined 15.3 Hz doublets (Figure 5.5A). Under these conditions, the H-10 (5.45 ppm)
and H-13 (5.50 ppm) olefinic protons appeared as doublets (J = 15.3 Hz) of poorly
resolved, residually coupled, triplets (Jresidual ~ 1–2 Hz) due to incomplete decoupling of
the adjacent H-11 and H-12 methylene protons at 2.04 ppm.
158

Chapter 5 - Isolation of AZA33 and -34 from phytoplankton
The H-19 (4.08 ppm) proton of 3 exhibited ROESY correlations that paralleled those
which we have previously observed for 1,18 including moderate intensity inter-ring
correlations to the equatorial H-40 proton (2.46 ppm) and the more shifted of the two
olefinic 26-methylene protons (H-26Z, 5.27 ppm). H-19 (4.08 pm) also showed ROESY
correlations to H-22 (2.37 ppm) and the 22-methyl group (0.89 ppm), as did H-20
(3.34 ppm). H-16 (3.907 ppm) showed ROESY correlations to the adjacent H-15
methylene protons (2.17 and 2.24 ppm) of the 10-carbon side-chain, and to one of the
H-17 protons (1.92 ppm), together with a low intensity (0.15%) ROESY correlation to
the more distant H-19 proton (4.08 ppm) as also seen in ROESY spectra of 1 and 2.
These observations showed that the C-16, C-19 and C-20 configurations of 1 and 3 are
essentially identical, that the dispositions of their C-16−C-20 tetrahydrofuran ring and
20-CHOH groups are similar, and that the inter-ring spatial relationships between the C19, C-26 and C-40 regions of 3 are comparable to those of 1. These observations are
consistent with the relative configuration proposed for the C-16–C-19 region of 3
(Figure 5.1).
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Figure 5.5. 1H NMR spectra of AZA33 (3) from 5.38–5.54 ppm, showing the sidechain olefinic protons (H-4, H-5, H-8 and H-9), with: (A) high-power decoupling at
2.21 ppm (decoupling ~ 2.16–2.26 ppm (H-2, H-3, and H-10)); (B) low power
decoupling at 2.04 ppm (decoupling H-6 and H-7), and; (C) no decoupling.
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NMR spectroscopy—AZA34 (4).

In full accord with the mass spectrometric and periodate cleavage results discussed
above, detailed analysis of 1H,

13

C, DEPT135, COSY, TOCSY, SELTOCSY, HSQC

and HMBC spectra showed that 4 possessed an intact C-6−C-40 ring system and that
the 5-carbon ring-A-side-chain present at C-6 in all other reported AZAs had been
replaced by a 3-carbon –CH2-CH2-COOH side chain. The 1H chemical shifts of the
modified side chain methylene groups were elucidated via correlations in COSY and
TOCSY spectra. H-6 (4.41 ppm), which was coincident with the H-19 signal, exhibited
COSY correlations to the H-5a/b methylene protons (1.76 and 1.85 ppm). These
correlations were readily differentiated from those which H-19 exhibited to H-18a/b
(2.02 ppm), H-20 (3.55 ppm), and H-17 (4.19 ppm). The TOCSY spectrum at the
frequency of H-6 (4.41 ppm) and at the frequencies of other protons associated with the
mutually coupled H-4a/b–H-5a/b–H-6–H-7–H-8–H-9a/b spin systems included
correlations to 2.21 and 2.31 ppm, attributable to the H-4a/b protons. The H-4 and H-5
methylene protons showed HSQC correlations to resonances at 34.7 and 33.2 ppm (C-4
and C-5, respectively), while the protons at 2.21 and 2.31 (H-4a/b) showed HMBC
correlations to 181.9 (C-3), 70.5 (C-6) and 33.2 ppm (C-5).
The chemical shifts of carbons and protons associated with the C-6–C-40 portion of 4
were similar, but not in all cases identical, to those of 1 (Table 5.2) and several other
AZAs.14−17 It is apparent from an analysis of published NMR data that the chemical
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shifts of atoms in the vicinity of the 40-NH group and the C-20 portions of AZA are
dependent on the pH of the examined NMR solutions.17,18 The presence of acetic acid
(or deuteroacetic acid) in NMR solutions significantly increases the chemical shifts of
the 40-methylene protons (reported chemical shifts for these protons are in the range
2.5–2.9 ppm), presumably due to protonation of the NH group, and that this in turn
influences the chemical shifts of some of the other more remote protons (most notably
H-20; reported chemical shifts are in the range 3.5−3.9 ppm) that are in close proximity
to H-19.18 However, because addition of weak acid promotes epimerization at C-37,
addition of d5-pyridine may be a better option for pH control during NMR analysis of
AZAs.18
The NMR spectra of all AZAs examined in our laboratory,18 including 3 and 4, have
exhibited moderate intensity inter-ring ROESY correlations between the equatorial H40 methylene proton and both H-19 and the more shifted of the two protons of the
exomethylene group located at C-26. Compound 4, in both 2D-ROESY and a series of
1D-SELROESY NMR experiments, exhibited an equivalent series of ROESY
correlations to that observed for 1, including a moderate intensity ROESY correlation
between H-6 (4.41 ppm) and the 14-methyl group (0.95 ppm) which showed its C-6
configuration to be identical to that of 1. H-6 (4.41 ppm) also showed ROESY
correlations to the H-5a/b protons (1.76 and 1.85 ppm). The foregoing ROESY
correlations were readily distinguishable from those which the superimposed H-19
signal showed to H-20 (3.55 ppm), H-18a/b (2.02 ppm), H-22 (2.24 ppm), the 22methyl group (0.89 ppm) and one of the olefinic methylene protons attached to C-26
(5.26 ppm), because none of the correlations exhibited by the H-6 and H-19 signals
overlapped and no nearby atoms possessed similar chemical shifts.
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The NMR data provided definitive proof of the structures, showing that 3 consists of a
trans,trans-4,8-decadienoic acid unit attached via its C-10 (i.e., C-15 of 3) to the C-16
of an AZA tetrahydrofuran D-ring. Compound 4 differed from 1 only by having a
shorter three carbon side chain without the double bond.
Many polyether toxins from dinoflagellates, such as okadaic acid and yessotoxin, are
generated by cyclisation of a long carbon chain assembled primarily from acetate units
via polyketide synthase enzyme clusters.34 Examination of their structures suggest that
this is also likely for AZAs, with the polyether structure of 1 being assembled from a
40-carbon chain. If this is indeed the case, it would appear that 4 is assembled from a
38-carbon chain and 3 from a 35-carbon chain. The production of 4 is consistent with a
failure to incorporate one acetate unit, into the growing carbon chain during polyether
biosynthesis. The fact that 3 has an odd numbered chain length may be due to oxidative
cleavage of a C-5/C-6 double bond in a 40 carbon chain precursor. Furthermore, the
structures of 3 and 4 suggest that AZAs may be assembled and cyclized from the
amino-end, because in both of these compounds the C-19–C-40 substructure, including
the relative configuration and all substituents, has been successfully assembled in an
identical manner to 1 and 2 in A. spinosum’s AZA-synthase.
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Table 5.2. NMR assignments (1H 600 MHz, 13C 150 MHz) for AZA1 (1), -33 (3) and 34 (4) in CD3OD.
1a

3
1
13
1
C
H
C
H
1
181.2
2
38.1
2.25, 2.25
3
30.2
2.33, 2.33
4
133.7
5.75
5
130.7
5.44
6
72.5
4.79
181.9
7
129.4
5.63
39.7
2.18, 2.18
8
123.2
5.73
30.9
2.26, 2.26
9
35.7
2.12, 2.46
131.5
5.48b
10
107.2
130.8
5.45c
d
11
37.5
1.97, 2.14
34.1
2.03, 2.03
12
33.2
1.66, 2.33
33.9d
2.03, 2.03
13
111.3
133.4
5.50c
14
31.0
2.02
127.8
5.43b
15
32.6
1.76, 1.85
40.5
2.17, 2.24
16
78.2
3.88
81.5
3.907
17
73.3
4.23
30.9
1.55, 1.92
18
37.3
1.99, 2.01
30.5
1.95, 2.00
19
79.2
4.43
80.3
4.08
20
76.9
3.86
77.4
3.34
21
100.2
100.0
22
36.6
2.12
35.7
2.37
23
38.3
1.43, 1.43
39.0
1.39, 1.39
24
42.3
1.35
42.2
1.36
25
79.6
3.98
79.5
3.911
26
148.3
148.0
27
49.5
2.24, 2.42
49.6
2.15, 2.34
28
98.6
98.0
29
44.3
1.36, 2.03
44.7
1.30, 1.98
30
26.4
2.23
26.7
2.25
31
35.4
1.52, 1.83
35.6
1.47, 1.77
32
72.8
4.35
72.7
4.24
33
81.2
4.01
79.4
3.74
34
74.9
4.98
75.4
4.81
35
41.9
2.41, 2.59
43.0
1.88, 2.39
36
96.6
95.8
37
36.0
1.95
37.7
1.76
38
38.0
1.28, 1.67
39.9
1.14, 1.54
39
29.8
1.85
31.0
1.69
40
46.4
2.79, 2.84e
47.4
2.53, 2.46e
14-Me
16.6
0.95
22-Me
16.4
0.91
16.9
0.89
24-Me
18.1
0.84
18.1
0.81
26=CH2
116.8
5.16, 5.34f
115.4
5.07, 5.27f
30-Me
23.5
0.95
23.7
0.93
37-Me
15.5
0.96
16.1
0.86
39-Me
18.6
0.94
19.5
0.85
a
From Kilcoyne et al.18
b
Decoupled by homonuclear decoupling at 2.21 ppm (Figure 5.5A).
c
Decoupled by homonuclear decoupling at 2.04 ppm (Figure 5.5B).
d
Assignments interchangeable.
e
Haxial, Hequatorial
f
H E, H Z
Position

13
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4
13

C

181.9
34.7
33.2
70.5
130.1
123.3
37.6
107.1
37.6
33.0
111.0
30.9
32.6
78.1
73.1
38.3
79.2
77.2
99.5
36.3
38.3
42.0
79.8
148.2
49.4
97.9
44.7
26.4
35.6
72.8
79.6
75.5
43.1
95.8
37.3
39.8
31.2
47.7
16.6
16.3
18.0
115.6
23.6
16.0
19.2

1

H

2.21, 2.31
1.76, 1.85
4.41
5.70
5.72
2.11, 2.46
1.94, 2.12
1.64, 2.32
2.01
1.75, 1.81
3.89
4.19
2.02, 2.02
4.41
3.55
2.24
1.41, 1.41
1.35
3.93
2.16, 2.35
1.31, 1.98
2.24
1.48, 1.78
4.26
3.77
4.82
2.00, 2.43
1.76
1.17, 1.55
1.68
2.55, 2.55
0.95
0.89
0.82
5.10, 5.26f
0.93
0.88
0.86
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5.4.3. Relative molar response
Compounds 3 and 4 were quantitated by quantitative NMR (qNMR), and their molar
responses in various LC-MS methods were assessed against purified 1, that had also
been quantitated by qNMR. A number of LC-MS analyses were performed employing
an acidic (isocratic and gradient) mobile phase in both SIM (selected ion monitoring)
and SRM (selected reaction monitoring) modes.
LC-MS data obtained in SIM mode suggested that 3 and 4 had very similar responses to
1 when analysed under the various conditions (Table 5.3). In SRM mode, differences in
response factors were observed. The response using the H2O loss fragment for 3 was
similar to that for 1, while a higher response factor was obtained for 4. The RDA
fragment for 4 gave a lower response factor than for 1, as did the m/z 462 fragment for
3. The m/z 362 transitions for both 3 and 4 were slightly lower than that for 1 (Table
5.3). These results suggest that, in the absence of standards, 3 and 4 would be more
accurately quantitated against 1 in SIM mode.

Table 5.3. Relative molar response factors (propagated standard deviation of the last
significant figure in parentheses) of AZA33 (3) and AZA34 (4) in relation to AZA1 (1)
(1(area/concentration)/(3 or 4(area/concentration)))a.
MS mode

3

4

Gradientb

Isocraticc

Gradientb

Isocraticc

1.03 (2)

0.97 (3)

1.01 (3)

1.05 (3)

1.03 (11)

1.05 (3)

1.22 (9)

1.17 (7)

SRM ([M+H] →672)

-

-

0.41 (2)

0.39 (2)

SRM ([M+H]+→462)

0.77 (5)

0.80 (5)

-

-

SRM ([M+H]+→362)

0.91 (6)

0.90 (4)

0.90 (7)

0.87 (4)

(ion/transition)
SIM [M+H]+
SRM ([M+H]+ − H2O)
+

a

Determined by SIM and SRM LC-MS experiments using gradient and isocratic LC elution with an
acidic mobile phase. bMethod F(i). cMethod F(ii).

165

Chapter 5 - Isolation of AZA33 and -34 from phytoplankton
5.4.4. Toxicity
Compounds 3 and 4 were cytotoxic to Jurkat T lymphocyte cells in a time- and
concentration-dependent manner (Figure 5.6), and were 0.22- and 5.5-fold as potent as
1, respectively (Table 5.4).

Figure 5.6. Effect of AZA analogues on T lymphocyte cell viability. Jurkat T cells were
exposed to various concentrations of (A) AZA1 (1), (B) AZA33 (3), and (C) AZA34 (4) for
24, 48, or 72 h and viability was assessed using the MTS assay. All data (mean ± SE; n=3)
were normalized to the control (10% MeOH vehicle). Non-linear, three parameter dose–
response (variable slope) analysis was performed and EC50 values calculated (Table 5.4).
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Although these compounds were present in minor amounts relative to 1 and 2 in French
and Irish shellfish, their major significance lies in their structural differences and their
usefulness in establishing structure–activity relationships. Analogue 3 is similar to 1 but
without the A/B/C ring structure, while 4 differs from 1 only by the shorter side chain
and absence of the 4,5- alkene. In the absence of the A/B/C ring structure, relative
cytotoxic potency was reduced ~ 5-fold (relative to 1) (Table 5.4), suggesting that
although this fragment of the AZA molecule influences toxicity, it is not the primary
toxicophore or epitope necessary for AZAs to bind to and affect their target(s). On the
other hand, the shorter side chain and absence of the 4,5-alkene in 4 enhanced cytotoxic
potency by > 5 fold (Table 5.4). This increase in potency may be due to greater
interaction of the molecular target(s) with the negatively charged carboxylic acid due to
the altered configuration. Although 1, 2 and AZA3 have been shown to induce
apoptosis13 and selectively inhibit hERG potassium channels,35 the effects of 3 and 4 on
these pathways have not yet been characterized. The results presented here suggest that
it may be possible to link a reporter molecule in the vicinity of the carboxyl moiety of
AZAs and still retain sufficient binding affinity to probe the AZAs’ molecular target.

Table 5.4. Calculated EC50 values (nM) with 95% confidence intervals (CI) and relative
potencies (Rel. Pot.) for AZA analogues based on T lymphocyte cytotoxicity.
24 h

AZA

48 h

72 h

Mean Rel.

EC50

95% CI

EC50

95% CI

EC50

95% CI

EC50

Pot.

1

0.96

0.19–4.9

1.10

0.46–2.5

1.3

0.59–3.0

1.1

1.0

3

3.3

0.79–13

5.9

2.4–15

6.4

2.8–15

5.2

0.22

4

0.23

0.042–1.2

0.18

0.098–0.34

0.20

0.11–0.38

0.20

5.5
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5.5.

Conclusions

Three new AZAs were identified in seawater (SPATT) samples and in cultured A.
spinosum, two of which (3 and 4) were present in sufficient amounts for purification.
Structures were determined by LC-MS/MS and NMR spectroscopy. Compound 3 was
found to have major structural differences compared to 1, while 4 only differed by a
shorter side chain and the lack of an alkene group at the C-4–C-5 position. The fact that
4 was more abundant in natural seawater samples and in culture medium raises
questions regards its biological and ecological roles. Analysis of these AZAs using a
neutral mobile phase indicates that 37-epimers also exist for these compounds.
Cytotoxicity was assessed employing Jurkat T lymphocyte cells, and potencies relative
to 1 for 3 and 4 were found to be 0.22 and 5.5, respectively. Both 3 and 4 were present
in Irish mussels at very low levels and are not considered of relevance to human health.
However, with the notable differences in structure and potency, these analogues further
our knowledge of AZA structure–activity relationships.
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CHAPTER 6 – STRUCTURE ELUCIDATION, RELATIVE LC-MS
RESPONSE, IN VITRO TOXICITY OF AZASPIRACIDS 7−10
ISOLATED

FROM

MUSSELS

(MYTILUS

EDULIS)

AND

PROPORTIONS IN SHELLFISH.
Kilcoyne, J., Twiner, M., McCarron, P., Crain, S., Giddings, S. D., Foley, B., Rise, F.,
Hess, P., Wilkins, A. L., Miles, C. O. Structure elucidation, relative LC-MS response
and in vitro toxicity of azaspiracids isolated from mussels (Mytilus edulis). Journal of
Agriculture and Food Chemistry, 2015, DOI: 10.1021/acs.jafc.5b01320.
Kilcoyne, J., McCarron, Hess, P., Miles, C. O. Effects of heating on proportions of
azaspiracids 1–10 in mussels (Mytilus edulis) and identification of novel carboxylated
analogues. Manuscript in preparation.

6.1.

Abstract

Azaspiracids (AZAs) 7–10 (7−10) were isolated from shellfish and their structures,
previously proposed based only on LC-MS/MS data, were confirmed by NMR
spectroscopy. Samples of AZA4–6 (4−6) and 7−10 accurately quantitated by qNMR,
were used for a relative molar response study, assaying cytotoxicity with Jurkat T
lymphocyte cells and assessing proportions in naturally contaminated mussels.
LC-MS/MS molar response studies performed using isocratic and gradient elution, in
both SIM and SRM modes, showed that responses for the analogues ranged from 0.3 to
1.2 relative to AZA1 (1). All AZA analogues tested were cytotoxic to Jurkat T
lymphocyte cells in a time- and concentration-dependent manner. However, there were
distinct differences in their EC50 values, with cytotoxicity potencies being AZA6 >
AZA8 > AZA1 > AZA4  AZA5  AZA9 > AZA10. This provides valuable
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information on structure–activity relationships. Analysis of heat-treated shellfish
naturally contaminated with AZAs revealed high levels of 3 and 6 in some samples that
were otherwise below the limit of quantitation before cooking. Relative to 1, the
average (n=40) levels of 4 (range 0–27%), 5 (range 1–21%) and 8 (range 1–27%) were
each ~ 5%, while 7, 9 and 10 (range 0–8%) were each under 1.5%.

6.2.

Introduction

The consumption of shellfish contaminated with azaspiracids (AZAs) leads to the
syndrome azaspiracid poisoning (AZP).1 Poisoning incidents associated with this toxin
group have been reported.2,3 In all cases, the source of the implicated shellfish was
Ireland where the levels and number of AZA occurrences have been most problematic.4
AZAs have been reported to produce “neurotoxin-like” symptoms via intraperitoneal
injection in mice, with death in 20–90 min.5 Oral administration was found to produce
clinical disease that was dose- and time-dependent, in addition to damaging the
intestinal organs.6−9 AZA1 (1) is a K+ channel blocker,10 and is highly cytotoxic to
multiple cell types which undergo atypical apoptosis after exposure.11
AZAs were first identified in the late 1990s and since then more than 30 analogues have
been identified in shellfish,12 phytoplankton,13−15 crabs16 and a marine sponge.17 Only 1,
AZA2 (2) and AZA3 (3) are currently regulated in raw shellfish.18 Compounds 1,19 2,
3,20 AZA4 (4), AZA5 (5)21 and AZA6 (6)22 have been isolated and their structures
elucidated through a combination of NMR spectroscopy and chemical reactions. More
recently, 37-epi-1 that was isolated from shellfish extracts, was found to differ
structurally from 1 in respect of the orientation of the methyl group at C-37, and to be 5fold more toxic than 1 using the Jurkat T lymphocyte cell assay.23
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LC-MS analysis revealed the presence of hitherto unknown AZAs in the dinoflagellates
Amphidoma languida,14 Azadinium poporum24 and Azadinium spinosum.15 The AZAs
identified in A. spinosum, subsequently named AZA33 and -34, were found to be the
same structurally at the amine end of the molecule (C-21–40) compared to 1, producing
the characteristic m/z 362 fragment during LC-MS/MS analysis.15 AZAs from A.
poporum (AZA36 and -37), on the other hand, appear to differ by the lack of a methyl
or methylene group in the I-ring, resulting in an equivalent fragment with m/z 348.9 The
AZAs (with molecular masses of 815 and 829 Da) detected in the A. languida also
displayed fragment ions with m/z 348, suggesting that these compounds also may lack a
methyl group in the I-ring.14
Here we describe the isolation of 4, 5, AZA7 (7), AZA8 (8), AZA9 (9) and AZA10 (10)
(Figure 6.1) from shellfish, with confirmation by NMR of the structures previously
postulated based on LC-MS/MS. Relative molar response studies using mass
spectrometry were performed following the preparation of reference standards which
were quantitated using quantitative NMR (qNMR). The toxicity of 4–10 was assessed
using the Jurkat T Lymphocyte cell assay and the results used to discern structure–
activity relationships (SARs). The relevance of these toxins for human health protection
in terms of toxicity and proportions detected in mussels was also evaluated.
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Figure 6.1. Structures of 1–10, their protonated masses and origin. The m/z values of
the fragments are for 1; corresponding fragments were observed for 2–10.

6.3.

Experimental section

6.3.1. General experimental procedures
NMR experiments for structure elucidation were run using Bruker Avance I and Avance
II 600 MHz spectrometers equipped with TCI cryoprobes and Z-gradient coils, at 30 °C
and a Bruker DRX-500 spectrometer using a TXI probe and Z-gradient coils at 20 oC
was used for qNMR.
Mass spectrometric studies were performed using a Waters 2695 LC coupled to a
Micromass triple-stage quadrupole (TSQ) Ultima, a Waters 2795 LC coupled to a
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Micromass quadrupole time of flight (QToF) Ultima and an Agilent 1200 LC system
connected to a SCIEX API4000 QTRAP mass spectrometer equipped with a
Turbospray ionization source.

6.3.2. Biological material
Mytilus edulis samples contaminated with AZAs were obtained from shellfish
harvesting sites along the West coast of Ireland. The samples selected for analysis
(n=40) were from different locations and harvested in different years.

6.3.3. Isolation and purification
The isolation procedure has been previously

described by Kilcoyne et al.22 Final

purification of AZAs was achieved by semi-preparative LC (Agilent 1200) with
photodiode array (PDA) detection (210 nm) using a Cosmosil C18 column, 5 µm, 250 ×
4.6 mm, Nacalai tesque) eluted with CH3CN/H2O (1:1, plus 2 mM ammonium acetate)
at 1 mL/min. The column temperature was 30 °C. Due to the presence of co-eluting
compounds two additional semi-preparative steps using CH3CN/H2O (0.8:1, plus 2 mM
ammonium acetate) were required to attain sufficient purity for NMR. Purified AZAs
were recovered by diluting the fractions with H2O (to 20% CH3CN), loading on to
solid-phase extraction (SPE) cartridges (Oasis HLB, 200 mg), washing with
MeOH/H2O (1:9, 10 mL) to remove the buffer, and eluting with MeOH/H2O (9:1,
20 mL). Removal of solvent by evaporation in vacuo afforded purified AZAs as white
solids.
AZA7 (7). white, amorphous solid; 1H and 13C data (CD3OD, 600 MHz), see Table 6.1;
HRESIMS m/z 858.4990 [M+H]+ (calcd for C47H71NO13, 858.5009).
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AZA8 (8). white, amorphous solid; 1H and 13C data (CD3OD, 600 MHz), see Table 6.1;
HRESIMS m/z 858.5002 [M+H]+ (calcd for C47H71NO13, 858.5009).
AZA9 (9). white, amorphous solid; 1H and 13C data (CD3OD, 600 MHz), see Table 6.1;
HRESIMS m/z 858.5007 [M+H]+ (calcd for C47H71NO13, 858.5009).
AZA10 (10). white, amorphous solid; 1H and

13

C data (CD3OD, 600 MHz), see Table

6.1; HRESIMS m/z 858.5012 [M+H]+ (calcd for C47H71NO13, 858.5009).

6.3.4. Analysis of raw and cooked shellfish tissues
AZA-contaminated raw samples, tested as part of the routine monitoring programme in
Ireland, were selected for analysis. The shellfish were shucked and homogenised before
extraction. Tissue samples were weighed (2 g) in duplicate into 50 mL centrifuge tubes
with one set placed in a H2O bath (Grant Ltd) and heated to 90 °C for 10 min, then
allowed to cool. The samples were extracted by vortex mixing for 1 min with 9 mL of
MeOH, centrifuged at 3,950 g (5 min), and the supernatants decanted into 25 mL
volumetric flasks. The remaining pellet was further extracted using an Ultra turrax
(IKA) for 1 min with an additional 9 mL of MeOH, centrifuged at 3,950 × g, 5 min, and
the supernatants decanted into the same 25 mL volumetric flasks, which was then
brought to volume with MeOH. The extracts were analysed by LC-MS/MS (method A).
Certified standards of 1–3 and the reference standards prepared for 4–10 were used for
quantitation.

6.3.5. Periodate cleavage
Dilutions (~ 100 ng/mL) of purified 7−10 in MeOH were used. To 100 µL of each
sample was added 50 µL of 0.2 M sodium periodate solution, and the reactions analyzed
immediately by LC-MS (method A) including traces at m/z 448.4 (for the 7 oxidation
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product), m/z 464.4 (for the 8 oxidation product), m/z 434.4 (for the 9 oxidation
product) and at m/z 450.4 (for the 10 oxidation product).
6.3.6. LC-MS experiments
Method A. Recoveries were determined by quantitative analysis of fractions on a Waters
2695 LC coupled to a Micromass triple-stage quadrupole (TSQ) Ultima operated in
SRM mode for the following transitions: m/z 842.5→824.5/362.3 (1 and 6); m/z
856.5→838.5/362.3 (2); m/z 828.5→810.5/362.3 (3); m/z 844.5→826.5/362.3 (4 and 5)
and m/z 858.5→ 840.5/362.3 (7–10). The cone voltage was 60 V, collision energy was
50 V, the cone and desolvation gas flows were set at 100 and 800 L/h, respectively, and
the source temperature was 150 °C.
Binary gradient elution was used, with phase A consisting of H2O and phase B of
CH3CN (95%) in H2O (both containing 2 mM ammonium formate and 50 mM formic
acid). Chromatography was performed with a Hypersil BDS C8 column (50 × 2.1 mm,
3 µm, with a 10 × 2.1 mm guard column of the same stationary phase) (Thermo
Scientific). The gradient was from 30% B, to 90% B over 8 min at 0.25 mL/min, held
for 5 min, then held at 100% B at 0.4 mL/min for 5 min, and returned to the initial
conditions and held for 4 min to equilibrate the system. The injection volume was 5 µL
and the column and sample temperatures were 25 °C and 6 °C, respectively.
Method B. Structure determination and purity was assessed on a Micromass time-offlight (QToF) Ultima coupled to a Waters 2795 LC by running MS scans (m/z 100–
1000) using the same chromatographic conditions as above. Identification of other
contaminant AZA analogues was also determined by performing product ion scans,
where the precursor ions were selected and then fragmented, for all the known AZA
analogues.
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Method C. Qualitative analysis of fractions for AZAs was performed by flow injection
analysis (FIA)-MS/MS using a Micromass quadrupole time of flight (QToF) Ultima
coupled to a Waters 2795 LC. Samples (2 µL) were injected directly (no column) into
the mass spectrometer, monitoring for the precursor ions.
Method D. For a relative molar response study accurate working standards were
prepared by diluting the qNMR stock solutions in high purity degassed MeOH. The
concentrations of the working solutions were ~ 1 µM for all analogues. Analysis was
performed on an Agilent 1200 LC system connected to an API4000 QTRAP mass
spectrometer (AB Sciex) equipped with a Turbospray ionization source. The MS was
operated in positive ion mode and SRM transitions were as follows: m/z
842.5→824.5/672.5/462.3/362.3

(1);

844.5→826.5/658.5/362.3

m/z

(4);

m/z

844.5→826.5/674.5/362.3

(5);

m/z

842.5→824.5/658.5/362.3

(6);

m/z

858.5→840.5/672.5/362.3

(7);

m/z

858.5→840.5/688.5/362.3

(8);

m/z

858.5→840.5/658.5/362.3 (9) and m/z 858.5→840.5/674.5/362.3 (10). For selected ion
monitoring (SIM) experiments m/z 842.5 (1 and 6), 844.5 (4 and 5) and 858.5 (7–10)
were analysed. Typical parameters were 5500 V electrospray voltage, 400 °C source
temperature, 70 V declustering potential and collision energies of 45 to 70 V (where
applicable). Method D (i) used gradient elution with the same acidic mobile phase as
method A, separation being performed on a 2.5 µm, 2.1 × 50 mm, Luna C18(2) HST
column (Phenomenex). The gradient was from 25 to 100% B over 5 min at 300 µL/min
and held at 100% B for 2 min, before re-equilibration for the next run. The injection
volume was 1–5 µL and the column and sample temperatures were 25 °C and 6 °C,
respectively. Method D (ii) used isocratic elution with the acidic mobile phase on the
same Luna column, with 60% B at 300 µL/min.
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Method E. For separation of the 37-epimers33 a neutral gradient elution was used.
Separation was performed on the same Luna column used in method D, operated at
15 °C, injecting 1–5 µL samples. A binary mobile phase of H2O (A) and CH3CN (95%)
in H2O (B), each containing 5 mM ammonium acetate (pH 6.8), was used with a linear
gradient from 25 to 100% B over 5 min at 350 µL/min and held at 100% B for 2 min,
before re-equilibration for the next run.
Method F. Accurate mass measurements and quantitation were performed on a Waters
Acquity UPLC coupled to a Xevo G2-S QToF operated in MSe mode, scanning from
100−1200 m/z and using leucine enkephalin as the reference compound. The cone
voltage was 40 V, collision energy was 50 V, the cone and desolvation gas flows were
set at 100 and 1000 L/h, respectively, and the source temperature was 120 °C.
Chromatography was performed with an Acquity UPLC BEH C18 (50 × 2.1 mm,
1.7 µm) column (Waters), using the same mobile phase described in method A. The
gradient was from 30–90% B over 2 min at 0.4 mL/min, held for 2 min, and returned to
the initial conditions and held for 1 min to equilibrate the system. The injection volume
was 2 µL and the column and sample temperatures were 25 °C and 6 °C, respectively.

6.3.7. NMR experiments
Structures were determined by analysis of 1H, COSY, TOCSY, NOESY, ROESY,
HSQC and HMBC, 13C and DEPT135 NMR spectra. Samples of 4–10 (~ 0.1 mg) were
dissolved in ~ 0.5 mL CD3OD at 30 °C, and chemicals shifts were referenced to
internal CHD2OD (3.31 ppm) or CD3OD (49.0 ppm). Single- or double-frequency presaturation of solvent resonances was performed using continuous wave and/or
excitation sculpting, as required.
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Quantitation of 1 and 4–10 was performed on aliquots of the purified compounds by
dissolving in CD3OH.34 The samples were run against external standards of caffeine
dissolved in H2O (4.10 mM) as described previously for AZA certified reference
materials.35

6.3.8. Toxins and other materials
All solvents (pesticide analysis grade) were from Labscan and Caledon. Distilled H2O
was further purified using a Barnstead nanopure diamond UV purification system
(Thermo Scientific). Sodium chloride (99+%), triethylamine (99%), ammonium acetate
(97+%), ammonium formate (reagent grade), formic acid (>98%), silica gel (10–40 µm,
type H), sodium chloride (99+%), sodium periodate, Trace CERT caffeine and CD3OD
(100.0 atom-% D) were from Sigma–Aldrich. Sephadex LH-20 was from GE
Healthcare, LiChroprep RP C8 (25–40 µm) was from Merck, Luna Phenyl-Hexyl
(15 µm) was from Phenomenex, CD3OH (99.5 atom-% D) for qNMR was from
Cambridge Isotope Laboratories. AZA CRMs were obtained from the National
Research Council of Canada.

6.3.9. Toxicology
Cell Culturing. Human Jurkat E6-1 T lymphocyte cells (American Type Culture
Collection TIB-152) were grown as described by Twiner et al.36 Briefly, cells were
grown in RPMI medium (cat. #11875-093, Invitrogen) supplemented with 10% (v/v)
fetal bovine serum (FBS; cat. #26140, Invitrogen) and maintained in a humidified
incubator (Sanyo 18AIC-UV) with 5% CO2 in air at 37 °C. Cells were subcultured with
fresh medium at an inoculum ratio of 1:4 every 3 to 4 days by transferring 2.5 mL of
cells to 7.5 mL of fresh supplemented medium in 75 cm3 screw cap culture flasks.
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Cytotoxicity Assay. To determine the effect of 1, 4−6 and 8–10 on cellular toxicity,
Jurkat T lymphocyte cells were continuously exposed to toxins and viability
determined. The non-adherent human cell line Jurkat T lymphocyte (ATCC cat. # TIB152) was grown in RPMI medium supplemented with 10% (v/v) fetal bovine serum
(FBS). Cells were maintained in humidified 5% CO2 in air at 37 °C and subcultured
with fresh medium at an inoculum ratio of 1:10 every 5 to 7 days by transferring 1 mL
of cells to 9 mL of fresh supplemented medium in 75 cm2 screw cap culture flasks.
Cells were seeded in a volume of 100 L of the supplemented medium at a density of
35,000 cells per well in black, sterile, 96-well culture plates for 24 h to allow for
recovery and settling. Each AZA was added at a single concentration (10 nM) for 24,
48, or 72 h of continuous exposure prior to assessment of cytotoxicity. Parallel controls
of equivalent amounts of MeOH/phosphate buffered saline were used to normalize the
viability data for each treatment. Cellular viability/cytotoxicity was assessed using the
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) assay (Promega Biosciences). Like other tetrazolium-based assays,
MTS in the presence of an electron coupling reagent (phenazine methosulfate; PMS)
measures

cellular

viability

by

determining

the

activity

of

mitochondrial

dehydrogenase.37 As a substrate for dehydrogenases, MTS becomes reduced into a
soluble, purple dye that can be quantitated colourimetrically to determine the relative
level of cellular viability/cytotoxicity per well. Following exposure of the cells to the
AZA analogues for the specified period of time, each well received 10 μL of a
PMS/MTS (1:20) solution. Cells were incubated for 4 h, after which absorbance
readings at 485 nm were obtained using a FluoStar microplate reader (BMG Lab
Technologies). Data are presented as means ± SE of three to five separate experiments
(n=3–5). In addition, each cytotoxicity experiment was performed using duplicate wells.
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Cytotoxicity data were blank-corrected and normalized to the control (% viability) and
plotted using GraphPad Prism (ver. 5.0c).
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6.4.

Results and discussion

The isolation of 6 has previously been described.22 Hydroxylated analogues 4, 5 and 7–
10 are less lipophilic than 1–3 and 6, and therefore eluted earlier (Figure 6.5) and were
more difficult to separate from the other contaminants in the sample. In the initial semi
preparative step 4 and 5 and 7–10 were collected as two separate fractions. Individual
analogues were separated in a second chromatographic step, while a third was required
to achieve sufficient purity for NMR spectroscopy. The amounts purified ranged from ~
100–200 µg. Each analogue also contained its corresponding 37-epimer (~ 2–15%) as
recently reported.23 Sufficient purity for the cytotoxicity assay was achieved for all
AZAs except for 7 (purity ~ 63%), which was contaminated with 5 and another hitherto
unreported AZA (~ 20%) with a molecular mass of 825 Da, which was also detected in
the initial hepatopancreas extract. Compounds 4, 5, 6, 8 and 10 all had purities
(including the 37-epimers) of > 95%, while 9 had a purity of 89%.

6.4.1. Structure determination
The AZAs isolated in this study showed typical AZA fragmentation patterns – a
molecular ion, retro Diels Alder (RDA) and m/z 362 fragments, all of which appeared in
clusters, indicative of several H2O losses. Structure assignments for 4 and 5 have been
published based on 1H NMR, fast atom bombardment (FAB) MS21 and high resolution
MS/MS.12 The data showed C-3 and C-23 hydroxylation for 4 and 5, respectively.
These analogues were suggested to be bioconversion products of 3.25
Postulated structures for 7–10 have been published based solely on high resolution
MS/MS. Compounds 7 and 9 were proposed to be hydroxylated at C-3.12 C-3 hydroxy
analogues show fragments within the molecular ion cluster indicative of a loss of CO2
followed by several H2O losses. The presence of a fragment peak at m/z 408 strongly
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suggested hydroxylation at C-23 for 8 and 10.12 Analogues 7 and 8 are proposed to be
bioconversion products of 1, while 9 and 10 are believed to be bioconversion products
of 2.25 The MS/MS data in this study supported the previously proposed structures.
LC-MS analysis showed that treatment of 7−10 with periodate yielded C-20–C-21cleavage products at m/z 448.4 for 7 (same for 1 and 2), m/z 464.4 for 8, m/z 434.4 for 9
(same for 3 and 6) and m/z 450.4 for 10 (same for 5).
The analogues were subjected to a thorough series of 1- and 2D NMR experiments to
verify their postulated structures. We also determined

13

C assignments for 4 and 5,

whose structures have previously been based only on 1H NMR data together with
oxidative cleavage of 4 and chiral synthesis of the resulting C-1 to C-4 cleavage
product. This facilitated comparison of a full set of 13C and 1H NMR assignments for 7
and 8–10 (Table 6.1).
Structure elucidation was done using 1- and 2-dimensional homonuclear 1H,
heteronuclear 1H{13C} NMR spectroscopy to assign the 1H and

13

13

C and

C resonances, the

chemical shifts of which were then compared with the published 1H and (for 1–3 and 6)
13

C NMR data for 1–6.19–22 The majority of chemical shifts in Table 6.1 are taken from

1-dimensional NMR spectra but some chemical shifts were taken from 2-dimensional
spectra where necessary due to weak or overlapping signals. All samples inevitably
contained low percentages of the corresponding 37-epimer,23 but this did not interfere
with NMR analyses and is not discussed further. Other minor AZAs were sometimes
present as contaminants in the samples but not at levels sufficient to prevent
spectrometric analysis. 1H NMR assignments for 4 and 5 closely paralleled those of
Ofuji et al.,21 apart from variations23 attributable to the degree of protonation on the
amino group. The

13

C and 1H chemical shifts for the 22-positions of 4, 5 and 9 were

markedly different to those reported for 6 (39.0, and 2.13 (2H) ppm),22 however
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examination of the original data indicates that these signals resonate at 31.5 ppm and at
1.50 and 2.10 ppm. This is in accord with the published NMR data for 3,20 as well as
that presented here for 4, 5, and 9.

In accord with structures previously proposed on the basis of mass spectrometric data,12
NMR spectrometric analysis demonstrated that 4, 7 and 9 were 3-hydroxylated
congeners of 3, 1 and 6, respectively (Figure 6.1). Although it is not possible to
determine the configuration at C-3 from ROESY correlations and coupling constants, 4
has been shown to be 3R-hydroxyazaspiracid-3 by degradation reactions and synthesis
of the degradation products.21 Compounds 7 and 9 showed the same pattern of chemical
shifts (Table 6.1), coupling constants and ROESY correlations as for 4, strongly
suggesting that all three congeners possess the same configuration at C-3. This is
consistent with their biogenesis in mussels via enzymatic oxidations and
decarboxylations of 1 and 2 produced by dinoflagellates.
NMR spectrometric analysis of 5, 8 and 10 showed that these were 23β-hydroxylated
congeners of 3, 1 and 6, respectively (Figure 6.1). The relative configuration of the Erings of 5, 8 and 10 were established from coupling constants (from 1H and SELTOCSY
spectra) and ROESY correlations (Figure 6.2). As 5, 8 and 10 are produced in mussels
by enzymatic oxidations and decarboxylations of 1 and 2 biosynthesized by
dinoflagellates, it follows that their absolute configurations are as shown in Figure 6.1.
Examination of the assignments within Table 6.1, and comparison with NMR
assignments for 1–319,20 and 622 obtained under the same conditions and calibrated
identically, reveals diagnostic effects on chemical shifts arising from the hydroxylations
and methylations of the azaspiracid skeleton. Hydroxylation at C-3 leads to not only to
marked changes in the C-3 and H-3 resonances, but also to significant changes (≥
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~1 ppm for

13

C, ≥ ~0.05 ppm for 1H) to the nearby C-2, C-4, H-2, H-5 and H-six

resonances. Similarly, hydroxylation at C-23 leads to consistent alterations in the
chemical shifts of C-22–C-25 and H-22–H-25 as well as the appended 22- (if present)
and 24-methyl groups in the E-ring. Addition of a methyl group at C-8 also results in
characteristic changes to the C-7–C-9 and H-6–H-9 resonances. Similarly, the presence
or absence of a 22-methyl has characteristic pronounced effects on the chemical shifts
of C-22–C-24 and H-22 and H-23. The previously reported effect attributed to the state
of ionization of the amino group23 is evident in Table 6.1, leading to systematic changes
to most of the resonances of rings F–I (C-35, C-37–C-40, H-29, H-31–H-40, and the 37and 39-methyl groups). This effect is also observable on a number of remote resonances
(H-18, H-19 and the olefinic methylene at C-26), consistent with molecular modelling
and ROESY correlations indicating the F–I-ring-system to be folded over in such a way
that the amino group is near H-19, so that 1, 2,23 4, 5 and 7–10 all showed ROESY
correlations between H-19 and H-40eq. Knowledge of these consistent substituent
effects on the AZA skeleton will be helpful during NMR structure analysis of other
AZA congeners and metabolites.
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Figure 6.2. Structures for the E-rings of 5 (top) and 8 (bottom), showing dispositions of
substituents. Observed 1H-1H coupling constants, and correlations (arrows) observed in
the ROESY NMR spectra, are also shown.
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Table 6.1. NMR Assignments for 4, 5 and 7−10 in CD3OH.
Position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

4
13

C

179.9
45.3
70.4
135.0
130.5
71.8
129.0
123.4
35.8
107.1
33.2
37.6
111.3
30.9
32.7
77.9
73.3
38.4
79.8
80.2
97.9
31.9
29.4
39.5
80.6

5
1

H

2.32, 2.36
4.42
5.77
5.67
4.86
5.67
5.74
2.12, 2.48
1.65, 2.31
1.96, 2.15
2.01
1.74, 1.83
3.92
4.18
1.99, 2.06
4.41
3.29
1.51, 2.11
1.58, 1.62
1.33
3.96

13

C

181.7
38.5
30.4
133.9
130.6
72.5
129.4
123.2
35.7
107.2
33.2
37.5
111.3
31.0
32.6
78.0
73.1
38.2
79.4
79.3
99.5
38.5
71.1
45.5*
74.1

7
1

H

2.23, 2.23
2.32, 2.32
5.75
5.43
4.79
5.64
5.73
2.11, 2.47
1.63, 2.32
1.95, 2.13
2.00
1.75, 1.83
3.90
4.20
2.00, 2.00
4.38
3.49
1.80, 2.29
3.93
1.48
4.35

13

C

179.7
45.3
70.5
135.0
130.5
71.8
129.0
123.4
35.8
107.1
33.2
37.6
111.3
30.9
32.7
78.0
73.1
38.7
79.3
77.3
99.8
36.1
38.7
42.0
79.7

8
1

13

H

C

2.32, 2.36
4.43
5.77
5.68
4.86
5.66
5.74
2.13, 2.48
1.65, 2.31
1.96, 2.15
2.03
1.75, 1.83
3.90
4.19
2.00, 2.04
4.41
3.48
2.28
1.41, 1.41
1.36
3.92
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181.6
38.5
30.4
133.9
130.6
72.5
129.5
123.2
35.7
107.2
33.2
37.5
111.3
31.0
32.6
78.2
73.2
37.9
78.9
76.7
102.2
40.0
76.5
46.7
73.6

9
1

H

2.23, 2.23
2.33, 2.33
5.75
5.43
4.79
5.64
5.72
2.12, 2.48
1.64, 2.33
1.96, 2.13
2.01
1.76, 1.83
3.89
4.22
2.00, 2.00
4.38
3.77
2.18
3.60
1.49
4.33

13

C

179.9
45.2
70.5
134.7
131.0
72.0
122.6
131.2
40.4
107.4
33.3
37.5
111.2
31.0
32.7
77.9
73.1
38.4
79.6
80.2
97.8
31.9
29.4
39.5
80.5

10
1

H

2.32, 2.36
4.42
5.75
5.65
4.79
5.37
1.98, 2.42
1.64, 2.32
1.97, 2.16
2.00
1.73, 1.82
3.91
4.16
2.00, 2.06
4.41
3.30
1.51, 2.11
1.58, 1.62
1.33
3.96

13

C

181.5
38.6
30.4
133.6
131.0
72.7
123.1
131.0
40.4
107.4
33.3
37.4
111.2
31.0
32.6
78.0
73.1
38.2
79.3
79.4
99.5
38.5
71.1
44.5
74.1

1

H

2.22, 2.22
2.32, 2.32
5.72
5.40
4.72
5.34
1.96, 2.42
1.63, 2.32
1.96, 2.15
1.99
1.73, 1.82
3.90
4.17
2.01, 2.01
4.38
3.50
1.80, 2.28
3.93
1.48
4.36
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26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
14-Me
22-Me
24-Me

147.2
48.5
98.0
44.3
26.7
35.8
72.7
79.3
75.6
43.1
95.9
37.9
40.0
31.7
47.8
16.7
18.2

0.819

14.7

0.918

148.0
49.3
98.0
44.8
26.7
35.9
72.9
79.4
75.5
43.0
96.0
37.7
39.9
31.8
47.5
16.7
16.5
18.1

26=CH2

116.1

5.14, 5.22

117.1

5.21, 5.35

30-Me
37-Me
39-Me
8-Me

23.9
16.1
19.5

0.928
0.860
0.855

23.6
15.7
18.9

0.952
0.929
0.921

2.17, 2.36
1.33, 1.98
2.24
1.48, 1.77
4.24
3.72
4.80
1.90, 2.38
1.74
1.14, 1.54
1.66
2.51, 2.57
0.938

147.6
48.9
98.5
44.2
26.5
35.5
72.8
79.3*
75.2
42.2*
96.4
36.5*
38.2*
30.8*
46.2*
16.6

2.23, 2.42
1.37, 2.05
2.25
1.52, 1.82
4.33
3.93
4.94
2.29, 2.52
1.88
1.24, 1.63
1.83
2.74, 2.74
0.941

1.74
1.14, 1.53
1.65
2.48, 2.52
0.942
0.890
0.813

148.0
49.3
98.6
44.3
26.4
35.4
72.9
81.2
75.0
41.8
96.5
36.0
38.0
29.6
46.3
16.6
13.7
14.9

18.2

0.818

14.7

0.917

115.3

5.09, 5.25

117.1

5.20, 5.39

116.1

5.14, 5.23

117.0

5.21, 5.35

23.8
16.1
19.4

0.929
0.855
0.850

23.5
15.5
18.7

0.958
0.952
0.940

23.9
16.1
19.5
23.0

0.929
0.860
0.862
1.70

23.7
15.7
18.9
23.0

0.951
0.927
0.922
1.69

2.15, 2.35
1.30, 1.97
2.24
1.47, 1.77
4.23
3.72
4.79
1.90, 2.38
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2.24, 2.43
1.36, 2.06
2.24
1.52, 1.83
4.35
4.01
4.99
2.42, 2.56
1.93
1.27, 1.65
1.88
2.77, 2.82
0.944
1.097
0.924

147.1
48.5
98.1
44.4
26.7
35.8
72.7
79.4
75.6
43.1
95.9
37.9
40.0
31.7
47.8
16.7

2.17, 2.36
1.33, 1.98
2.25
1.48, 1.78
4.24
3.72
4.80
1.90, 2.39
1.75
1.14, 1.54
1.66
2.51, 2.57
0.927

147.5
48.9
98.5
44.2
26.5
35.5
72.8
79.7
75.2
42.1
96.4
36.5
38.6
30.3
46.3
16.6

2.23, 2.42
1.37, 2.05
2.25
1.51, 1.81
4.33
3.93
4.94
2.11, 2.52
1.88
1.24, 1.63
1.83
2.74, 2.74
0.930
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6.4.2. Relative molar response
For the AZAs studied, differences in response factors were less significant in selected
ion monitoring (SIM) mode under isocratic conditions (Table 6.2). In LC-MS/MS the
mobile phase composition can influence the ionization efficiency; therefore analysis
under isocratic conditions produces more accurate results. The response factor for 6 was
very similar to that of 1. Given that 6 differs from 1 only by the position of a methyl
group, this is not surprising. All the hydroxylated AZAs gave lower response factors,
with 7, 9 and 10 being the lowest at ~ 0.5.
The data shows that the SRM transition selected for analysis of all the AZAs, including
6, can significantly impact quantitation when using 1 as a calibration standard (Table
6.2). The H2O loss transition for 6 was similar to that of 1; however the RDA cleavage
of the A-ring resulted in significantly higher response factors under both isocratic and
gradient conditions. For all the other AZAs, the differences in SRM mode were even
greater. The results suggest that, in the absence of standards for the hydroxylated
analogues, quantitation will be most accurate in SIM mode under isocratic conditions.
Even so, the concentration of hydroxylated AZAs may be significantly underestimated
when AZA1 alone is used as the only analytical standard (Table 6.2).
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Table 6.2. Relative (to 1) molar responses of 4–10 by LC-MS/MS under acidic
conditions.
AZA

SIM

SRM isocratic

SRM gradient

isocratic

gradient

H2O loss

RDA

362

H2O loss

RDA

362

4

0.88

0.75

0.80

0.81

0.86

0.96

0.96

1.03

5

0.77

0.70

0.55

0.47

0.47

0.61

0.54

0.53

6

0.95

0.93

1.06

1.21

1.17

1.05

1.21

1.13

7

0.45

0.40

0.37

0.33

0.37

0.40

0.37

0.40

8

0.84

0.81

0.58

0.41

0.47

0.59

0.47

0.51

9

0.53

0.49

0.45

0.48

0.61

0.50

0.53

0.68

10

0.49

0.48

0.34

0.33

0.35

0.34

0.35

0.36

6.4.3. Toxicology
All available AZA analogues tested were cytotoxic to Jurkat T lymphocyte cells in a
time- and concentration-dependent manner (Figure 6.3). However, there were distinct
differences in the relative potencies of each analogue as revealed by their EC50 values
(Table 6.3). The range of EC50 values for the eight analogues tested in this study were
0.1 to 3.07 nM, a 31-fold range. Based on the EC50 values, the relative potencies were:
227 > 6 > 8  327 > 1 > 4  5  9 >10. Impurities in 7 prevented it from being subjected
to the Jurkat cell assay.
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A

125

Cell Viability, %

Cell Viability, %
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-6
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125

100
75
50
25

-7

-6

-5

D

75
50
25
0

Control -12 -11 -10

-9

-8

-7

-6

-5

Control -12 -11 -10

AZA6 concentration (log M)

-9

-8

-7

-6

-5

AZA8 concentration (log M)

E

Cell Viability, %

Cell Viability, %

-8

100

0

125

-9

AZA5 concentration (log M)

Cell Viability, %

Cell Viability, %

125

B

100
75
50
25

125

F

100
75
50
25

0

0
Control -12 -11 -10

-9

-8

-7

-6

-5

AZA9 concentration (log M)

Control -12 -11 -10

-9

-8

-7

-6

-5

AZA10 concentration (log M)

Figure 6.3. Effect of various AZA analogues on T lymphocyte cell viability. Jurkat T cells
were exposed to various concentrations of (A) AZA4 (4), (B) AZA5 (5), (C) AZA6 (6), (D)
AZA8 (8), (E) AZA9 (9), and (F) AZA10 (10) for 24, 48, or 72 h and viability was assessed
using the MTS assay. All data (mean ± SE; n=3–5) were normalized to the control (10%
MeOH vehicle). Non-linear, three parameter dose-response (variable slope) analysis was
performed and EC50 values were calculated (Table 6.3).
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In the present study, the AZAs tested represented differing sites of methylation, and
hydroxylation. Collectively, SAR analysis using these data and published data for 2 and
326 suggest that AZA potency was somewhat increased by methylation at C-8 and/or C22 (i.e., 2, 6) whereas potency was reduced somewhat by hydroxylation at C-3 and/or
C-23 (i.e., 4, 5) (Table 6.3, Figure 6.3). These findings allow us to speculate on the
relative potencies of other analogues such as AZA12 (predicted to have relatively higher
potency) and AZA13 (predicted to have relatively lower potency) based on their
structures. Interestingly, reduced potencies of 4 and 5 relative to 1 in the Jurkat cell
assay are the same as those determined by intraperitoneal injection in mice.21 The utility
of this in vitro cytotoxicity assay for relative analogue potencies (i.e., TEFs) are further
corroborated by previous in vitro and in vivo studies whereby both techniques also
clearly demonstrated increased potencies of 2 and 3 relative to 1.19,20,26 However, recent
in vivo studies (mouse intraperitoneal and mouse oral) showed that 1 is more toxic than
2 (mouse intraperitoneal  oral; TEF = 0.6−0.7) and 3 (mouse intraperitoneal = oral;
TEF = 0.5).9 Furthermore the toxicity of 6 was determined by mouse intraperitoneal for
the first time and was found to be less toxic (TEF = 0.7) than 1.9 Although the reason
for this discrepancy is unknown at this time, the highest credence should be
acknowledged to oral in vivo studies. However, these experiments are logistically
difficult to perform due to the high mass of toxins needed. Hence, further studies should
be conducted to isolate more of the minor analogues to conclusively clarify their
toxicological importance.
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Table 6.3. Calculated EC50 values (nM) with 95% Confidence Intervals (CI) and
relative potencies (Rel. Pot.) for AZA analogues based on T lymphocyte cytotoxicity.
AZA

24 h

48 h

72 h

Mean

Rel.

EC50

95% CI

EC50

95% CI

EC50

95% CI

EC50

Pot.

1

0.96

0.19–4.9

1.10

0.46–2.5

1.3

0.59–3.0

1.1

1.0

4

2.1

0.31–15

2.1

0.97–4.4

1.9

1.0–3.5

2.0

0.55

5

2.7

0.48–15

3.4

1.7–6.9

2.8

1.6–4.7

3.0

0.38

6

0.1

0.026–0.41

0.18

0.083–0.37

0.2

0.079–0.49

0.16

7.0

8

0.27

0.060–1.2

0.25

0.12–0.51

0.22

0.12–0.40

0.25

4.5

9

2.2

0.66–7.4

1.7

0.95–3.0

1.7

1.1–2.6

1.87

0.4

10

2.9

1.20–6.8

3.2

2.1–4.8

3.1

1.8–5.5

3.07

0.2

6.4.4. Analysis of cooked shellfish
Compounds 3, 4, 6 and 9 are produced by heat-induced decarboxylation of AZA17, -21,
-19 and -23 respectively, and are not normally present in significant amounts in
uncooked mussels.27 As 5 and 10 are proposed to be direct bioconversion products of 3
and 6 respectively,25 these compounds also would not be present in significant amounts
in uncooked shellfish. The analysis of cooked shellfish most accurately reflects what is
ingested by the consumer, and additional differences have been reported between the
analysis of raw and cooked shellfish (M. edulis) in terms of concentration levels.28 To
determine the relative importance of 1–10, raw shellfish contaminated with AZAs were
heated to simulate cooking (with no water loss). LC-MS analysis with quantitative
standards showed that 1–3 (regulated) and 6 (not regulated) were the predominant
toxins in cooked mussels (Figure 6.4), however in some samples levels of 4 were higher
than 6 (Table 6.5 and Figure 6.5). Levels of the metabolites were very variable, possibly
due to differing rates of shellfish metabolism25,29 and time of harvesting i.e., mussels
harvested directly following an intense bloom will likely have higher levels of 1 and 2
than if they were harvested some time after the bloom (due to metabolism). The average
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levels of the remaining analogues relative to 1 were low; 4, 5 and 8 were each ~ 5%,
while 7, 9 and 10 were each under 1.5%, however there was huge variation and in some
samples these analogues were present in significant amounts, particularly for 4, 5 and 8.

160

10.0

140

8.0
6.0

120

%

Proportions (%) relative to AZA1

(Figure 6.4 and Table 6.5).

4.0
100

2.0

80

0.0
7

60

8

9

10

40
20
0
1

2

3

4

5

6

7

8

9

10

AZA analogue

Figure 6.4. Proportions of 2–10 relative to 1 in cooked M. edulis (mean ± standard
deviation; n=40), see Table 6.5.

The feeding study (of M. edulis with A. spinosum) performed by Jauffrais et al25 showed
that metabolism of 1 and 2 to AZA17 and -19, respectively is observed after 3 h with
levels of these analogues increasing up to 2 days and then remaining constant up to the
end of the experiment (4 days). Relative to 1 the proportions of AZA17 and -19 reached
a maximum of 145% and 55% respectively while the analogues 4, 5 and 7–10
accounted for ~ 58%. However, these studies were performed under laboratory
conditions and the high levels of AZA accumulation observed in real life samples could
not be replicated.
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In this study levels of 5 and 10 increased significantly (Figures 6.5 and 6.6) after heat
treatment suggesting that they are predominantly bioconversion products of AZA17 and
-19 i.e., decarboxylation (at C-22) of hydroxylated (at C-23) AZA17 and -19. In the
heating process enzymes responsible for hydroxylation would have been destroyed,
hence it is unlikely that the observed increase in 5 and 10 levels were due to
hydroxylation of 3 and 6 respectively.
Biotoxin monitoring programs operated under the EU regulatory framework must
analyse raw shellfish, and typically very low levels of 3 and 6 (if monitored) are
detected in such samples.4 However, in the heat treated mussels, levels (relative to 1) of
3 ranged widely from 11–501%, (Figure 6.4 and Table 6.4). Similarly levels (relative to
1) of 6 ranged from 3–170% (Figures 6.4 and 6.5). In this study 6 was found to be 7fold more potent than 1 while a mouse oral study found it to be only slightly less toxic
than 1.9 These results highlight the degree to which AZA-toxicity can be underestimated
in routine monitoring programs where raw mussels are tested, and suggest that 6 should
be included in the regulation of these compounds. Previously, levels of AZA analogues
other than 1–3 were reported to comprise less than 5%,12 however this study indicates
that the analogues 4–10 comprise on average 13% (ranging from 5% to 24%) of the
total AZAs (1–10) in cooked shellfish. Different toxin profiles have been reported from
other countries, where 2 is more predominant than 117,30−32 and the shellfish from these
locations are thereby more likely to contain higher levels of 6, 10 and possibly 9, and in
such circumstances these analogues may have greater significance.
Many samples analysed as part of the Irish monitoring program which were below the
regulatory limit (and subsequently marketed with no reports of human intoxications),
would have been above the limit had the tissues been cooked prior to analysis (Table
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6.4). This suggests that the current regulatory limit may be sufficiently low for the
prevention of the acute illness associated with this toxin group.

3

1

2

6
m/z 856.5

4

m/z 842.5

9 7 810
5

m/z 828.5
m/z 858.5
m/z 844.5
2.0

2.5

3.0

3.5

4.0

4.5

5.0

Time (min)

Figure 6.5. Analysis (method F) of a cooked M. edulis sample extract (from the Marine

Azaspiracid analogue

Institute biotoxin monitoring programme) showing peaks for AZA1–10.

Uncooked
M. edulis

Cooked
M. edulis

% relative (to 1) proportions

Figure 6.6. Proportions of 2–10 relative to 1 in uncooked and cooked M. edulis (n=40).
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Table 6.4. Measured concentrations of 1−3 and 6 in Irish M. edulis samples before and after cooking.
Harvesting location

Harvesting

(Irish Atlantic

date

coast)

Raw

Cooked

1

2

3

6

*AZA

1

2

3

6

*AZA

AZA equiv.

(µg/g)

(µg/g)

(µg/g)

(µg/g)

equiv.

(µg/g)

(µg/g)

(µg/g)

(µg/g)

equiv.

including

(1−3)

(1−3)

AZA6 (no

(µg/g)

(µg/g)

TEF)
(µg/g)

West

26/09/2012

0.06

0.02

0.00

0.00

0.10

0.06

0.02

0.07

0.02

0.18

0.20

Southwest

27/09/2012

0.16

0.04

0.01

0.00

0.24

0.16

0.04

0.06

0.01

0.30

0.31

Southwest

27/09/2012

0.10

0.02

0.00

0.00

0.15

0.10

0.02

0.04

0.01

0.20

0.21

Northwest

27/09/2012

0.04

0.01

0.00

0.00

0.07

0.04

0.02

0.07

0.02

0.17

0.19

West

24/09/2012

0.22

0.05

0.01

0.00

0.33

0.20

0.05

0.12

0.03

0.48

0.51

West

24/09/2012

0.12

0.03

0.00

0.00

0.18

0.10

0.03

0.07

0.02

0.24

0.26

Southwest

24/09/2012

0.11

0.03

0.00

0.00

0.16

0.09

0.02

0.04

0.01

0.18

0.19

West

24/09/2012

0.03

0.01

0.01

0.00

0.07

0.03

0.02

0.14

0.04

0.25

0.29

Southwest

26/09/2012

0.08

0.02

0.00

0.00

0.12

0.08

0.02

0.03

0.00

0.16

0.17

West

24/09/2012

0.02

0.02

0.01

0.00

0.06

0.03

0.02

0.08

0.02

0.18

0.20

*AZA equivalents calculated following application of the toxic equivalent factor for 2 (1.8) and 3 (1.4) relative to 1.
Red indicating areas where there is significant change.
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Table 6.5. Proportions (%) of 2–10 relative to 1 (method F) in cooked M. edulis (n=40) harvested off the Atlantic
coast of Ireland.
Harvesting Harvesting
location
date
West
10/12/2013
Southwest 09/12/2013
Southwest 09/12/2013
Southwest 09/12/2013
Northwest 09/12/2013
Northwest 24/10/2013
Southwest 23/10/2013
Southwest 23/10/2013
West
22/10/2013
Southwest 22/10/2013
Southwest 21/10/2013
Northwest 21/10/2013
Southwest 21/10/2013
West
21/10/2013
West
21/10/2013
Southwest 21/10/2013
Southwest 21/10/2013
Northwest 17/10/2013
Southwest 15/10/2013
#
Southwest 15/10/2013
Northwest 14/10/2013
Southwest 14/10/2013
Southwest 13/10/2013
Southwest 01/11/2012
Southwest 27/09/2012
Southwest 27/09/2012
Northwest 27/09/2012
West
26/09/2012
Southwest 26/09/2012
Southwest 24/09/2012
West
24/09/2012
Southwest 24/09/2012
West
24/09/2012
West
24/09/2012
West
24/09/2012
Northwest 24/09/2012
West
27/08/2012
Southwest 22/09/2011
Southwest 17/11/2009
Southwest 22/07/2008
Avg %
stdev

2

3

4

5

6

7

8

9

10

23.2
24.6
19.6
21.4
18.0
30.8
27.2
23.9
27.2
21.9
29.2
27.8
23.8
21.2
22.9
25.2
26.3
29.2
28.6
35.6
30.2
27.1
32.1
25.0
26.8
31.0
44.7
33.9
23.3
22.2
21.7
23.6
32.4
78.8
70.3
49.7
26.9
32.1
10.9
28.0
29.4
12.3

15.2
17.4
35.5
33.2
45.0
34.5
29.6
32.8
22.1
26.5
34.9
29.7
27.1
26.4
14.1
16.6
41.2
34.1
46.4
96.7
43.4
21.2
60.2
10.5
30.6
41.6
204.1
114.4
37.3
36.8
57.0
42.2
78.4
501.5
330.7
127.1
19.2
28.2
30.8
16.6
62.3
90.7

2.8
5.6
5.2
5.5
6.7
7.5
12.9
2.5
2.4
6.6
12.2
6.0
6.1
3.2
2.0
1.0
5.4
7.6
13.5
26.5
10.2
8.3
17.1
0.9
1.7
0.0
0.0
2.2
0.4
0.6
0.0
0.6
2.4
0.2
0.0
0.5
0.7
1.5
4.5
7.9
4.9
5.5

4.0
2.9
4.9
4.9
5.1
2.8
3.1
2.5
2.8
2.6
2.9
1.9
2.1
4.8
2.2
1.3
3.5
2.5
3.7
5.4
3.1
2.1
3.9
1.7
2.6
3.9
11.1
6.7
3.7
3.2
5.4
5.1
8.1
21.2
9.8
12.4
1.3
2.1
4.7
1.7
4.5
3.7

4.9
3.3
8.4
8.6
12.4
6.3
6.9
5.5
6.1
5.9
6.7
5.8
6.0
7.5
4.0
2.9
9.5
6.0
8.7
23.2
8.9
5.2
14.4
2.8
6.9
10.0
67.3
30.3
10.9
11.9
17.5
10.7
19.1
170.2
103.1
55.6
4.8
6.4
9.3
3.6
18.0
31.0

0.0
1.5
0.3
1.0
2.2
0.4
0.6
0.0
0.0
0.5
0.8
0.8
0.5
0.2
0.3
0.0
1.0
0.4
0.4
1.4
0.7
0.5
0.9
0.8
0.6
0.0
0.0
1.6
0.4
3.0
1.2
0.7
0.0
0.0
0.0
0.0
0.3
0.3
0.0
0.3
0.6
0.6

1.3
2.4
2.1
2.1
1.6
2.2
3.8
1.9
2.1
3.6
5.3
2.3
2.6
1.4
1.3
1.2
4.2
2.6
5.3
8.3
4.1
2.8
7.1
1.1
2.3
1.5
12.6
0.9
1.9
1.6
1.9
1.9
3.3
27.0
19.5
13.0
1.0
3.1
0.0
1.8
4.1
5.3

0.8
1.2
1.1
0.1
0.3
1.4
3.4
0.0
0.2
1.5
3.1
1.3
1.9
1.3
0.1
0.0
0.6
2.1
3.3
7.6
1.6
3.0
4.7
0.0
0.9
0.0
0.0
0.0
0.7
0.0
0.1
0.1
0.0
0.0
1.7
0.9
0.0
0.0
0.0
1.8
1.1
1.6

0.5
0.5
1.6
1.0
2.3
0.7
0.6
0.6
0.0
0.8
1.1
0.5
0.7
1.7
1.0
0.8
1.4
0.6
1.1
2.0
0.8
0.7
1.1
0.6
1.1
1.2
0.0
6.9
2.5
2.4
3.7
2.6
0.0
0.0
0.0
0.0
0.9
0.4
0.0
0.7
1.2
1.3

*AZA equiv.
(µg/g)
0.63
1.72
0.38
0.39
0.21
1.04
1.44
0.41
0.19
0.32
1.10
0.91
0.94
0.31
0.52
0.54
0.37
0.85
0.89
0.70
0.98
1.75
1.05
0.99
0.44
0.15
0.07
0.10
0.12
0.20
0.33
0.16
0.18
0.07
0.06
0.06
2.50
0.27
0.30
4.80

* Values for raw shellfish, AZA equivalents calculated following application of the toxic equivalent factor for 2 (1.8) and 3
(1.4) relative to 1.
#
See Figure 6.5 for chromatogram.
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6.5.

Conclusions

Compounds 4–10 were purified from shellfish, with the structures of 7–10 being
elucidated for the first time by NMR, which confirmed the previously postulated
structures based on LC-MS/MS studies. qNMR was performed on all purified samples
and subsequent LC-MS relative molar response factors and cytotoxicity were
determined. Differences in the LC-MS molar responses relative to 1 were observed,
particularly for the hydroxylated analogues (up to 3-fold). Greatest accuracy was
achieved by analysis in SIM mode under isocratic conditions. Combining all the
cytotoxicity data published to date for AZAs using the Jurkat T lymphocyte cell assay,
the order of potencies are: 2 > 6  AZA3415  37-epi-123 > 8  3 > 1 > 4  9 > 5  10 >
AZA33.15 Analysis of heat-treated mussels from Ireland that were naturally
contaminated with AZAs revealed high levels of 3 and 6. These compounds were not
present at significant levels in the raw shellfish, highlighting the fact that AZA
equivalent values for raw mussels grossly underestimate the toxicity of the AZAs
present. Not only do these results suggest that tissues should be heat-treated prior to
analysis, but also that 6 should be included in the regulations to more accurately reflect
the toxin profile of to which shellfish consumers are exposed. Levels of analogues 4, 5
and 7–10 were low in Irish mussels, and did not contribute significantly to overall
toxicity, although the situation may be different for other shellfish varieties. However,
in areas where 2 is the predominant AZA analogue, 6, 9 and 10 will most likely have
more relevance than in Irish mussels. This study further suggests that the current
regulatory limit may be sufficiently low for protection of human health from acute AZA
intoxication from Irish mussels.
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CONCLUSIONS AND FUTURE WORK
7.1.

Conclusions

Matrix effects were assessed on two LC-MS/MS instruments – a TSQ and a QToF.
Matrix interferences were observed on both instruments but interestingly the type of
interferences were quite different despite the fact that there were no differences in the
type of source (ESI) nor in the methods of analysis (one theory is that matrix
interferences occur in the source). Matrix suppression was observed for the AZAs on
the TSQ (with the degree of suppression changing between shellfish varieties), while
matrix enhancement was observed for OA on the QToF. The matrix suppression on the
TSQ was overcome by changing the pH of the mobile phase from acidic (pH = 2.5) to
alkaline (pH = 11) but also by extending the run time such that the column could be
flushed with organic solvent to flush out any late eluting compounds. The matrix
enhancement on the QToF was eliminated by the use of an on-line SPE method and by
the use of matrix matched standards (since there was no significant difference in matrix
effect between shellfish varieties). These methods were implemented in the routine
monitoring programme at the MI to ensure accuracy of results being reported.
An isolation procedure from shellfish was adapted and improved such that recoveries
increased ~ 2-fold. Using this procedure AZA6, 37-epi-AZA1 and AZA7−10 were
isolated, subsequently characterised and assessed for toxicity for the first time. The
previously proposed structure for AZA6−10, based on LC-MS/MS analysis, was
confirmed by NMR.
A method was further developed for the isolation of AZAs from bulk cultures of A.
spinosum. Using this method the novel AZAs, AZA33 and -34 were purified,
characterised and assessed for toxicity.
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Using the purified AZAs isolated as part of this PhD both in vitro and in vivo toxicity
studies were performed (as part of the ASTOX 2 project) confirming AZA toxicity. The
results from the oral and intraperitoneal mice studies correlated very well, contradicting
previous reports and showing that AZA1 is more toxic than AZA2 (TEF = 0.6) and -3
(TEF = 0.5). An in vivo (mouse intraperitoneal) study was additionally performed for
AZA6 and it was found to be slightly less toxic than AZA1 (TEF = 0.7). Additional
studies looking at the combined effects of AZA1 with OA and YTX showed that there
is no increased toxicity when these groups co-occur.
In vitro toxicity analysis was performed using the Jurkat T lymphocyte cell assay (Table
7.1) and demonstrated the following potencies: AZA2 > AZA6 > AZA34  37-epiAZA1 > AZA8  AZA3 > AZA1 > AZA4  AZA9 > AZA5  AZA10 > AZA33. The
results indicate AZA potency is gained by methylation of C-8 and/or C-22 (AZA2, -6, 8) while AZA potency is reduced by C-3 and/or C-23 hydroxylation (AZA4, -5, -9, 10).
AZA33 (AZA1 missing A/B/C rings) was less potent than AZA1 (~5-fold), whereas
AZA34 (AZA1 missing C-4/C-5 alkene) was 5.5-fold more potent. Similarly, 37-epiAZA1 was 5.1-fold more potent than AZA1.
In addition to the above mentioned analogues, AZA1–3 were also purified in sufficient
quantities for the preparation of CRMs (to ensure a sustained supply). Bulk culturing of
the producing organisms and improvements in isolation procedures have enabled more
effective purification of a range of AZA analogues. In this study reference standards
were prepared for 16 AZA analogues (Table 7.1) enabling the relevance of these
analogues to be established, in terms of proportions and toxicity. Proportions were
determined in AZA contaminated shellfish that were submitted to the biotoxin national
monitoring programme. Previous studies showed that levels of AZA3, -4, -6 and -9 can
increase when shellfish are cooked due to decarboxylation of AZA17, -21, -19 and -24
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respectively. These results were confirmed in this study. Levels of AZA3 and -6 ranged
widely probably due to the different rates of AZA1 and -2 metabolism (oxidation of
methyl at C-22 to produce the carboxy analogues AZA17 and -19 respectively) in the
mussels tested. However, in some samples the proportions of AZA3 and -6 were 3-fold
those of AZA1 and -2 respectively. These results highlight the degree to which AZA
equivalents are underestimated in routine monitoring programs where uncooked
shellfish are tested, and suggest that AZA6 should be included in the AZA regulation.
Levels of the 37-epimers were also found to be significant in terms of human health
protection.

7.2.

State of the art

Over the course of the ASTOX 2 project ten additional Azadinium and related species
have been identified from samples taken from European (Ireland, Britain, Scandinavia,
Iceland, Greenland, Italy), Asian (China, Korea) and South American (Argentina)
waters. Some of these species are producers of novel AZAs, whilst others do not appear
to produce any AZAs. Interestingly, different strains of the same species (A. poporum)
were found to have very different toxin profiles, some producing novel AZAs, whilst
others were found to produce either known AZAs or none at all. During the project a
molecular probe was developed capable of detecting and distinguishing between A.
spinsoum, A. obesum and A. poporum. These probes currently contribute to the
monitoring programme at the Marine Institute, enabling effective detection and
forecasting of blooms which otherwise are difficult to detect.
Feeding studies performed as part of the ASTOX 2 project with A. spinosum showed
that mussels will feed directly on these organisms with no requirement for a vector
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species. Mussels reached the regulatory limit after 5 days; however, the high
concentrations observed in the wild could not be replicated under laboratory conditions.
This may indicate: (i) that vectors are required to facilitate shellfish toxin accumulation
(e.g., Favella ehrenbergii which has been shown to actively feed on A. spinosum); (ii)
longer term feeding trials are required or (iii) other variables, as yet unknown,
contribute to high uptake of toxins. The laboratory studies also showed that A. spinosum
has a negative effect on shellfish in terms of mortality rates, feeding behaviour and
physiology. Additionally, these studies showed that mussels take up AZAs from the
dissolved phase and therefore the release of AZAs from decaying blooms may also have
consequences for other species, not normally associated with these toxins.
Both calibrant and tissue CRMs are available for AZA1–3, which were produced as part
of the ASTOX project. Replacement stocks have recently been prepared to keep with
demand using the purified toxins produced as part of this thesis.
The heat-induced transformation of AZA17 and -19 into AZA3 and -6, respectively,
was confirmed in the project. Using the RMs produced, the relevance of some of the
minor and novel AZAs were determined, highlighting AZA6 as a potential significant
contributor to overall toxicity. The other purified analogues for which RMs were
prepared were found to be of less significance. The importance of other novel AZA
analogues identified in the project, such as those which lack a methyl group in the
amino ring, have yet to be established.
The in vitro and in vivo toxicity studies performed to date confirm AZA toxicity.
Studies on mini pigs showed that these animals are less susceptible to AZAs than
humans, and that AZAs cross the intestinal barrier and distribute throughout the body
causing internal organ damage at cellular and tissue levels. The results from the oral and
intraperitoneal mice studies carried out as part of the ASTOX 2 project correlated very
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well, contradicting previous reports and showing that AZA1 is more toxic than AZA2
and -3. These results were reflected in the analysis of the mini pig blood samples that
showed AZA1 is most rapidly taken up into the blood, followed by AZA2 and then -3.
Studies looking at the combined effects of AZA1 with OA and YTX showed that there
is no increased toxicity when these groups co-occur. The in vitro studies were
effectively used to assess the toxicity of the minor analogues and demonstrated the
following potencies: AZA2 > AZA6 > AZA34  37-epi-AZA1 > AZA8  AZA3 >
AZA1 > AZA4  AZA9 > AZA5  AZA10 > AZA33  AZA36 > AZA37 > AZA26.
The mode of action of AZAs has remained elusive for some time. Recent studies by
Twiner et al have shown that AZAs are potassium channel blockers, however the
concentrations required to induce such effects are 2-fold those required to cause
cytotoxicity and therefore this is not considered to be the primary mode of action.
Hence other modes of action need to be explored and it is likely that the various
analogues may exhibit unique modes of action and/or receptors.

7.3.

Future work

Although much has been learned about this toxin group in recent years thanks to
projects such as ASTOX and ASTOX 2, there still remains many unanswered questions
and ongoing research. Future work should focus on the following areas to protect the
shellfish industry and allow relevant authorities to more accurately assess the impacts of
these toxins on human health and the marine environment.



There is a strong need for high quality CRMs as monitoring and research
laboratories move away from animal based assays towards chemical methods of
211

7. Conclusions and future work
analysis. Replacement stocks of the regulated AZAs are now available due to the
work performed as part of this thesis; however, these stocks are limited and
depending on demand may only last a few years. Stocks of RMs are additionally
required for some of the unregulated AZA toxins (e.g., AZA6). This issue is fast
becoming problematic not only due to the increasing intensity and distribution of
these toxic blooms but also due to increasing detection of novel phytoplankton
species producing novel toxins. Future work will include the isolation of these
novel AZAs. The availability of RMs for as many of these analogues as is
possible will enable effective monitoring, the development of rapid assay test
kits, more in depth toxicological studies and determination of the mode of
action.


The development of early warning system for the aquaculture industry and
monitoring laboratories is required to limit losses for the industry. Mapping of
these species using gene probes at sea and development of in situ biosensors will
assist in this process.



An assessment of the relevance of the additional species/toxins to the shellfish
industry and human health is required in terms of shellfish (and other species)
populations and development, prevalence and accumulation in shellfish and
toxic effects on humans.



It is still not fully understood how mussels may become so highly contaminated
in the field. ASTOX 2 studies have shown only limited accumulation occurs
when mussels are fed A. spinosum. Additionally, the shellfish are adversely
affected by this species. Knowledge of feed and environmental factors and what
additional vectors could be involved would aid in developing mitigation
strategies.
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More toxicological and epidemiological data is required. AZAs are suspected
carcinogens; therefore more long term exposure studies need to be performed.
The primary mode of action needs to be determined to enable the development
of an effective antidote.



There is the potential for some of the Azadinium and related species to be
producers of novel compounds with therapeutic effects, potentially with effects
antagonistic to those by AZAs. Full knowledge of their molecular targets may
lead to these compounds having a positive impact.



It is important to know how AZAs behave when consumed i.e., only accounting
for less than 30% of what had been administered following mouse and pig
studies. Studies performed to date have not identified any AZA metabolites in
these animals. Such knowledge will reveal how organisms process and eliminate
AZAs following exposure, with the potential for interspecies extrapolation
(including humans) and may lead to an understanding of the molecular
mechanisms involved.
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Table 7.1. List of AZA analogues purified and characterized, their protonated masses, origin and toxicity.
Left hand side (LHS)

Right hand side (RHS)

1

8
7

a

1

A

3

39

I 37

B

H

23

C D19

20

E

F
30

2

b
c
Type§

R1

7,8

R2

R3

R4

R5

R6

AZA1
a1
H
H
H
CH3
H
CH3
Δ
37-epi-AZA1
a1
H
H
H
CH3
H
CH3
Δ
AZA2
a1
H
CH3
H
CH3
H
CH3
Δ
AZA3
a1
H
H
H
H
H
CH3
Δ
AZA4
a1
OH
H
H
H
H
CH3
Δ
AZA5
a1
H
H
H
H
OH
CH3
Δ
AZA6
a1
H
CH3
H
H
H
CH3
Δ
AZA7
a1
OH
H
H
CH3
H
CH3
Δ
AZA8
a1
H
H
H
CH3
OH
CH3
Δ
AZA9
a1
OH
CH
H
H
H
CH3
Δ
3
AZA10
a1
H
CH
H
H
OH
CH3
Δ
3
AZA26
a2
H
H
Δ
AZA33
b1
H
CH
H
CH
Δ
3
3
AZA34
c1
H
CH3
H
CH3
Δ
§
The type refers to variations of the LHS and RHS parts of the molecule.

[M+H]+
842.5
842.5
856.5
828.5
844.5
844.5
842.5
858.5
858.5
858.5
858.5
824.5
716.5
816.5
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Origin

Status

A. spinosum
A. spinosum
A. spinosum
shellfish
shellfish
shellfish
shellfish
shellfish
shellfish
shellfish
shellfish
shellfish
A. spinosum
A. spinosum

phycotoxin
artefact
phycotoxin
metabolite
metabolite
metabolite
metabolite
metabolite
metabolite
metabolite
metabolite
metabolite
phycotoxin
phycotoxin

Toxicity (Jurkat) EC50
1.1
0.2
0.3
0.6
2.0
3.0
0.2
0.3
1.9
3.1
36.6
5.2
0.2

APPENDIX

1

H NMR spectrum of AZA1 in CD3OD
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1

H NMR spectrum of 37-epi-AZA1 in CD3OD
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1

H NMR spectrum of AZA2

217

1

H NMR spectrum of AZA3
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1

H NMR spectrum of AZA4
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1

H NMR spectrum of AZA5

220

1

H NMR spectrum of AZA6

221

1

H NMR spectrum of AZA7

222

1

H NMR spectrum of AZA8
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1

H NMR spectrum of AZA9
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1

H NMR spectrum of AZA10
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1

H NMR spectrum of AZA33 in CD3OD
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1

H NMR spectrum of AZA34 in CD3OD
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